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INTRODUCTION AND OUTLINE OF THE THESIS

Introduction and outline of the thesis 
1.  Introduction 
 
The poultry industry represents a major segment of the food producing industry and is 
characterized by high density flocks. The latter increases the risk of fast spread of infectious 
diseases within and between flocks, resulting in suffering of animals and economical damage. 
Therefore, the economical success of the poultry industry largely relies on biosecurity, including 
vaccination and hygienic measures, to prevent the outbreak and spread of diseases (Glisson & 
Kleven, 1993; Guittet et al., 1997).  
 
The large number of chickens normally contained in a single flock requires inexpensive mass 
vaccination techniques such as drinking water and spray or aerosol vaccination. For respiratory 
diseases such as Newcastle disease (ND), it is general practice to vaccinate the chickens by 
nebulizing a reconstituted freeze-dried live attenuated vaccine as a coarse spray or fine aerosol 
(for primary and secondary vaccination, respectively). The vaccine virus reaches the mucosa of 
the respiratory system and a mucosal immune response is developed next to a systemic immune 
response (Glisson & Kleven, 1993; Guittet et al., 1997; Sharma, 1999). Although successful, 
several aspects of spray and aerosol vaccination, such as broad droplet size distributions (Cargill, 
1999), inactivation of virus in the reconstituted suspension (Guittet et al., 1997), and evaporation 
of nebulized droplets (Gough & Allan, 1973; Landman & van Eck, 2001; Yadin & Orthel, 1978), 
result in reduced efficiency. Additionally, non-optimal droplet sizes during primary vaccination (i.e. 
droplets inhalable into the lower airways) increase the risk of strong post-vaccination reactions in 
young birds (Gough & Allan, 1973; van Eck & Goren, 1991; Yadin & Orthel, 1978).  
 
It was the aim of this research project to overcome the disadvantages of liquid spray and aerosol 
vaccination by developing a dry powder vaccine with a narrow size distribution which can be 
dispersed as such in the poultry houses (i.e. without reconstitution), and thereby providing a new 
approach to increase efficiency and safety of poultry vaccination. 
 
 
2.  Outline of the thesis 
 
A first step towards an efficient dry powder vaccine is the determination of the optimal particle 
size to target the different sites of the respiratory system. However, only a limited number of 
studies have addressed this issue in chickens and since those studies used anaesthetized 
chickens or submicron particle sizes (which are not representative for spray and aerosol 
vaccination) (Hayter & Besch, 1974; Mensah & Brain, 1982), the first part of this research aimed 
at the development of a method to expose chickens to differently sized microspheres and the 
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setup of a procedure to analyse the deposition site of the microspheres. Once optimised, this 
method was used for the exposure of differently aged chickens to differently sized microspheres 
in order to determine optimal particle size ranges for primary and secondary vaccination. 
 
The optimal particle size ranges obtained in the deposition study were subsequently compared 
with the droplet sizes generated by spray and aerosol generators currently used in field 
applications of poultry vaccination. This allowed to estimate the fraction of non-optimally sized 
droplets and to identify the reasons for reduced efficiency of liquid spray and aerosol vaccination. 
 
Next to the deposition study, the development of the dry powder vaccine was the second 
challenge of this project. The drying method of choice was spray drying, as this allows to produce 
single particles of defined narrow size distribution in a one-step process. This part of the study 
included the development of different spray-dried formulations and the characterization of     
solid-state and particle properties. Afterwards, the survival of an ND vaccine virus during spray 
drying with the different carriers and during storage was evaluated. 
 
Finally, vaccination experiments were performed where the immune response in chickens after 
vaccination with some of the developed dry powder vaccines was compared with the immune 
response obtained with commercial liquid vaccines.  
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Chapter 1
VACCINATION OF POULTRY
Picture: Mass application of vaccines by spray or aerosol
(from ‘Spray Vaccination’ brochure published by Intervet International)

Chapter 1 – Vaccination of poultry 
1.  Introduction 
 
Approximately 200 years after Jenner’s studies on the protection of humans against smallpox by 
inoculation with the cowpox virus, and 130 years after the serendipitous observation of 
attenuation of the fowl cholera bacterium by Pasteur (Bazin, 2003; Davison, 2003; Fenner et al., 
1997), vaccination has shown to be an important technique to support human and veterinary 
health (Bey et al., 1998; Mittal et al., 2002). The poultry industry has become one of the most 
developed segments of food animal production, which was mainly related to the successful 
application of vaccination strategies (Glisson & Kleven, 1993; Guittet et al., 1997). The success 
of vaccination in poultry industry, as in other animal species, has relied for years on killed and live 
attenuated pathogens. However, recently, the implementation of achievements in biotechnology, 
immunology and microbial pathogenesis in vaccine research has led to the development of 
several new vaccines and vaccination techniques (Horzinek et al., 1997; Mittal et al., 2002), 
which are also promising for poultry vaccination.  
 
After a review of the general characteristics of veterinary vaccines and the developments in the 
field, this chapter focuses on specific vaccination techniques and vaccination programs in poultry 
industry. Moreover, as an attenuated Newcastle disease (ND) virus has been used to develop the 
dry powder vaccine in this thesis, a further part of the chapter discusses Newcastle disease and 
its prevention. Finally, the rationale for a dry powder vaccination and some aspects about the 
development of a dry powder vaccine are given. 
 
 
2.  Veterinary vaccination 
 
2.1.  Aims and requirements 
 
In veterinary medicine, and especially in low profit sectors such as poultry industry (Carter & 
Carmichael, 2003), vaccination provides a cost-effective control of infectious diseases to avoid 
suffering, decreased economical value of animals and expensive treatment upon outbreak of 
these diseases (Horzinek et al., 1997; Shams, 2005). Next to prevention and limitation of the 
consequences of infectious diseases in the target species, an additional goal of veterinary 
vaccination is to prevent transmission between susceptible species and in some cases between 
animal species and humans (i.e. prevention of zoonosis) (Horzinek et al., 1997; van Oirschot, 
1994). 
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As in human vaccinology, veterinary vaccines should be pure (free of contaminating micro-
organisms), potent (inducing high level of immunity), safe and efficacious (both tested in target 
species) (Bey et al., 1998; Carter & Carmichael, 2003; Povey & Carman, 1997). Regarding safety, 
the ideal vaccine does not have residual virulence, is safe in immunosuppressed, pregnant and 
differently aged hosts, is not toxic, and does not persist or shed after vaccination. A vaccine with 
optimal efficacy elicits a lifetime protective immune response against all likely challenges 
(including strain variants), that is rapidly induced and overcomes maternal immunity (Povey & 
Carman, 1997).  
 
Additional requirements appear when the vaccines have to be applied in the food animal field, 
where economical pressure does not advocate the use of high cost vaccines (Carter & 
Carmichael, 2003). Costs can originate during production where for example concentration and 
purification of antigens for non-viable vaccines and freeze drying of live vaccines are expensive 
techniques. Also, as vaccine administration should be cheap, a single dose and mass application 
are preferred above multiple doses and individual administration (Povey & Carman, 1997). In this 
respect, it is advantageous to combine vaccines (live, killed and/or subunit) into multivalent 
vaccines to reduce the number of applications (Horzinek et al., 1997; Povey & Carman, 1997; 
Strube, 1997a).  
 
Furthermore, highly contagious diseases such as avian influenza require ‘marker’ vaccines that 
allow differentiation between infected and vaccinated birds (DIVA strategy, i.e. Differentiating 
Infected from Vaccinated Animals). In other words, it should be possible to distinguish the 
antibody array originating from a virulent virus and a vaccine virus. This is important in view of 
export bans and related economical losses when antibodies indicate that animals might have 
been in contact with the virulent virus (Capua & Marangon, 2003; van Oirschot, 1997c).  
 
 
2.2.  Conventional veterinary vaccines 
 
Live and killed vaccines are two types of frequently applied vaccines in veterinary vaccination. 
Both have their advantages and disadvantages and are applied in specific situations.  
 
 
2.2.1.  Conventional live vaccines 
 
The observation of Jenner that a certain strain of a virus can have a different virulence in different 
species led to the first application of live vaccines that did not induce severe disease symptoms 
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in the vaccinated host (Bazin, 2003; Fenner et al., 1997). Other straightforward applications of 
live vaccines include the introduction of a virulent strain via another route than the natural route 
of infection (Mittal et al., 2002) and the use of mild field isolates of a certain virus that induce 
immunity against the more virulent strains (Sharma, 1999). However, for some viruses there are 
no such strains and laboratory attenuation is necessary to generate a suitable live vaccine. This 
can be obtained by culturing the virus in non-optimal conditions (e.g. host, temperature) or by 
repeated passages in a susceptible host, where it is the aim to acquire a non-virulent strain with 
the same replicating and antigenic properties as the virulent strain (Mittal et al., 2002; van 
Oirschot, 1997b). 
 
The main advantage of live vaccines is their ability to replicate and stimulate the immune system 
as if a natural infection would have occurred, resulting in both humoral and cell-mediated 
immunity. This makes live vaccines particularly suited for mucosal vaccination and inoculation via 
the natural infection route (Mittal et al., 2002; van Oirschot, 1997b). This then results in local and 
systemic immune responses, where the first might prevent spread of an infecting virus to 
susceptible organs and the environment. Moreover, the common mucosal system allows immune 
responses in mucosal sites distant to the inductive mucosal site (McGhee et al., 1999; Murphy, 
1999). Additional advantages of live vaccines are the low inoculum and therefore low cost (virus 
replicates after administration), the reduced number of inoculations due to long-term immunity, 
the adaptability to mass application, and the absence of adjuvantia. However, the possibility of a 
low level of residual virulence, or even reversion to virulent state, the pathogenicity in 
immunocompromised hosts, the need of freeze drying, stabilizers and cold-chain maintenance for 
storage, and the need of reconstitution, can increase the risks and costs and reduce the efficacy 
of this type of vaccines (Bey et al., 1998; Horzinek et al., 1997; Mittal et al., 2002; Povey & 
Carman, 1997; Shams, 2005; van Oirschot, 1997b). 
 
 
2.2.2.  Conventional inactivated vaccines 
 
Inactivated or killed vaccines are available for viruses that can be inactivated (with for example 
chemicals, heat or gamma-irradiation) without disturbing the conformation of the immunogenic 
antigens (Bey et al., 1998; Mittal et al., 2002). As these vaccine viruses do not replicate, they are 
safe to be administered to breeding and gestating animals, which is their major application (Bey 
et al., 1998). However, the lack of replication requires a more frequent inoculation with larger 
doses and the addition of adjuvants that enhance the immune response non-specifically. This 
makes the application of inactivated vaccines more expensive than vaccination with live agents. 
Whereas the adjuvants (classically aluminium salts or mineral oil) are necessary to obtain a good 
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immune response, they are also the major cause of reduced safety of inactivated vaccines, due to 
the local or systemic toxicity of some adjuvants. Reduced safety can also originate from 
occasional incomplete inactivation. Furthermore, inactivated vaccines have to be administered 
parenterally and only elicit a humoral immune response. Therefore, they are not very efficient 
against mucosal or intracellular pathogens (Bey et al., 1998; Horzinek et al., 1997; Mittal et al., 
2002; Povey & Carman, 1997; Shams, 2005; van Oirschot, 1997a).  
 
 
2.3.  Developments in veterinary vaccinology 
 
2.3.1.  Identification of virulence genes 
 
In contrast to the rather empirical approach for obtaining conventional vaccines, the advent of 
molecular genetics allowed detection of virulence genes of micro-organisms and a more 
purposeful vaccine development. 
 
In a first approach, this allowed to better direct the attenuation of live vaccines. For most 
conventional live vaccines, the attenuated strain is obtained randomly and attenuation is often 
based on point mutations with high risk of reversion to virulence. However, mapping of the 
virulent genes allowed to create gene-deleted mutants or to introduce specific multiple mutations. 
These methods greatly enhance safety of live vaccines without eliminating their inherent 
advantage of replication (Horzinek et al., 1997; Mittal et al., 2002; Shams, 2005). An application 
of gene-deleted mutants in veterinary vaccination are marker vaccines. The absence or presence 
of antibodies against a specific deleted antigen then indicates if the animal was vaccinated with 
the gene-deleted mutant or infected with the virulent virus, respectively (van Oirschot, 1997c). 
 
Another approach to increase safety of vaccines was solubilization of the virus and subsequent 
purification and concentration of the specific antigens that induce immunity (subunit vaccines). 
However, purification and concentration of antigens are expensive and advances in recombinant 
DNA technology were necessary to make the administration of individual proteins and epitopes of 
pathogens economically feasible (Babiuk, 1997a; Bey et al., 1998; Horzinek et al., 1997; Mittal 
et al., 2002). Currently, expression systems such as bacteria, yeasts, mammalian cells, insect 
cells and plants are available to produce large quantities of selected antigens (Babiuk, 1997a; 
Mittal et al., 2002). 
 
A further improvement in the delivery of antigens, could be the production of synthetic peptide 
vaccines. This means that no expression systems are needed but that the antigens are chemically 
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produced in a well-defined and reproducible manner. However, a lot of research is still needed in 
this field, despite some encouraging results (Meloen, 1997; Povey & Carman, 1997). 
 
Finally, the administration of DNA plasmids that encode for certain antigenic proteins shows a lot 
of potential for vaccination. Here, the antigens are produced in vivo after uptake of the DNA in the 
host cell. DNA vaccines combine advantages of live and killed vaccines without having their 
disadvantages: they are able to induce both humoral and cellular immune responses without 
being virulent. Additionally, the immune response is long-lasting due to a continuous production 
of low levels of antigens, which could be an economical advantage in veterinary vaccinology and a 
method for overcoming maternal immunity. Good results have already been obtained in animal 
models, but possible side-effects such as integration in the host genome and subsequent 
mutagenesis or formation of anti-DNA antibodies should further be investigated (Horzinek et al., 
1997; Mittal et al., 2002; Ulmer et al., 1997). 
 
 
2.3.2.  Antigen delivery strategies 
 
Although non-living vaccines have the advantage of safety, they are not as immunogenic as live 
vaccines. Therefore, several adjuvants and carrier systems have been developed. Often, a 
combination of both is applied for an optimal response (Horzinek et al., 1997). Some of the 
antigen delivery systems have additionally been evaluated for mucosal application (McGhee et 
al., 1999). The mechanisms whereby the different adjuvants and carrier systems enhance the 
immune response can be summarized as immunostimulation, altered processing of antigens 
and/or sustained release of antigens (depot effect) (Bowersock & Martin, 1999; Kaeberle, 1986; 
Mittal et al., 2002).  
 
 
A. Adjuvants 
 
Glenny and co-workers were in 1926 the first to report the use of an aluminium salt as adjuvant 
(Bazin, 2003; Fenner et al., 1997). Aluminium salts are extensively used in veterinary vaccines 
and up to now, they are the only adjuvants licensed by the Food and Drug Administration (FDA) for 
use in humans (Bunn et al., 1986; Horzinek et al., 1997; Mittal et al., 2002). In veterinary 
medicine, also oil emulsions (McKercher, 1986) and saponins from the bark of the Quillaja 
saponaria Molina tree (e.g. purified fractions Quil A and QS-21) are frequently applied as 
adjuvants (Bey et al., 1998; Horzinek et al., 1997; Mittal et al., 2002). Additional components 
that are investigated for their adjuvanticity are for example lipopolysaccharides (and the derivate 
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monophosphoryl lipid A), cholera toxin, and muramyl dipeptide originating from bacteria or 
mycobacteria (Bey et al., 1998; Horzinek et al., 1997; Ribi, 1986). A relatively new group of 
explored adjuvants are cytokines that naturally modulate and regulate the immune response 
(Horzinek et al., 1997; Strube, 1997b).  
 
 
B. Carrier systems 
 
A first class of carrier systems are recombinant vector vaccines. These are live organisms where 
the virulent genes have been deleted and replaced by genes from other pathogens. Examples of 
successful viral vectors are adeno- and poxviruses (e.g. vaccinia virus), while Escherichia coli, 
Salmonella and Mycobacterium species have been used as bacterial vectors (Babiuk, 1997b; 
Collins & Schödel, 1997; Mittal et al., 2002). As the vectors are replicating organisms, they 
stimulate all parts of the immune system (Mittal et al., 2002; Ulmer et al., 1997). However, 
existing or induced immunity against these vectors may reduce the effectiveness of vaccination or 
eliminate the possibility of repeated vaccinations, respectively (Ulmer et al., 1997).  
 
A lot of research is also performed on the use of non-living microparticulate delivery systems. 
Their adjuvanticity would originate from protection of the antigens against degradation and slow 
release of the antigens (Kaeberle, 1986; Mittal et al., 2002). A first example, which has already 
been applied in commercial veterinary vaccines, are immunostimulatory complexes (ISCOMs) that 
are stable, cage-like structures containing phosphatidylcholine, cholesterol, the saponin fraction 
Quil A and antigens (Bowersock & Martin, 2000; Horzinek et al., 1997; Mittal et al., 2002). Also 
liposomes (particles formed by a phospholipid bilayer around an aqueous core) have been tested 
as controlled release delivery systems for veterinary antigens. Liposomes can additionally be 
adapted with viral fusion proteins, resulting in so called virosomes that allow a more efficient 
uptake in the host cells (Bowersock & Martin, 2000; Horzinek et al., 1997; Mittal et al., 2002; 
Rouse et al., 1986). Other evaluated microparticles are constructed with detergent molecules 
(micelles), viral coat proteins (virus-like particles), proteins such as albumins (cross-linked protein 
crystals) and polymers (Bittle et al., 1986; Bowersock & Martin, 2000; Brown et al., 1986; 
Horzinek et al., 1997; Mittal et al., 2002). Polymeric microparticles can be constructed with a 
large diversity of polymers, but aliphatic polyesters, and more specifically copolymers of 
polylactide and polyglycolide esters (PLG) have been most extensively investigated and have been 
approved by the FDA for use in humans. Whereas PLG particles are used for parenteral 
application, chitosan has become an important carrier for mucosal application of antigens due to 
its positive charge and subsequent easy attachment to the negatively charged mucosal surfaces 
(Bowersock & Martin, 2000; Illum et al., 2001). 
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3.  Characteristics of poultry vaccination 
 
3.1.  Vaccine administration techniques 
 
In poultry industry, large numbers of chickens are raised under intensive rearing. This means that 
up to tens of thousands of birds are in close proximity in a confined space, which increases the 
chances of fast spreading of infectious diseases. Therefore, prevention of these diseases and 
their consequences by vaccination is one of the pillars of an economical poultry business. The 
vaccine administration methods can be divided in mass and individual vaccination methods. 
Mass vaccination is more economical for such large groups of animals, in contrast with the high 
labour costs of individual application (Glisson & Kleven, 1993; Guittet et al., 1997; Sharma, 
1999). Additionally, the capture of animals for individual application of vaccines can induce 
stress and reduce production parameters (Glisson & Kleven, 1993). A disadvantage of mass 
vaccination methods in comparison to individual vaccination can be the less consistent dosing 
(Guittet et al., 1997) but it has been found that increasing the immunity of the population, rather 
than the immunity of the individual, can be sufficient to prevent outbreaks of diseases (Cargill, 
1999; Carpenter, 2001). As mass vaccination is preferred, due to the above mentioned reasons, 
mainly live attenuated vaccines are used in poultry industry. Although for example aerosol 
application of a classical formaldehyde inactivated ND vaccine (with or without adjuvant) was 
effective, the large dose and number of exposures was not economically feasible (van Eck, 
1990b). This means that most poultry vaccines are distributed as stabilized, freeze-dried 
powders, which need to be reconstituted before usage. 
 
In the following sections, the different vaccine application methods will be discussed briefly. 
 
 
3.1.1.  Spray and aerosol vaccination 
 
Spray and aerosol vaccination are the preferred methods for vaccination against respiratory 
infectious diseases (Cargill, 1999; Dekich, 1998; Guittet et al., 1997). However, as part of the 
vaccine deposited in the upper airways will be swallowed, these methods can also be used for 
vaccination against enteric diseases (van Eck, 1990a). The use of spray (coarse droplets, 
deposited on the birds and in the upper airways) or aerosol (fine droplets, able to reach the lower 
airways) depends on the age and health status of the flock. In general, the application of a 
vaccine by aerosol causes a stronger immune response than the application by spray (van Eck, 
1990a). However, in young birds vaccinated for the first time, this strong immune response is 
often accompanied by strong post-vaccination reactions, resulting in suffocation and increased 
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susceptibility to secondary infections (van Eck & Goren, 1991). Chickens with existing bacterial 
(such as Mycoplasma, Pasteurella, E. coli) or viral (such as infectious bronchitis (IB), infectious 
laryngotracheitis (ILT)) infections are more sensitive to post-vaccination reactions when a live 
vaccine is deposited in the lower airways (Guittet et al., 1997). To prevent economical losses, it is 
general practice to apply a coarse spray whenever the risk of post-vaccination reactions is high 
and to reserve aerosol vaccination for secondary applications (Guittet et al., 1997; van Eck, 
1990a).  
 
Coarse spray generators can be hand-held or knapsack sprayers or are integrated in spraying 
cabinets for 1-day-old chickens. The generated droplets, ranging between 100 and 800 µm, are 
sprayed onto the chickens from a short distance. Therefore, coarse spray vaccination can also be 
considered as a mass application method for eye and intranasal vaccination, where the immune 
response is further aided by drinking of the droplets (Cargill, 1999; Glisson & Kleven, 1993; 
Guittet et al., 1997).  
 
For aerosol vaccination, portable pressurised equipment or controlled droplet application devices 
are used, where droplet sizes range between 50 and 1000 µm and 80 and 100 µm, respectively 
(Cargill, 1999). As these droplets are generated at larger distances above the chickens, the 
droplets can evaporate to particles with an inhalable size (< 5 µm (Hayter & Besch, 1974)), where 
the obtained size depends on the solids content of the nebulized liquid and on the characteristics 
of the diluent (Gough & Allan, 1973; van Eck, 1990b; Yadin & Orthel, 1978). However, although 
evaporation is necessary to obtain inhalable particle sizes, it also represents the major cause of 
vaccine inactivation. Therefore, it is unlikely that the minimal effective dose can be inhaled after 
evaporation of aerosol droplets of vaccines with relatively low titres (van Eck, 1990a). 
 
Currently, coarse spray vaccination is often used for vaccination against ND, IB, infectious bursal 
disease (IBD or Gumboro disease), Mycoplasma gallisepticum (MG), and ILT (Glisson & Kleven, 
1993). Aerosol vaccination is mainly performed for ND (van Eck, 1990a), where most vaccines 
contain at least 106 EID50 per dose. Aerosol vaccination is less successful for low titre vaccines 
such as IB (at least 103 EID50 per dose) and ILT (at least 102 EID50 per dose) (BCFI, Belgisch 
Centrum voor Farmacotherapeutische Informatie) (2006). 
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3.1.2.  Drinking water vaccination  
 
Drinking water vaccination is used for infectious agents that find receptors in the gastro-intestinal 
tract mucosa but also for respiratory viruses, as the large slit-like opening in the upper beak 
(choanal cleft) of chickens is expected to allow orally consumed vaccine virus to reach the nasal 
cavity (Cargill, 1999; Glisson & Kleven, 1993). However, dye studies showed that this is not so 
self-evident and that the success of drinking water vaccination against respiratory diseases rather 
depends on accidental exposure of the nasal cavity during drinking (Robertson & Egerton, 1981). 
 
Important aspects for an efficient drinking water vaccination are usage of clean water and 
drinking systems (e.g. avoid chlorinated water and presence of algae and organic matter in 
drinking systems), and the assurance that all birds drink within the time period that the vaccine is 
present (i.e. active) in the drinking water. The latter requires careful and thorough planning of the 
vaccination (Cargill, 1999; Glisson & Kleven, 1993; Guittet et al., 1997). 
  
Vaccination against ND, IB, IBD, reoviruses, avian encephalomyelitis (AE), and ILT is often 
performed via drinking water (Glisson & Kleven, 1993). 
 
 
3.1.3.  In ovo vaccination 
 
In ovo vaccination is a mass application method where the vaccine is injected in embryos of 18 
days old. This technique has been developed for Marek’s disease, but is expected to become 
important for other diseases as well. The major advantage is the immediate protection of birds, 
i.e. already at the day of hatch (Cargill, 1999; Glisson & Kleven, 1993; Guittet et al., 1997; 
Sharma, 1999). However, the immunological mechanism of action when vaccinating at this 
immature stage is not fully understood yet (Davison, 2003). 
 
 
3.1.4.  Eye drop vaccination 
 
Eye drops are considered as the most effective means for vaccination of birds as each bird is 
individually treated and receives a full dose (Cargill, 1999; Degefa et al., 2004). The Harderian 
gland, a lymphoid gland located ventral and posteromedial to the eyeball, is capable of 
generating local antibodies (Glick, 2000; Sharma, 1999) and as the vaccine droplet continues 
along the lacrimal duct, it can also generate mucosal immune responses in the upper respiratory 
and gastro-intestinal tract (Robertson & Egerton, 1981). Vaccines against ND, IB, IBD, ILT, and 
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MG are commonly applied via eye drops, preferably on occasions that birds have to be handled 
for other purposes to avoid frequent induction of stress (Glisson & Kleven, 1993). 
 
 
3.1.5.  Intranasal administration 
 
Similar to the administration of eye drops, it is possible to drop the vaccine into the nostrils. 
Another approach for intranasal administration is beak-dipping where the nostrils are shortly 
submerged in the vaccine liquid. This technique also requires individual handling of the birds 
(Guittet et al., 1997). 
 
 
3.1.6.  Intramuscular or subcutaneous injection 
 
Intramuscular injection in the breast or leg and subcutaneous injection in the neck are mainly 
performed for inactivated vaccines. Due to the high cost of these vaccines and their 
administration, they are practically only applied for revaccination of laying and breeding stock. 
Additionally, injection is often used for the application of Marek’s disease vaccine at the day of 
hatch. Injections can be performed by hand-operated automatic syringes or automatic injection 
machines. Accuracy of administration and hygienic measures (e.g. sufficiently changing needles) 
are extremely important to reduce local reactions, spread of infections, and the iatrogenic 
induction of disease (Cargill, 1999; Glisson & Kleven, 1993; Guittet et al., 1997; Steentjes et al., 
2002). However, more safe needle-less injection systems (Giudice & Campbell, 2006) have 
recently become available for poultry industry (Cargill, 1999). 
 
 
3.1.7.  Transfixion and scarification 
 
In this case, a vaccine needle is dipped in the vaccine solution and subsequently pricked in the 
skin. As this is mainly performed into the skin of the wing-web, this method is also referred to as 
wing-web vaccination (Cargill, 1999; Glisson & Kleven, 1993; Guittet et al., 1997). Fowlpox, AE 
and Pasteurella multocida vaccines are often administered by this method (Glisson & Kleven, 
1993). 
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3.2.  Vaccination programs 
 
The selection of vaccine type and method of administration depends on a number of factors such 
as type of poultry, flock history, endemic infectious agents, proximity to other birds, age and 
genetic background of birds, health status of the parent flock, level of biosecurity being practiced, 
and other management and environmental influences. In most cases, a primary vaccination is 
followed by booster vaccinations to keep immunity at a high level. Only Marek’s disease 
vaccination results in a life-long immunity after a single application (Sharma, 1999).  
 
Vaccination of broiler chickens, reared in traditional poultry houses, that are normally slaughtered 
at 42 days of age, is omitted in some countries. Maternal immunity, which persists during the first 
three weeks of life, is then believed to be sufficient to protect the chickens during their short life-
span. In contrast, free-range broilers that live approximately 84 days require vaccination. 
Furthermore, vaccination largely depends on the endemic situation. For example in Belgium and 
the Netherlands, where outbreaks of ND have occurred, ND vaccination is compulsory, also for 
standard broilers. Similarly, IB, IBD and fowlpox vaccines are only applied where the disease is 
prevalent (Guittet et al., 1997). 
 
Layer and breeding chickens are vaccinated several times during their life time. During the 
rearing period, the birds receive live vaccines (such as Marek’s disease, ND, IB and IBD vaccines), 
while immediately before the laying period inactivated vaccines are used. Some of the latter 
applications are intended to protect the birds (e.g. ND, IB and egg drop syndrome vaccines), 
whereas some vaccines (e.g. AE and IBD vaccines) are intended to protect the progeny during the 
first weeks of life (i.e. passive immunization). Certain vaccines are not administered 
systematically, but only when disease outbreaks are reported. These include vaccines against pox 
virus, reovirus, ILT, swollen head syndrome, and some bacterial diseases such as Mycoplasma 
gallisepticum and Salmonella Enteritidis (Guittet et al., 1997). 
 
Typical vaccination schedules applied in Belgium for the different types of chickens are 
summarized in Table 1.1. 
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Table 1.1. Classical vaccination schedule for poultry (and  administration methods) in Belgium (BCFI, Belgisch Centrum 
voor Farmacotherapeutische Informatie) (2006) 
 
Age  Type of poultry 
  Broilers Layers and breeders 
1 day 
 
Newcastle disease (spray) 
Infectious bronchitis (spray) 
Marek’s disease (intramuscular) 
Newcastle disease (spray) 
Infectious bronchitis (spray) 
 
2-4 weeks  Newcastle disease (spray/drinking water) 
Infectious bursal disease (spray/drinking water) 
Newcastle disease (spray/drinking water) 
Infectious bursal disease (spray/drinking water) 
 
7-12 weeks   Newcastle disease (spray/drinking water) 
Infectious bronchitis (spray/drinking water) 
 
14-18 weeks   Newcastle disease (spray/drinking water) 
Encephalomyelitis (spray/drinking water) 
 
19-21 weeks   Newcastle disease (intramuscular) 
 
 
 
3.3.  Newcastle disease 
 
3.3.1.  Newcastle disease virus 
 
Outbreaks of ND have first been reported in 1926 in Java, Indonesia, and in Newcastle-upon-
Tyne, England. The virus belongs to the family of Paramyxoviridae, and more specifically the 
genus Paramyxovirus. The ND virus is an RNA virus, between 80 and 120 nm in size, with a 
single-stranded genome of negative polarity, a symmetrically helical capsid and an envelope. 
Similar to the Orthomyxoviridae (e.g. influenza virus), the viruses of the genus Paramyxovirus 
have a haemagglutinin and neuraminidase antigen (HN protein) at their surface, but in contrast to 
the former virus family, the Paramyxovirus HN protein is genetically stable. However, there are 
several strains of the ND virus that can be grouped into five pathotypes based on the clinical 
signs in infected chickens. The viscerotropic velogenic strains are highly pathogenic with 
haemorrhagic intestinal lesions, while the neurotropic velogenic strains cause a high mortality, 
usually following respiratory and nervous signs. The mesogenic strains induce respiratory signs 
and occasionally nervous signs, with low mortality. The lentogenic strains cause a mild or 
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subclinical respiratory infection, and finally, the asymptomatic enteric strains only generate a 
subclinical enteric infection (Alexander, 1991; Devos, 1973; Gallili & Ben-Nathan, 1998; OIE, 
2004).  
 
 
3.3.2.  Newcastle disease infections 
 
The introduction of the disease in a flock has been related to airborne spread, exposure to 
contaminated food and water, vaccination, and movement of birds, other animals, people, 
equipment and poultry products. However, people and equipment are suggested to be the major 
vehicles for the virus. Within a flock, the virus mainly spreads by inhalation of infectious aerosols 
and/or by ingestion of contaminated faeces (Alexander, 1991; Bell et al., 1991).  
 
After an average incubation time of 5 to 6 days, symptoms occur that are very diverse depending 
on the pathotype and tropism of the virus. Furthermore, the effect of the different strains 
depends on the age of the infected chickens, the virus dose, the route of exposure, the immune 
status of the chickens, secondary infections, and stress. However, the clinical signs of ND can be 
summarized as respiratory distress, nervous signs, enteric symptoms and loss of egg production 
(Alexander, 1991). 
 
 
3.3.3.  Control and prevention of Newcastle disease 
 
Due to the severe economical consequences of an ND outbreak for poultry industry, the disease 
has been listed as a notifiable disease. This means that all countries have to report ND outbreaks 
within their borders to the World Organization for Animal Health (OIE). National policies differ 
according to the epidemiological situation and are based on prevention of introduction of the 
disease (for countries where no ND exist) and on prevention of spread of the disease (for 
countries where outbreaks occur or have occurred). The latter can implicate statutory regulations 
to control disease outbreaks and/or compulsory vaccination. For example, in Belgium, these 
regulations were translated in a Ministrial Order for regulation of vaccination against Newcastle 
disease (1993) and a Royal Order for measures against avian influenza and Newcastle disease 
(1994). Many countries also define the type of vaccine, the age of vaccination and the method of 
administration as illustrated in an extract from the Belgian Ministrial Order given below              
(Figure 1.1). 
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Vaccination against Newcastle disease 
 
1. Chickens 
 
1.1. Commercial poultry 
1.1.1° Poultry for consumption 
 
1.1.1° 1) Broiler chickens 
1st vaccination: 
time:     1 day old 
vaccine:     any live vaccine 
vaccination method:   coarse spray – full dose 
2nd vaccination: 
time:     at the age of 10 to 18 days 
vaccine strain:    La Sota strain or cloned La Sota strain 
vaccination method:   fine aerosol or drinking water – full dose 
 
1.1.1° 2) Table-egg layer chickens 
1st vaccination: 
time:     at the age of 10 to 18 days at the rearing farm 
vaccine strain:    La Sota strain or cloned La Sota strain 
vaccination method:   fine aerosol or drinking water – full dose 
2nd vaccination: 
time:     at the age of 7 weeks 
vaccine strain:    La Sota strain or cloned La Sota strain 
vaccination method:   fine aerosol or drinking water – full dose 
3rd vaccination: 
time:     at transfer to the production farm 
vaccination method:   vaccination by subcutaneous application of an inactivated adjuvanted vaccine 
4th and further vaccinations: 
a. revaccination during the laying period is compulsory when serology performed on a representative number of blood 
samples indicates insufficient immunity in the flock. The analysis has to be performed at the latest 8 months after the start 
of production. 
b. after induced moulting: 
vaccination method:   vaccination by subcutaneous application of an inactivated adjuvanted vaccine 
 
 
 
Figure 1.1. Extract from Appendix of the Ministrial Order for regulation of vaccination against Newcastle disease 
(translated from Dutch) (‘Ministrieel Besluit houdende reglementering van de vaccinatie tegen pseudovogelpest en tot 
wijziging van het Ministrieel Besluit van 4 mei 1992 houdende tijdelijke maatregelen ter bestrijding van de 
pseudovogelpest 25.01.1993 (Belgisch Staatsblad 26.01.1993)’). 
 
 
Generally, conventional live or killed vaccines are used for vaccination against ND. The live 
vaccines are field strains or attenuated strains and can be divided in lentogenic and mesogenic 
vaccines. Due to their virulence and higher risk of strong post-vaccination reactions, mesogenic 
vaccine strains have been forbidden in some countries, but in other countries, where velogenic 
strains are endemic, the higher immune response induced by the mesogenic strains is 
indispensable. Examples of mesogenic strains are Strain H, Mukteswar, Komarov and Roakin 
(Alexander, 1991; OIE, 2004). In Belgium, only lentogenic and avirulent strains are registered: the 
Clone 30, VG/GA, Clone CL/79, Hitchner B1 and Ulster strains can be used for primary 
vaccination while the La Sota strain, which has the highest virulence amongst the registered 
vaccines, is reserved for secondary vaccination (BCFI, 2006). The latter illustrates the general 
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practice of increasing the virulence of ND vaccines in subsequent vaccinations to gradually 
increase the level of immunity (Alexander, 1991; Gallili & Ben-Nathan, 1998). Also two combined 
inactivated vaccines are registered for the Belgian poultry industry, which enable a simultaneous 
vaccination against ND and IB or against ND and egg drop syndrome (BCFI, 2006).  
 
The immune response after live vaccination (as after a natural infection) starts with the activation 
of the cell-mediated immunity within 2 to 3 days after exposure to the virus. After 6 to 10 days, 
also the humoral immune response is active and antibodies against the surface antigens HN and 
F can be detected. Generally, the serum antibody titres reach a maximal level at 3 to 4 weeks 
post-vaccination, followed by a steady decline of antibodies if no secondary vaccination follows 
(Alexander, 1991). Next to serum antibodies, also local IgA antibodies appear in mucosal 
secretions, resulting in mucosal immunity that protects the chickens already at the portal of virus 
entry and reduces the shedding of virus from infected birds (Alexander, 1991; McGhee et al., 
1999; Murphy, 1999; Takada & Kida, 1996). When breeders are vaccinated, antibodies are 
passed to the yolk and albumen of the developing embryo. Yolk mainly contains IgG, and provides 
the hatched chick with humoral serum antibodies, while swallowing of the IgA-containing albumen 
by the developing embryo results in mucosal immunity. This passive maternal immunity is 
protective in early stages of life and should be taken into consideration when performing 
vaccinations (Alexander, 1991; Glisson & Kleven, 1993).  
 
 
3.3.4.  New perspectives for Newcastle disease vaccination 
 
As in other branches of veterinary industry, expanding knowledge of molecular biology, 
immunology and pathogenicity of microorganisms has led to new approaches in poultry 
vaccination. New vaccine types and formulation techniques hold promise to overcome several 
disadvantages associated with the classical live attenuated and inactivated vaccines. Some of 
the reported research for ND vaccination has been summarized in Table 1.2. However, the cost of 
these new products is still high in comparison to current poultry vaccines, and only a substantial 
increase of safety and/or efficacy of new vaccine types will justify their future use (Glisson & 
Kleven, 1993).  
 
 
 
 
- 23 - 
Chapter 1 
Table 1.2. Some examples of reported research for development of improved Newcastle disease vaccines and 
vaccination strategies 
 
Vaccine type Components Administration method Reference 
Inactivated -    
adjuvanted 
ND virus encapsulated in 
ISCOMs 
 
Intravenous / eye-drops 
 
(Russell & Koch, 1993) 
 
Live ND virus encapsulated in 
ISCOMs 
 
Orally (Rehmani & Spradbrow, 1995) 
DNA Linear plasmid DNA expressing 
F protein of ND virus 
 
Intramuscular (Sakaguchi et al., 1996) 
Inactivated -    
adjuvanted 
ND virus with cholera toxin B 
subunit adjuvant 
 
Intranasal (Takada & Kida, 1996) 
Recombinant - 
adjuvanted 
Fowlpox virus co-expressing HN 
and F protein of ND virus and 
chicken type 1 interferon 
 
In ovo (Karaca et al., 1998) 
Subunit -         
adjuvanted 
Virosomes and ISCOMs with HN 
and F protein of ND virus 
 
Subcutaneous (Homhuan et al., 2004) 
Inactivated -    
adjuvanted 
ND virus with CpG 
oligodeoxynucleotide adjuvant 
Intramuscular (Linghua et al., 2007) 
 
 
 
4.  A new approach for mass vaccination of poultry via the respiratory route 
 
The high cost of the above mentioned emerging vaccine types does not make them very attractive 
for application in the low-profit poultry sector. The overview in Table 1.2 also indicates that most 
of these vaccines need to be administered individually. However, an economical approach to 
more efficient vaccines could originate from a re-thinking of the existing technique of spray and 
aerosol vaccination.  
 
A first problem with spray and aerosol vaccination is the broad droplet size distribution generated 
by the available nebulizers (Cargill, 1999). On the one hand this implies the presence of small 
droplets in a coarse spray, which can result in severe post-vaccination reactions after a primary 
vaccination. On the other hand, a large fraction of non-inhalable droplets in an aerosol cloud 
- 24 - 
Vaccination of poultry 
results in a reduced immune response during secondary vaccination (Gough & Allan, 1973; van 
Eck & Goren, 1991; Yadin & Orthel, 1978).  
 
A second problem occurs due to the large number of steps between harvesting the vaccine virus 
and inhalation of the vaccine by the chickens: the vaccine virus is grown in the allantoic fluid of 
embryonated eggs, freeze dried for storage, reconstituted at the moment of vaccination, and the 
vaccine is again obtained in dry form after nebulization due to evaporation of the generated 
droplets. Several of these steps can lead to inactivation of a live vaccine virus. For example, the 
use of tap water for reconstitution (which can contain virucidal agents, such as chlorines) (Guittet 
et al., 1997) and inactivation of the vaccine virus during uncontrolled evaporation (Gough & Allan, 
1973; Landman & van Eck, 2001; Yadin & Orthel, 1978) lead to the necessity of nebulizing much 
higher doses than required for inducing an immune response. 
 
A possible solution for these problems is the formulation of the existing vaccines as readily 
dispersible dry powders. The formulation of powders with a defined particle size allows a better 
targeting to the upper or lower airways and it circumvents inactivation during reconstitution and 
evaporation of droplets. Dry powder vaccines have been produced successfully by mechanical 
milling of a freeze-dried pellet of a live Newcastle disease vaccine (Fournier et al., 1976; Gaudry 
et al., 1976) and a live measles vaccine (LiCalsi et al., 1999; LiCalsi et al., 2001). The former 
research never found large-scale application in poultry industry, probably related to difficulties in 
obtaining defined narrow particle size spectra. However, spray drying, where a liquid is 
transformed in dry particles by nebulization of droplets in hot drying air, has been recommended 
as an alternative to freeze drying for the preparation of inhalation products, as it allows to 
produce individual spherical particles with a controlled size and shape in a one-step process 
(Broadhead et al., 1992; Maa & Prestrelski, 2000; Masters, 2002; Van Campen & Venthoye, 
2002). Moreover, spray drying is a faster and more cost-effective dehydration process than freeze 
drying (Tzannis & Prestrelski, 1999). 
 
The spray drying process, illustrated in Figure 1.2, can be divided in three major steps: 
nebulization of the liquid, drying of the droplets, and separation of the resulting powder particles 
from the drying air. 
 
Nebulization of the liquid can be performed with a rotary nozzle (where a spinning disc provides 
the energy for droplet formation), a pressure nozzle (where the liquid is forced through the nozzle 
under pressure), a two-fluid nozzle (where the liquid is mixed with air that causes the break-up in 
droplets), or a sonic nozzle (where sonic energy forms the droplets).  
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Figure 1.2. The spray drying process: a liquid feed is nebulized (in this case by means of a rotary nozzle)  into a drying 
chamber  where the generated droplets are transformed in dry powder particles by evaporation of the liquid under the 
influence of hot inlet drying air. The dry powder particles leave the drying chamber together with the outlet air from 
which they are separated by means of a cyclone and bag filter (www.niro.com).  
 
 
Drying of the droplets includes the contact of the droplets with the drying air which mainly occurs 
in co-current or counter-current manner. Co-current spray drying means that the air and liquid 
pass through the spray drying chamber in the same direction, whereas liquid and air are 
introduced at opposite ends of the chamber in counter-current spray drying.  
 
In the last step of the spray drying process the powder is separated from the drying air using 
cyclones and/or bag filters (Broadhead et al., 1992; Masters, 2002). 
 
Despite the application of higher than ambient temperatures during a spray drying process,       
co-current spray drying can be used to dry heat-sensitive materials as the materials are hardly 
exposed to the higher temperatures. During evaporation, the temperature of a droplet does not 
rise above the wet-bulb temperature (i.e. temperature of the saturated surface): heat is used for 
evaporation of liquid and not for heating of the droplet. As evaporation continues, the original 
temperature of the drying air (inlet temperature) decreases to lower values (outlet temperature). 
Only when all liquid has evaporated, the remaining dry particle becomes sensitive to heating. 
However, dried particles are immediately transported to a collection vessel where the 
temperature of the air further decreases (Broadhead et al., 1992; Maa & Prestrelski, 2000; 
Masters, 2002). 
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In summary, the reformulation of existing live attenuated vaccines as dry powder formulations by 
spray drying would offer an interesting approach to increase the efficiency of poultry vaccinations 
without increasing the costs of the vaccines. The applicability of this concept was investigated 
during the course of the here presented research. 
  
 
5.  Conclusion 
 
Veterinary industry, and especially poultry industry, relies largely on economical vaccination 
strategies to control infectious diseases. Next to the extensive use of classical live and inactivated 
vaccines, a lot of effort is put in the development of efficient subunit, recombinant and DNA 
vaccines with attention for the optimal adjuvant and carrier system. For vaccination of poultry, an 
array of application methods is available but mass vaccination methods are preferred. One of the 
most important diseases in poultry is Newcastle disease, which has led to regulations in 
prevention of the disease and a lot of effort to find more efficacious and safe vaccines. However, 
the benefits of these experimental vaccines do not yet overcome their high costs compared to the 
conventional Newcastle disease vaccines. In contrast, reformulation of the existing live 
attenuated vaccines as dry powders seems a promising approach to increase efficiency without 
increasing the costs of vaccination. 
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1.  Introduction 
 
If powder vaccines are to be efficient, a first requirement should be obtaining accurate knowledge 
about the deposition pattern of particles of various sizes in the respiratory system. Once the 
optimal particle sizes for targeting specific sections of the respiratory system have been defined, 
vaccine powders with corresponding narrow particle size distribution may be manufactured. 
 
Previously, studies have been performed to estimate the influence of droplet size in spray and 
aerosol vaccination on the immune response (Gough & Allan, 1973; Villegas & Kleven, 1976). 
However, at the time no estimates were made on the exact deposition site of the differently sized 
droplets. Subsequently, other studies with monodisperse radioactively-labelled microspheres 
(Hayter, 1977; Hayter & Besch, 1974; Mensah & Brain, 1982) or iron oxide particles (Stearns et 
al., 1987) were performed. The work of Hayter & Besch (1974) in which radioactively-labelled 
microspheres ranging between 0.1 and 7 µm were administered to anaesthetized adult chickens 
became the main reference for particle and vaccine deposition in the airways of chickens. 
However, it has some limitations. A major drawback is that in this study anaesthetized chickens 
were used, which have a different breathing pattern compared to their unanaesthetized 
counterparts (Ludders, 2001; Powell, 2000; Yadin, 1980). Moreover, the use of external 
detection of the deposited radioactive microspheres (Hayter, 1977) may not have allowed a clear 
distinction between signals from neighbouring tissues. Anaesthesia was not used in the studies 
performed by Mensah & Brain (1982) and by Stearns et al. (1987), but these authors used     
0.45 µm radioactive microspheres and 0.18 µm iron oxide particles, which are not representative 
for current aerosol particle sizes. In addition, these studies were only performed on adult 
chickens, whereas most poultry is vaccinated several times, mainly at younger ages during the 
rearing period. As particle deposition is affected by the dimensions of the respiratory system 
(Brain et al., 1985), deposition patterns of airborne particles will differ between adult and young 
birds. In summary, a method is needed in which unanaesthetized chickens of different ages can 
be exposed to microspheres with sizes that are representative for the application of respiratory 
vaccines. 
 
As an alternative to radioactive microspheres, there is a general tendency to utilize fluorescent 
microspheres (Prinzen & Glenny, 1994). Fluorescence is a highly sensitive photoluminescence 
process which occurs when electrons, excited to a higher energy level by absorbed light of a 
specific wavelength, fall back to their original energy level accompanied by emission of light with 
a higher wavelength than the excitation light (Schulman & Hughes, 2002). In contrast to 
radioactivity, fluorescence does not imply health risks, there are no extensive laboratory 
precautions needed, disposal of used materials is cheaper, and longer shelf lives allow 
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experiments over longer time periods. Additionally, it is possible to separate different 
fluorochromes in a single sample on the basis of their different excitation and emission 
wavelenghts (Glenny et al., 1993; Prinzen & Glenny, 1994). 
 
The fluorescent microsphere method elaborated by Glenny et al. (1993) has already been used to 
evaluate lung ventilation of anaesthetized, mechanically-ventilated pigs. An aerosol of fluorescent 
microspheres was administered directly into the trachea of the pigs, after passing through a 
complex system featuring in-line drying of droplets, microsphere counting, administration of 
anaesthetics and regulation of respiration (Robertson et al., 1997). However, this system is not 
suitable for the nebulization of micron-sized microspheres since only small droplets (0.3 µm) can 
be generated and larger particles, if nebulized at all, would impact in the complex tubing of the 
system. Moreover, the system has to be used under anaesthesia. Simultaneous to the current 
research, fluorescent microspheres have been used to determine the deposition pattern in the 
respiratory tract of pigeons. However, the pigeons were anaesthetized and the microspheres were 
delivered by intubation and intermittent positive pressure ventilation (Tell et al., 2006). 
  
Therefore, in this part of the project, a nebulization system (including nebulization equipment and 
exposure chamber) for fluorescently-labelled microspheres has been optimized to allow its 
application in unanaesthetized chickens. Additionally, the sample processing method presented 
by Glenny et al. (1993) was adjusted to the specific requirements of the applied microspheres 
and subsequently optimized. After in vitro evaluation of the nebulization system and sample 
processing procedure, preliminary in vivo experiments were performed to test the applicability of 
this new technique for particle deposition studies. 
 
 
2.  Materials and methods 
 
2.1.  Evaluation of the microsphere nebulization method 
 
2.1.1.  Exposure chamber and nebulization equipment 
 
The exposure chamber (Figure 2.1) was assembled from polycarbonate and its standard 
dimensions were 25 x 25 x 45 cm (length x width x height) (total volume = 28.1 L), but its height 
could be extended to 65 cm (total volume = 40.6 L).  
 
The top of the box was not closed, but only covered with a moisture-absorbing cloth (Wypall® L40 
cloth; Kimberly-Clark, Zaventem, Belgium) which acted as a vent filter to prevent excessive air 
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pressure during nebulization. At different heights (25, 33 and 50 cm) inlet holes for the 
nebulization equipment were made in opposite vertical walls, allowing nebulization with a 
horizontal trajectory.  
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Figure 2.1. Polycarbonate exposure chamber composed of a standard box (25 x 25 x 45 cm) and one extension box 
(25 x 25 x 20 cm), with inlet holes for the nebulization equipment and air gun at different heights. 
 
 
Two nebulizers were evaluated: a Walther Pilot I spray-head with a 0.5 mm diameter nozzle 
(Walther Spritz- und Lackiersysteme, Wuppertal, Germany) (Figure 2.2.A) coupled to an air 
compressor (Airpress Compressor HL 215/25; Fribel, Wilrijk, Belgium), and a Pari LC nebulizer 
(Figure 2.2.B) coupled to a PariBoy compressor (Pari, Starnberg, Germany). The spray-head was 
previously described for experimental administration of aerosols to chickens (Landman et al., 
2004; Landman & van Eck, 2001), and Pari nebulizers are commonly used jet nebulizers for 
human aerosol therapy.  
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A. B. 
 
Figure 2.2. A: Walther Pilot I spray-head; B: Pari LC jet nebulizer. 
 
 
A counter-current air stream generated by the same pressure as that of the nebulizer was 
introduced in the box at the same height as the nebulizer, creating a turbulent zone in the middle 
of the box when both flows converged. This prevented droplets and microspheres from impacting 
on the opposite wall of the exposure chamber and enhanced droplet evaporation to ensure that 
the microspheres had dried when they had sedimented to the bottom of the exposure chamber. 
 
 
2.1.2.  Effect of aerosol generation on relative humidity in the exposure chamber 
 
To control the relative humidity (RH) in the exposure chamber, and subsequently allow the 
complete evaporation of the liquid film around the nebulized microspheres in further 
experiments, the same moisture-absorbing cloth used as cover of the exposure chamber was 
attached to the inner walls of the box. The effect of the cloth was evaluated by nebulizing distilled 
water in the standard box with and without cloth lining. The Pari nebulizer was fitted in the 33 cm 
inlet and actuated during 20 s. The evolution of RH in function of time was monitored using a 
humidity logger (Testostor 171-2, Testo, Ternat, Belgium). The temperature during the 
experiments was 25.9°C. 
 
The influence of spray duration and spray interval on RH in the exposure chamber was evaluated 
with the Walther Pilot I spray-head: 1.5 ml distilled water was either nebulized continuously 
(during 70 s) or intermittently during 10 s periods using an interval of 50 s or 110 s until the total 
volume was nebulized. The volume was completely nebulized after 7 and 14 min for the 50 and 
110 s spray interval, respectively. These experiments were performed with a spray rate of       
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1.25 ml/min and a nebulizing air pressure of 0.5 bar, using the inlet at 33 cm height of the 
exposure chamber. RH in the box was monitored in function of time with the Testostor humidity 
logger. During the experiments, the environmental temperature was 26.0°C. 
 
 
2.1.3.  Spray rate and nebulizing air pressure: effect on droplet size distribution 
 
The droplet size distribution, which also influences the droplet evaporation, was measured by 
laser diffraction (Mastersizer-S long bed; Malvern Instruments, Malvern, UK) with the nebulizers 
held at 4 cm from the laser beam and 4 cm from the lens (Figure 2.3). 
 
 
 
 
 
Figure 2.3. Setup to measure the droplet size distribution generated by the Walther Pilot I spray-head via laser 
diffraction (Mastersizer-S long bed; Malvern Instruments, Malvern, UK). The aerosol is nebulized through the laser 
beam and the diffracted laser light is detected after passing a Fourier transform lens, shown in the picture. 
 
 
The influence of spray rate and nebulizing air pressure on the droplet size distribution generated 
by the Walther Pilot I spray-head was evaluated with distilled water. The air pressure of the spray-
head was set at 0.5 bar to evaluate the influence of spray rate (0.75 to 5 ml/min), while the spray 
rate was set at 1.25 ml/min for the evaluation of nebulizing air pressure (0.5 to 2 bar). The 
PariBoy compressor did not allow to vary the spray conditions and the water droplets produced by 
the Pari nebulizer were measured as such. During the droplet size measurements, the room 
temperature and relative humidity were 22.5°C and 27%, respectively. 
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2.2.  Characterization of the microsphere aerosols: particle size, output, agglomeration, 
         and sedimentation 
 
2.2.1.  Fluorescent microspheres 
 
Custom-designed monodisperse polystyrene microspheres were obtained from Duke Scientific 
Corporation (Palo Alto, California, USA). These microspheres were supplied as a 2% (w/v) 
suspension and labelled with a high-efficiency fluorochrome, in order to obtain sufficient 
fluorescent intensity in the tissue samples after inhalation. The following microspheres were 
used: 1 µm and 5 µm spheres having a green fluorochrome (excitation and emission wavelength 
of 470 and 508 nm, respectively) and 3 µm, 10 µm and 20 µm spheres having a red 
fluorochrome (excitation and emission wavelength of 560 and 596 nm, respectively). The 1 µm 
spheres were nebulized in combination with 3 µm spheres and the 5 µm spheres with 10 µm 
spheres, the different fluorochromes allowing simultaneous analysis. The 20 µm spheres were 
nebulized separately. The number of microspheres per millilitre was calculated from the 
microsphere concentration, the material density (density of polystyrene = 1.06 g/ml) and the 
microsphere diameter: 
  
 Number of microspheres per ml = (6 x % solids x 1010) / (ρ x π x d³) 
 
   With % solids = concentration (g/100 ml) 
    ρ = material density (g/ml) (1.06 g/ml for polystyrene) 
    d = microsphere diameter (µm) 
 
 
 
2.2.2.  Evaporation of the water film surrounding the nebulized microspheres 
 
A model 3321 Aerodynamic Particle Sizer® spectrometer (TSI Incorporated, Shoreview, 
Minnesota, USA) was used to measure the aerodynamic particle size of microspheres at the 
bottom of the exposure chamber. The chamber, lined with Wypall® L40 cloth, was open at the 
bottom and placed on top of the spectrometer with the inlet nozzle of the spectrometer in the 
middle of the chamber base. Three experiments were performed with the Walther Pilot I spray-
head: firstly, distilled water without microspheres was nebulized; secondly, a 1 and 3 µm sphere 
suspension; and thirdly, a 5 and 10 µm sphere suspension (0.16% (w/v) of each microsphere size 
in 1.5 ml distilled water). The spray-head (spray rate = 1.25 ml/min, nebulizing air pressure =   
- 44 - 
A method for determining the deposition pattern of nebulized microspheres in the airways of chickens 
0.5 bar) was operated in continuous mode until two measurements with a 20 s sampling duration 
were made. Ambient temperature and relative humidity were 20°C and 36%, respectively. 
 
 
2.2.3.  Output of microspheres 
 
The output of microspheres from the nebulizers was determined by nebulizing 1.5 ml of a 
microsphere-containing suspension (concentration: 0.04% (w/v) of each microsphere size in 
distilled water) in a sealed container (volume: 1000 ml) equipped with a vent filter. The 
microspheres were combined as described above. The Walther Pilot I spray-head (spray rate = 
1.25 ml/min, nebulizing air pressure = 0.5 bar) was activated for 10 s using an interval of 110 s 
until the reservoir was empty. For the output determination of the Pari nebulizer, spray duration 
was increased to 30 s with an interval of 90 s due to its lower spray rate (0.4 ml/min). After 
evaporation of the water, Cellosolve® acetate (2-ethoxyethyl acetate; Sigma-Aldrich, Steinheim, 
Germany) was added to the container to extract the fluorochromes from the microspheres. The 
fluorescent signal, which correlates with the number of microspheres, was measured and the 
number of recovered microspheres was expressed as a percentage of the total number of 
microspheres in 1.5 ml suspension. 
 
 
2.2.4.  Microsphere agglomeration and sedimentation 
 
The degree of agglomeration was determined by counting the number of microspheres (as singles 
or in agglomerates) deposited on five microscope cover glasses (20 x 20 mm), placed on the 
bottom of the exposure chamber. The cover glasses were subsequently superimposed on a 
Bürker counting chamber, followed by counting the microspheres with a Wilovert® light 
microscope (Hund, Wetzlar, Germany). The number of single microspheres was expressed as a 
percentage of the total number of microspheres per microsphere size. 
 
To evaluate the influence of the design of the exposure chamber and the nebulization conditions 
on microsphere agglomeration, 1.5 ml of a suspension containing 0.04% (w/v) 3 µm spheres and 
0.04% (w/v) 10 µm spheres in distilled water was nebulized with the Walther Pilot I spray-head 
(spray rate = 1.25 ml/min and nebulizing air pressure = 0.5 bar). Firstly, the volume of the 
exposure chamber (28.1 and 40.6 L) was evaluated in combination with the nebulization height 
(25, 33 and 50 cm). Secondly, the influence of spray duration and interval was determined by 
comparing continuous nebulization with intermittent spraying (spray duration of 10 s using 
intervals of 50 or 110 s). In a third set of experiments, the influence of sedimentation time 
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(ranging from 15 to 45 min) was evaluated. Finally, the microsphere concentration in the 
nebulized suspension was varied from 0.04% (w/v) to 0.08% (w/v). The settings for these tests 
are summarized in Table 2.1. 
 
Furthermore, both nebulizers were evaluated for their influence on microsphere agglomeration. 
During these experiments, the 1 and 3 µm spheres were combined, as were the 5 and 10 µm 
spheres, in a suspension containing 0.16% (w/v) of each microsphere size in distilled water. The 
concentration was increased to 0.53% (w/v) for the 20 µm spheres. The Walther Pilot I spray-
head was used (spray rate = 1.25 ml/min and air pressure = 0.5 bar) to nebulize 1.5 ml of each 
suspension (intermittent nebulization during 10 s with 110 s interval) in the extended exposure 
chamber. Additionally, the 1 and 3 µm spheres were nebulized using two Pari nebulizers 
simultaneously, which were placed in counter-current positions in the exposure chamber. Each 
nebulizer reservoir was filled with 1.5 ml suspension containing 0.08% (w/v) 1 µm spheres and 
0.08% (w/v) 3 µm spheres, and was nebulized by intermittent spraying during 30 s with intervals 
of 90 s. 
 
 
2.3.  Optimization of filtration procedure 
 
For the optimization of the filtration procedure, two stock suspensions of microspheres were 
prepared in 4 N KOH with 2% Tween™80. The first suspension contained 0.0008% (w/v) of the 1 
and 3 µm spheres, while the second suspension contained 0.0008% (w/v) of the 5 and 10 µm 
spheres. GF51 glass fibre filters (Schleicher & Schuell, Dassel, Germany) were placed in Swinnex® 
filter holders (Millipore, Brussels, Belgium) which were mounted on a solid phase extraction 
vacuum manifold (Alltech Europe, Lokeren, Belgium). To optimize the filtration procedure, 10 ml 
of one of the stock suspensions was filtered per filter. Subsequently, the filter was rinsed with 
water and/or phosphate buffer (2.990% (w/v) K2HPO4 and 0.588% (w/v) KH2PO4 in distilled 
water; pH 7.4). Afterwards, the filter was placed in a glass test tube and allowed to air-dry. The 
dried filter was immersed in 5 ml Cellosolve® acetate to extract the fluorochromes from the 
microspheres. After removal of the filter, the extract was centrifuged at 2500g for 10 min to 
precipitate the remaining filter fibres and microspheres. Finally, the fluorescence of the sample, 
which correlates with the number of microspheres present, was measured on a Shimadzu         
RF-5001PC spectrofluorometer (Shimadzu, Antwerp, Belgium). The number of retained 
microspheres per filter was calculated and expressed as a percentage of the number of 
microspheres in 10 ml stock suspension. 
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2.3.1.  Evaluation of vacuum pressure 
 
The vacuum pressure used for filtration of the above described stock suspensions was increased 
from 20 kPa to 60 kPa (increase of 10 kPa per experiment). The vacuum pressure was 
maintained for rinsing the filters with 20 ml distilled water and 20 ml phosphate buffer. Three 
filters were used per setting. 
 
 
2.3.2.  Evaluation of rinsing procedure 
 
To evaluate the effect of an increasing rinsing volume on the microsphere retention of the glass 
fibre filters, the rinsing volume was increased from 40 ml (20 ml distilled water and 20 ml 
phosphate buffer) to 200 ml (180 ml distilled water and 20 ml phosphate buffer) (increasing the 
water volume with 40 ml per experiment; n = 3). The vacuum pressure was set at 40 kPa. 
 
Additionally, the sequence of the applied rinsing fluids was evaluated. Five filters were prepared 
by filtration of 10 ml of the KOH-Tween™80 solution without microspheres. All filters were rinsed 
with a total volume of 40 ml but the water volume was gradually replaced by phosphate buffer 
solution (increasing the buffer volume with 10 ml per experiment; n = 1). The neutralization of the 
remaining alkaline KOH on the glass fibre filters was monitored for these different rinsing 
procedures by measuring the pH of the filtrate. 
 
 
2.4.  Optimization of extraction procedure 
 
The original 2% (w/v) microsphere suspensions were diluted to a concentration of 0.0008% in 
distilled water with 2% Tween™80 (v/v). The 1 µm and 3 µm spheres were combined as well as 
the 5 µm and 10 µm spheres. The 20 µm spheres were used separately. Glass fibre filters were 
placed in Petri dishes, spiked with 1 ml of a microsphere suspension and placed in test tubes 
after air-drying. Afterwards, the filters were immersed in Cellosolve® acetate, subsequently filters 
were removed and extracts were centrifuged at 2500g for 10 min. The fluorescent intensities 
were measured and the number of microspheres extracted was expressed as a percentage of the 
number of microspheres present in 1 ml of microsphere suspension.  
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2.4.1.  Evaluation of extraction time 
 
The optimal extraction time was evaluated by immersing the filters in 6 ml of Cellosolve® acetate 
for a different period of time ranging between 5 and 125 min after which each filter was 
immediately processed and measured. One filter was used per extraction time. 
 
 
2.4.2.  Evaluation of extraction volume 
 
For the evaluation of the optimal extraction volume, three filters were used per microsphere 
combination and per extraction volume. The evaluated volumes of Cellosolve® acetate were 2, 4 
and 6 ml. Extraction was allowed for 2 h after which the filters were removed, the extracts 
centrifuged and the fluorescent intensities measured. 
 
 
2.5.  Microsphere recovery during complete sample processing procedure 
 
Using the optimal filtration and extraction conditions, the recovery percentage of the 
microspheres after sample processing was determined. Stock suspensions (10 ml of 0.16% (w/v) 
of microspheres in a 4 N KOH-solution, containing 2% (v/v) Tween™80, were filtered at 40 kPa 
vacuum pressure and the filters were rinsed with 20 ml distilled water and 20 ml phosphate 
buffer. After drying, the filters were immersed in 6 ml Cellosolve® acetate for 2 h to extract the 
fluorochromes. Afterwards, the filters were removed, the extracts were centrifuged at 2500g for 
10 min and fluorescent intensities were measured. The recovery percentage was calculated by 
comparing the number of microspheres detected in the extracts with the number of microspheres 
initially added to the stock suspensions. Three filters were used per microsphere combination (i.e. 
1 and 3 µm spheres combined; 5 and 10 µm spheres combined; 20 µm spheres separately). 
 
 
2.6.  Preliminary in vivo experiments 
 
2.6.1.  Evaluation of deposition of microspheres in adult layers 
 
Adult unanaesthetized layers (ISA brown, 18 weeks; n = 5) were obtained from a commercial 
farm. Before aerosol exposure, the birds were fasted for at least 12 h. The microspheres were 
nebulized with the Walther Pilot I spray-head operated at an air pressure of 0.5 bar and a spray 
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rate of 1.25 ml/min, and placed in the 50 cm inlet of the extended exposure chamber. 
Intermittent nebulization with a 110 s interval in between 10 s nebulization periods was used to 
nebulize a suspension containing 0.16% (w/v) of both 1 and 3 µm spheres or 0.16% (w/v) of both 
5 and 10 µm spheres. 
 
 
2.6.2.  Evaluation of deposition of microspheres in broilers using two different nebulizers 
 
In a second experiment, the influence of microsphere agglomeration on in vivo results was 
evaluated using both nebulizers in 2-week-old broiler chickens obtained from commercial farms 
(Cobb; n = 10 with Walther Pilot I spray-head, n = 5 with Pari nebulizer). The birds were exposed 
to an aerosol of 1 and 3 µm spheres. The same settings as described for the first in vivo 
experiment were used to nebulize the microspheres with the Walther Pilot I spray-head. As for the 
Pari nebulizers, the same number of 1 and 3 µm spheres were nebulized; however, these were 
equally divided over two nebulizers with 0.08% (w/v) of both sizes in each reservoir. The spray 
rate of the Pari nebulizers was 0.4 ml/min and a nebulization protocol of 30 s spraying periods 
with 90 s intervals was used. 
 
In all in vivo experiments, birds were placed separately in the chamber and exposed during        
20 min to one of the aerosols. As blank control, two chickens were exposed to nebulized water 
without microspheres. 
  
Birds were handled and treated according to a protocol approved by the Ethical Committee of the 
Faculty of Veterinary Medicine (Ghent University) in agreement with the Belgian regulations on 
protection and welfare of animals. 
 
 
2.6.3.  Counting of fluorescent microspheres in the birds 
 
Immediately after exposure, chickens were killed by cervical dislocation and subsequently bled. 
The skin and feathers were removed to prevent contamination of the internal tissues with 
microspheres deposited on the body of the chickens. Before removing the sternum completely, it 
was carefully lifted approximately 2 cm in order to precisely excise the cranial and caudal thoracic 
air sacs by transecting the ribs. The lungs were separated from the extrapulmonary primary 
bronchi, which in turn were separated from the trachea, 1 cm cranial of the syrinx. The trachea 
was excised together with the larynx. Additionally, the following parts of the gastro-intestinal tract 
were sampled: lower beak with tongue, and oesophagus with crop. Finally, the anterior part of the 
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head (including the upper beak with the nasal conchae and eyes with accessory glands) was 
sampled by transversally cutting the head at the height of the processus orbitalis of the os 
temporale. In summary, the samples collected were: anterior part of the head (further referred to 
as “nose and eyes”), larynx with trachea, syrinx (with extrapulmonary primary bronchi), left and 
right lung, left and right thoracic air sacs, lower beak with tongue, and oesophagus with crop. 
 
The tissue samples were digested at 60°C with 5 ml of a 4 N KOH-solution, containing 2% (v/v) 
Tween™80, per gram of tissue. The liquefied tissue samples were subsequently filtered on the 
vacuum manifold, operated at a vacuum pressure of 40 kPa. The recipients and filters were 
rinsed with 20 ml distilled water and 20 ml phosphate buffer, the filters were placed in glass test 
tubes and allowed to dry. The dried filters were immersed in 6 ml Cellosolve® acetate during 2 h 
to extract the fluorescent labels from the microspheres. After removal of the filters, the extracts 
were centrifuged at 2500g during 10 min to precipitate the remaining fibres and microspheres. 
The fluorescence of the samples was measured and the number of microspheres was corrected 
for the background fluorescence measured in the blank control birds and for the loss of 
microspheres during sample processing. Finally, the deposition percentage was calculated, which 
is the number of microspheres per tissue sample expressed as a percentage of the total number 
of microspheres detected per chicken. The detection limit was determined according to the 
guidelines of the International Conference on Harmonization (ICH) for validation of analytical 
methods: detection limit = 3.3 x σ / S with σ = standard deviation of Y-intercept of mean 
calibration curve and S = slope of mean calibration curve (EMEA, European Medicines Agency) 
(1995). 
 
 
2.6.4.  Statistical analysis 
 
Statistical analyses (SPSS version 12.0; SPSS, Chicago, Illinois, USA) of the deposition 
percentages were considered significant at P < 0.05. To evaluate the effect of microsphere size 
for microspheres detected in different chickens, a two-way analysis of variance (ANOVA) was 
used. This allowed comparing the 1 and 5 µm spheres, the 1 and 10 µm spheres, the 3 and 5 µm 
spheres, and the 3 and 10 µm spheres. To compare the microsphere sizes measured in one 
chicken (1 vs. 3 µm; 5 vs. 10 µm), or to compare the different tissue samples, a multivariate 
repeated-measures ANOVA design was used, with the microsphere size or the tissue sample as 
within-subject factor, respectively. The suspension of which the microspheres originated divided 
the population in subgroups and was used as the between-subject factor for these analyses. The 
repeated-measures design was also used for the evaluation of the influence of different 
nebulizers, with the nebulizer type as between-subject factor and the microsphere size as within-
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subject factor. In all ANOVA analyses, the normality of the data was evaluated with the 
Kolmogorov-Smirnov test. The homogeneity of variances was checked with the Levene’s test and 
the data were transformed if necessary. Additionally, the Box’s test of Equality of Covariance 
Matrices was used to evaluate the homogeneity of covariance matrices. A Bonferroni correction 
was applied for post hoc investigation of the effects. 
 
 
3.  Results 
 
3.1.  Evaluation of the microsphere nebulization method 
 
3.1.1.  Effect of aerosol generation on relative humidity in the exposure chamber 
 
Lining the chamber walls with Wypall® L40 cloth could keep RH on the starting value of 50% while 
in a chamber with uncovered side walls RH increased to 60% after a 20 s nebulization period with 
the Pari nebulizer (Figure 2.4). 
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Figure 2.4. Relative humidity (RH) in the exposure chamber (V = 28.1 L) upon nebulization of water with the Pari 
nebulizer during 20 s from the 33 cm inlet of the chamber. RH was monitored from the start of nebulization and the 
arrow indicates the end of the nebulization period. 
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Following continuous nebulization of 1.5 ml water with the Walther Pilot I spray-head, RH reached 
75% within a short period of time. A similar RH was obtained using intermittent nebulization with 
a 50 s interval in between 10 s nebulization periods. However, with a larger interval (110 s) the 
maximal RH only reached 60% (Figure 2.5). 
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Figure 2.5. Relative humidity (RH) in the exposure chamber (V = 28.1 L) upon nebulization of 1.5 ml water with the 
Walther Pilot I spray-head (spray rate = 1.25 ml/min and nebulizing air pressure = 0.5 bar) from the 33 cm inlet of the 
chamber. RH was monitored from the start of nebulization and evaluated for different spraying procedures (n = 1). The 
arrows indicate the end of the nebulization period: 70 s for continuous nebulization, 7 and 14 min for the 50 and the 
110 s interval nebulization, respectively. 
 
 
 
3.1.2.  Spray rate and nebulizing air pressure: effect on droplet size distribution 
 
The droplet size distributions produced by the Walther Pilot I spray-head in function of nebulizing 
air pressure are shown in Figure 2.6. The aerosol spectra of the spray-head depended on 
nebulizing air pressure as the median volume diameter (D[v,0.5]) decreased from 21.2 µm to 
12.5 µm with increasing pressure (0.5 - 2 bar). Spray rate did not influence the spectra        
(Figure 2.7) with D[v,0.5] varying between 20.1 and 21.8 µm, and no major differences in 
distribution width. The Pari nebulizer produced an aerosol with a D[v,0.5] of 5.4 µm (Figure 2.8). 
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Figure 2.6. Average droplet size distribution (n = 3) produced by the Walther Pilot I spray-head for increasing nebulizing 
air pressure (spray rate = 1.25 ml/min). The results are expressed as a volume distribution (i.e. percentage of droplets 
with a certain volume are plotted in function of their diameter). 
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Figure 2.7. Average droplet size distribution (n = 3) produced by the Walther Pilot I spray-head for increasing spray rate 
(nebulizing air pressure = 0.5 bar). The results are expressed as a volume distribution (i.e. percentage of droplets with 
a certain volume are plotted in function of their diameter). 
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Figure 2.8. Average droplet size distribution (n = 3) produced by the Pari LC jet nebulizer. The results are expressed as 
a volume distribution (i.e. percentage of droplets with a certain volume are plotted in function of their diameter). 
 
 
 
3.2.  Characterization of the microsphere aerosols: particle size, output, agglomeration, 
         and sedimentation 
 
3.2.1.  Evaporation of the water film surrounding the nebulized microspheres 
 
Figure 2.9 shows the number distribution of aerodynamic particle sizes detected on the bottom of 
the exposure chamber. Sharp peaks were present at size values which corresponded with the 
polystyrene microsphere sizes. For the 3, 5 and 10 µm spheres, there were no considerable 
signals at sizes larger than the microsphere size, and peak broadness was symmetrical within the 
limits of regular size distribution of monodisperse polystyrene particles. However, at 1 µm, tailing 
at the right side of the peak (1.1 to 2.0 µm) was observed, which comprised 28% of the particles 
detected. When water without microspheres was nebulized, most of the water droplets 
evaporated to sizes smaller than 1 µm. 
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Figure 2.9. Average aerodynamic particle diameters detected at the bottom of the exposure chamber (n = 2) after 
nebulization of water without microspheres and nebulization of microsphere suspensions. Sharp, symmetrical peaks 
indicate complete evaporation of the water film around the microspheres. 
 
 
 
3.2.2.  Output of microspheres 
 
The output from the Walther Pilot I spray-head was nearly complete as 92, 100 and 87% of 1, 3 
and 5 µm spheres, respectively, were recovered. The output was lower for the larger 
microspheres, although still 75 and 50% was nebulized for the 10 and 20 µm spheres, 
respectively. The output of the Pari nebulizer varied between 1 and 9%, and the same 
relationship between microsphere size and output was seen as with the spray-head (i.e. lower 
output for larger microspheres). 
 
 
3.2.3.  Microsphere agglomeration and sedimentation 
 
The influence of nebulization parameters on microsphere agglomeration evaluated with the 
Walther Pilot I spray-head and a combination of 3 and 10 µm spheres, is shown in Table 2.1. 
 
When the exposure chamber volume was increased from 28.1 to 40.6 L (nebulization height of 
25 and 50 cm, respectively), the single microsphere percentage increased from 63 to 87% and 
from 66 to 95% for the 3 and 10 µm spheres, respectively. Using intermittent nebulization, the 
single microsphere percentage was 10 and 25% higher for the 3 and 10 µm spheres, 
respectively, in comparison with continuous nebulization. The number of microspheres detected 
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on the cover glasses still increased after 20 min as can be seen from the higher number of 
microspheres counted after 45 min sedimentation. Increasing the microsphere concentration 
from 0.04% (w/v) to 0.08% (w/v) did not have an influence on the 10 µm sphere agglomeration, 
and reduced the percentage of single 3 µm spheres only slightly (Table 2.1). 
 
 
Table 2.1. Influence of different nebulization parameters on microsphere agglomeration and sedimentation of 3 and 
10 µm spheres after nebulization with the Walther Pilot I spray-head (n = 1) 
 
Evaluated parameter Parameter settings a  3 µm 10 µm 
  
 
Single 
spheres 
(%) 
Number 
of 
counted 
spheres 
Single 
spheres 
(%) 
Number 
of 
counted 
spheres 
Nebulization height (box volume) 25 cm (V = 28.1 L)  62.8 15124 66.0 473 
 33 cm (V = 28.1 L)  77.9 7698 83.6 298 
 50 cm (V = 40.6 L)  86.6 8595 95.3 408 
       
Spray duration and interval Continuous  68.1 6359 58.3 108 
 10 s every 50 s  80.8 4899 84.8 151 
 10 s every 110 s  77.9 7698 83.6 298 
       
Sedimentation time  15 min  80.8 6001 91.9 310 
(nebulization height of 50 cm) 20 min  86.6 8595 95.3 408 
 45 min  76.1 12717 82.8 436 
       
Microsphere concentration (w/v) 0.04% of 3 and 10 µm  77.9 7698 83.6 298 
 0.08% of 3 and 10 µm  70.4 14295 83.7 398 
 
a Standard parameter settings for nebulization are 33 cm nebulization height (V = 28.1 L) / 10 s every 110 s / 20 min 
sedimentation time / 0.04% (w/v) of 3 and 10 µm spheres, unless specified differently. 
 
 
The intermittent nebulization with the 110 s interval was subsequently used for nebulization of 
microsphere suspensions in the 40.6 L box from the 50 cm inlet, as these parameters were 
considered as best ‘fit’. The experimental period was limited to a sedimentation time of 20 min. 
After nebulization with the Walther Pilot I spray-head, the single microsphere percentage for 1 
and 3 µm spheres was 5 and 30%, respectively. This percentage increased to 73 and 84% for the 
5 and 10 µm spheres, respectively. No agglomerates were detected after nebulization of the     
20 µm spheres with the spray-head (i.e. these microspheres were presented in a monodisperse 
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aerosol cloud). Using the Pari nebulizer, the single microsphere percentage was 72 and 87% for 
the 1 and 3 µm spheres, respectively.  
 
 
3.3.  Optimization of filtration procedure 
 
3.3.1.  Evaluation of vacuum pressure 
 
The influence of vacuum pressure on the recovery of microspheres is shown in Table 2.2. Mainly 
the 1 µm spheres were sensitive to higher vacuum pressure, as an increase from 20 to 60 kPa 
reduced the recovery by 20%. Also for the other microspheres the recovery tended to decrease 
with increasing vacuum pressure, although the differences between 20 and 60 kPa were only 
about 10%. 
 
 
Table 2.2. Recovery of microspheres (average ± SD) after filtration of stock suspensions of the combined microspheres 
(i.e. 1 µm with 3 µm and 5 µm with 10 µm) over GF51 glass fibre filters and after rinsing with 20 ml distilled water and 
20 ml phosphate buffer (pH 7.4) using increasing vacuum pressures (n = 3 per vacuum pressure) 
 
Vacuum pressure  Recovery (%) 
  1 µm spheres 3 µm spheres 5 µm spheres 10 µm spheres 
20 kPa  60.3 ± 3.5 63.9 ± 1.3 97.6 ± 0.3 95.9 ± 0.6 
30 kPa  57.3 ± 3.3 65.2 ± 2.4 96.4 ± 1.8 96.3 ± 0.8 
40 kPa  49.8 ± 5.0 63.7 ± 4.7 90.5 ± 4.1 88.6 ± 2.8 
50 kPa  48.2 ± 1.9 59.0 ± 3.3 91.5 ± 4.3 85.5 ± 2.5 
60 kPa  42.9 ± 2.9 58.0 ± 2.4 90.4 ± 1.2 83.4 ± 2.5 
 
 
 
3.3.2.  Evaluation of rinsing procedure 
 
A gradual decrease in recovery percentage was seen when larger volumes were used for rinsing 
the filters: depending on the microsphere size, the recovery dropped by as much as 20% when 
the rinsing volume was increased from 40 to 200 ml (Table 2.3). 
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Table 2.3. Recovery of microspheres (average ± SD) after filtration (vacuum pressure: 40 kPa) of stock suspensions of 
the combined microspheres (i.e. 1 µm with 3 µm and 5 µm with 10 µm) over GF51 glass fibre filters and after rinsing 
with increasing volumes (n = 3 per rinsing volume) 
 
Rinsing volume  Recovery (%) 
  1 µm spheres 3 µm spheres 5 µm spheres 10 µm spheres 
40 ml  49.8 ± 5.0 63.7 ± 4.7 90.5 ± 4.1 88.6 ± 2.8 
80 ml  50.3 ± 1.9 57.8 ± 1.9 83.6 ± 2.2 79.4 ± 4.8 
120 ml  44.9 ± 6.7 55.5 ± 3.3 75.5 ± 5.1 74.4 ± 3.4 
160 ml  43.3 ± 2.3 53.7 ± 2.7 77.5 ± 2.9 71.9 ± 2.5 
200 ml  35.1 ± 1.7 52.1 ± 3.7 71.5 ± 3.2 69.5 ± 8.9 
 
 
The effect of different combinations of rinsing fluids on the neutralization of the filters (evaluated 
via pH of the filtrate) is shown in Table 2.4. Rinsing with 40 ml distilled water could only reduce 
pH of the filtrate to 12.1. When 10 ml phosphate buffer was used for the last rinsing step, a 
neutral pH of 7.6 was reached. Neutral pH was already obtained after the third rinsing step when 
phosphate buffer was used instead of water in this step. However, further replacement of water 
with phosphate buffer did not contribute to a faster neutralization as neutral pH was also only 
reached after the third rinsing step. 
 
 
Table 2.4. pH of filtrates for different rinsing fluid combinations after filtration of 4 N KOH digestion solution without 
microspheres over GF51 glass fibre filters with a vacuum pressure of 40 kPa (n = 1 per rinsing fluid combination) 
 
Rinsing fluid combination  pH of filtrates after each rinsing step 
  1st filtrate 2nd filtrate 3rd filtrate 4th filtrate 
4 x 10 ml water  13.4 12.4 12.1 12.1 
3 x 10 ml water; 1 x 10 ml buffer  13.4 12.7 12.3 7.6 
2 x 10 ml water; 2 x 10 ml buffer  13.3 12.8 7.7 7.7 
1 x 10 ml water; 3 x 10 ml buffer  13.5    8.1 7.6 7.6 
4 x 10 ml buffer  12.4    8.5 7.9 7.7 
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3.4.  Optimization of extraction procedure 
 
3.4.1.  Evaluation of extraction time 
 
Extraction efficiency (i.e. the number of microspheres extracted expressed as a percentage of the 
number of microspheres spiked on the filter) increased for all microspheres in function of 
extraction time (Figure 2.10). After 1 h, more than 80% of the fluorochrome of all microsphere 
types was extracted by the solvent and in all cases values of about 100% were found after 2 h in 
the extraction solvent. 
 
0
20
40
60
80
100
120
0 20 40 60 80 100 120 140
Ext rac t ion  t ime ( min )
E
xt
ra
c
ti
o
n
 e
ff
ic
ie
n
cy
 (
%
)
1 µm 3 µm 5 µm 10 µm 20 µm
 
Figure 2.10. Extraction efficiency of differently sized microspheres after spiking on GF51 glass fibre filters in function  
of increasing extraction time (n = 1). 
 
 
 
3.4.2.  Evaluation of extraction volume 
 
The extraction efficiency in function of increasing extraction volumes is presented in Table 2.5. 
The percentage of extracted microspheres increased for all microspheres when higher volumes of 
Cellosolve® acetate were added to the filters in the test tubes. In addition, standard deviation 
generally decreased with higher volumes. 
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Table 2.5. Extraction efficiency (average ± SD) of differently sized microspheres after spiking on GF51 glass fibre filters 
in function of increasing extraction volume (n = 3) 
 
Extraction volume  Recovery (%) 
  1 µm spheres 3 µm spheres 5 µm spheres 10 µm spheres 20 µm spheres 
2 ml      95.3 ± 10.9   100.5 ± 14.2 93.3 ± 6.0 94.6 ± 9.4 92.6 ± 8.0 
4 ml  100.8 ± 1.8 110.6 ± 1.3 94.3 ± 2.0 98.1 ± 5.3 93.2 ± 2.1 
6 ml  101.8 ± 0.6 110.0 ± 1.0 98.5 ± 1.7 98.4 ± 1.2 95.2 ± 5.4 
 
 
 
3.5.  Microsphere recovery during complete sample processing procedure 
 
The microsphere recovery during filtration and extraction was independent of microsphere size 
and repeatable for all microspheres (Table 2.6). 
  
 
Table 2.6. Microsphere recovery (average ± SD) of differently sized microspheres during filtration and extraction (n = 3) 
 
Microsphere size  Recovery (%) 
1 µm  78.3 ± 6.0 
3 µm  82.1 ± 1.9 
5 µm  72.7 ± 3.8 
10 µm  77.8 ± 1.9 
20 µm  78.0 ± 4.2 
 
 
 
3.6.  Preliminary in vivo experiments 
 
Detection limits obtained with the microspheres applied for the in vivo experiments (expressed as 
number of microspheres per ml) were 15472, 24, 250, 4, and 0.12 for 1, 3, 5, 10, and 20 µm 
spheres, respectively. The number of microspheres in each separate tissue sample was for all 
microsphere types above detection limit. 
 
 
- 60 - 
A method for determining the deposition pattern of nebulized microspheres in the airways of chickens 
3.6.1.  Evaluation of deposition of microspheres in adult layers 
 
Table 2.7 shows the average deposition percentages of four different microsphere sizes, 
nebulized by the Walther Pilot I spray-head, after inhalation by adult unanaesthetized layers. The 
results are graphically shown in Figure 2.11.  
 
 
Table 2.7. Deposition percentages (average ± SD) in adult layers (n = 5) obtained after nebulization of microspheres 
with the Walther Pilot I spray-head 
 
Tissue sample  Deposition (%) 
  1 µm spheres 3 µm spheres 5 µm spheres 10 µm spheres 
Oesophagus + crop           2.7 ± 1.6          2.6 ± 1.4          2.1 ± 1.8           3.1 ± 2.1 
Lower beak + tongue         12.1 ± 8.2          9.7 ± 8.1          4.7 ± 2.9           6.7 ± 4.3 
Thoracic air sacs           1.6 ± 0.5          1.2 ± 0.3          1.1 ± 0.4           2.2 ± 1.3 
Lungs         37.8 ± 7.6        36.2 ± 7.9        12.7 ± 1.9           5.1 ± 1.9 
Syrinx           0.5 ± 0.2          0.3 ± 0.1          1.3 ± 1.0           0.4 ± 0.2 
Larynx + trachea         15.5 ± 8.8        13.2 ± 5.7          5.7 ± 5.2           1.8 ± 1.2 
Nose + eyes         30.0 ± 7.7        37.0 ± 9.4        72.3 ± 7.5         80.7 ± 6.8 
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Figure 2.11. Average deposition percentages in adult layers (n = 5) obtained after nebulization of microspheres with 
the Walther Pilot I spray-head. The blue segments represent the deposition in the upper airways (i.e. nose and eyes, 
larynx with trachea, and syrinx), the red segments comprise the deposition in the lower airways (i.e. lungs and thoracic 
air sacs), and the yellow segments show the amount of microspheres in part of the gastro-intestinal tract (i.e. lower 
beak with tongue and oesophagus with crop). 
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The upper airways (nose and eyes, larynx with trachea, syrinx) retained 46 and 50% of the 1 and 
3 µm spheres, respectively. These percentages increased to 79 and 83% for the 5 and 10 µm 
spheres, respectively. Thirty nine and 37% of the 1 and 3 µm spheres, respectively, were 
deposited in the lower airways (lungs, thoracic air sacs), whereas 14% of the 5 µm spheres and 
7% of the 10 µm spheres were detected in these samples. The remainder of the microspheres 
was deposited in the gastro-intestinal samples (lower beak with tongue, oesophagus with crop). 
 
 
3.6.2.  Evaluation of deposition of microspheres in broilers using two different nebulizers 
 
The Walther Pilot I spray-head and the Pari nebulizers were compared by analyzing the deposition 
patterns in 2-week-old broiler chickens after generating aerosols of 1 and 3 µm spheres        
(Table 2.8 and Figure 2.12).  
 
Regarding 1 µm spheres (Figure 2.12.A), 60 and 43% were deposited in the upper airways, while 
31 and 49% were detected in the lower airways using the Walther Pilot I spray-head and the Pari 
nebulizers, respectively. After nebulization of 3 µm spheres (Figure 2.12.B), 72 and 71% were 
found in the upper airways whereas 20 and 22% were deposited in the lower airways with the 
spray-head and the Pari nebulizer, respectively. When the samples were considered separately in 
the statistical analysis, the 1 µm spheres were deposited in a significantly lower percentage in the 
lungs (P = 0.018) and the thoracic air sacs (P = 0.000) after nebulization with the Walther Pilot I 
spray-head. The deposition in all other samples was not significantly influenced by the nebulizer 
type. 
 
 
Table 2.8. Deposition percentage (average ± SD) of 1 and 3 µm spheres in 2-week-old broiler chickens using the 
Walther Pilot I spray-head (n = 10) and the Pari nebulizers (n = 5) 
 
Tissue sample  Deposition (%) 
  1 µm spheres 3 µm spheres 
  Spray-head Pari nebulizers Spray-head Pari nebulizers 
Oesophagus + crop    4.5 ± 5.0   4.0 ± 3.8 5.2 ± 7.5 4.1 ± 6.9 
Lower beak + tongue    3.7 ± 2.9   4.1 ± 2.0 3.5 ± 3.3 2.5 ± 1.7 
Thoracic air sacs    2.1 ± 0.6        3.5 ± 0.5 0.6 ± 0.4 0.8 ± 0.3 
Lungs    29.4 ± 11.8 45.6 ± 5.6 19.1 ± 15.2 21.5 ± 11.8 
Syrinx    2.8 ± 3.0   1.2 ± 0.5 2.8 ± 3.1 1.3 ± 1.3 
Larynx + trachea    22.1 ± 13.1 18.8 ± 4.0 23.2 ± 17.0 43.8 ± 14.7 
Nose + eyes    35.3 ± 16.7 22.8 ± 8.6 45.7 ± 22.8 26.1 ± 12.6 
- 62 - 
A method for determining the deposition pattern of nebulized microspheres in the airways of chickens 
 
            A.           B. 
             
0
10
20
30
40
50
60
70
80
90
100
Spray-
head
Pari
D
e
p
o
s
it
io
n
 p
e
rc
e
n
ta
g
e
 (
%
)
               
0
10
20
30
40
50
60
70
80
90
100
Spray-
head
Pari
D
e
p
o
s
it
io
n
 p
e
rc
e
n
ta
g
e
 (
%
)
Oesophagus + crop
Lower beak + tongue
Thoracic air sacs
Lungs
Syrinx
Larynx + trachea
Nose + eyes
 
Figure 2.12. Evaluation of deposition of microspheres (A: 1 µm spheres; B: 3 µm spheres) in 2-week-old broiler 
chickens using the Walther Pilot I spray-head (n = 10) and the Pari nebulizers (n = 5). The blue segments represent the 
deposition in the upper airways (i.e. nose and eyes, larynx with trachea, and syrinx), the red segments comprise the 
deposition in the lower airways (i.e. lungs and thoracic air sacs), and the yellow segments show the amount of 
microspheres in part of the gastro-intestinal tract (i.e. lower beak with tongue and oesophagus with crop). Although 
some differences can be observed, these are not significant, except for the 1 µm spheres deposited in the lungs. 
 
 
4.  Discussion 
 
As the microspheres are suspended in a liquid environment, they are found in moisture droplets 
after aerosol generation. It is essential for the water to completely evaporate if the microspheres 
are to be inhaled by the chickens in their original size. The evaporation rate is influenced by 
temperature, relative humidity in the exposure chamber and droplet size itself. A low RH and 
small droplet size will enhance evaporation rate. During the in vitro evaluation, the aim was to 
keep RH as low as possible since humid air exhaled by the chickens could further increase RH 
during the in vivo experiments. A successful measure to control RH in the exposure chamber was 
lining the chamber walls with Wypall® L40 cloth. This moisture-absorbing cloth reduced RH in the 
exposure chamber upon nebulization of water in comparison to an exposure chamber without 
lining by approximately 10%. In addition, adjusting the spray duration and spray interval allowed 
control of RH in function of time. The use of a 110 s interval in the nebulization protocol reduced 
the maximal RH obtained to 60% compared to 75% with the other nebulization protocols, as the 
moisture had more time to dissipate from the exposure chamber during each interval. In this 
perspective, it was also important to use a low spray rate (1.25 ml/min) as RH is expected to 
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reach higher values when introducing larger volumes in the chamber within a certain period of 
time.  
 
The median droplet sizes (D[v,0.5]) produced by the Walther Pilot I spray-head could be 
decreased by increasing the nebulizing air pressure. This is explained by the droplet forming 
mechanism where the liquid is first stretched into a thin layer, which then splits into droplets. 
Both of these steps require energy: firstly, to overcome viscous forces and, secondly, to overcome 
an increasing surface tension related to the creation of a larger air-contact surface. When more 
energy is added, for example by increasing the nebulizing air pressure, it is possible to extend this 
air-contact surface and to form smaller droplets (Swift, 1980). Although smaller droplets would 
assure faster evaporation, the lowest air pressure (0.5 bar) was selected for further experiments 
for a number of reasons, the first being the formation of some very large droplets (> 500 µm) at 
higher air pressures, as can be seen from the higher end-peaks in Figure 2.6. Although the 
number of large droplets was low in all cases, their number was clearly increasing with higher 
nebulizing air pressures. Secondly, a higher air pressure created more turbulence in the exposure 
chamber, which might stress the chickens and subsequently alter their breathing pattern. Thirdly 
and finally, the determination of the size of particles reaching the bottom of the exposure 
chamber showed that water droplets generated by the Walther Pilot I spray-head at 0.5 bar 
evaporated to droplets mainly smaller than 1 µm. Evaporation of the water film around the 
microspheres was confirmed after nebulization of microsphere suspensions: the sharp peaks in 
Figure 2.9 indicate that no water film remained around microspheres larger than 1 µm when they 
reached the bottom of the exposure chamber. However, the particles in the size range between 
1.1 and 2.0 µm do not range within regular size limits of monodisperse 1 µm polystyrene 
microspheres and might be due to some water remaining around the 1 µm spheres. As this is only 
a small part of the total number of 1 µm spheres present in the exposure chamber, it is not 
expected that this will influence the deposition pattern detected for the 1 µm spheres. 
  
The droplet sizes produced by the Pari nebulizer comply with the general requirement of 5 µm 
droplets for reaching the human lungs. The small droplet sizes are yielded due to the presence of 
obstacles (baffles) in the nebulizer reservoir, which will retain larger droplets that subsequently 
will flow back into the reservoir (Atkins et al., 1992). 
 
As a sufficient number of microspheres had to be available for inhalation by a chicken placed in 
the exposure chamber, it was essential that only a limited percentage of the microspheres were 
retained in the nebulizer reservoir. The output of the microspheres was adequate using the 
Walther Pilot I spray-head; however, it decreased with increasing microsphere sizes. This lower 
output for larger microspheres was due to the smaller difference between droplet size and 
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microsphere size, reducing the probability that droplets carry microspheres. The extremely low 
output of the Pari nebulizer, was explained by the fact that the baffles in the reservoir removed 
large particles from the aerosol, as mentioned previously. The dead volume of the reservoir also 
contributed to the low output as a considerable fraction of the microsphere suspensions 
remained in the Pari nebulizer. Overall, the Pari nebulizer seemed less suitable to present a high 
number of microspheres to the chickens. 
  
Microsphere agglomeration had to be as low as possible in order to prevent that the chickens 
inhaled agglomerates which are larger than the original microspheres. To minimize this, the 
probability of microspheres colliding in the air after nebulization should be as low as possible. 
This could be achieved by increasing the volume of the chamber in which the microspheres were 
nebulized and/or by varying the nebulization procedure (intermittent nebulization vs. continuous 
nebulization), as confirmed by the results of the different evaluations. An additional benefit using 
intermittent nebulization during in vivo experiments was that microspheres were available for 
inhalation over a much longer period. Additionally, the influence of concentration on 
agglomeration was tested as it might be necessary to increase microsphere concentration in 
order to obtain detectable fluorescent signals in the respiratory system during the in vivo 
experiments. An increase in concentration might increase the agglomeration tendency due to a 
higher probability of droplets containing multiple microspheres, but the results did not support 
this. 
 
The sedimentation data showed that the microspheres were still available for inhalation long after 
their theoretical sedimentation time in still air (e.g. 3 min for sedimentation of 10 µm spheres 
over 50 cm; Stokes’ law). Therefore, leaving the chickens longer in the exposure chamber will 
favour an additional uptake of microspheres. However, although exposure during 45 min would 
increase the inhaled amount, a 20 min exposure period was used as it was observed during 
preliminary in vivo trials that chickens became restless during longer exposure periods. 
  
Comparison of nebulizers showed that the Walther Pilot I spray-head had a high output but a low 
single microsphere percentage for 1 and 3 µm spheres, while the Pari nebulizer had the opposite 
result. The high output of the Walther Pilot I spray-head compensated for the low single 
microsphere percentage as the absolute number of nebulized single microspheres with the spray-
head and the Pari nebulizer was similar for 1 µm spheres, whereas for 3 µm spheres, the number 
of nebulized single microspheres was higher using the spray-head. 
  
It should be noted that the agglomeration was evaluated on the bottom of the box during these   
in vitro experiments and that agglomerates sediment faster than single microspheres. Therefore, 
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the single microsphere percentage on the bottom of the box is likely to be an underestimation of 
the amount of single microspheres presented to the chickens. 
 
The filtration procedure was evaluated in order to optimize the microsphere recovery from the 
tissue samples. Instead of membrane filters (Glenny et al., 1993; Raab et al., 1999) it was opted 
to use glass fibre filters. Membrane filters retain particles at their surface with a sharp cut-off 
value, but get easily clogged (Jornitz, 2002). However, GF51 glass fibre filters have a retention 
capacity of ± 1 µm allowing all microspheres in this study to be retained in the fibre network, they 
have a slow to medium filtration speed, and can be used when the samples contain high loads of 
particulate matter (no clogging). Additionally, these filters can withstand high alkaline 
concentrations. 
 
Due to the more random retention mechanism of glass fibre filters in comparison to membrane 
filters, the retention depends on the applied vacuum pressure and the rinsing volume. Firstly, the 
vacuum pressure determines the filtration force and speed. This reduces the recovery of 
microspheres when vacuum pressure is increased, as can be seen in Table 2.2. However, the 
lowest vacuum pressure will unnecessarily prolong the filtration time of viscous tissue samples 
and a vacuum pressure of 40 kPa was chosen as a compromise between good retention and high 
filtration speed. Secondly, large rinsing volumes can drag the microspheres deeper in the fibre 
network, eventually carrying them through the filter. This was illustrated by lower recovery 
percentages when larger rinsing volumes were used. However, the needed rinsing volume in 
terms of KOH neutralization was 30 ml of which at least the last 10 ml should be a buffer 
solution. The first rinsing steps mainly serve to rinse KOH from the filter and the buffer rinsing 
step neutralizes the low concentration of KOH left in the filter. An additional buffer rinsing step 
was adopted (i.e. rinsing with 20 ml water and 20 ml buffer), as the stability of extracted 
fluorochromes can be affected when pH deviates from 7 (Schulman & Hughes, 2002). 
  
Additionally, it was important to optimize the extraction procedure with respect to extraction time 
and volume of the extraction solvent. As expected, the extracted fluorochrome concentration 
gradually increased for all microspheres with longer extraction times. Although the increase was 
low in the second hour, it was necessary to completely recover the fluorochromes from the 
polystyrene microspheres. The evaluation of the extraction volume showed the highest and most 
repeatable results when 6 ml Cellosolve® acetate was used, logically explained by complete 
immersion of the filters. The lower extraction volumes were mainly evaluated in view of tissue 
samples with a low number of microspheres, in order to increase the fluorochrome concentration 
and the probability of reaching detection limits in each sample. An additional conclusion from the 
extraction experiments is that the extracted fluorochromes are stable in Cellosolve® acetate. It is 
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known that the intensity of fluorochromes not incorporated in a stabilizing polystyrene matrix 
might be affected by solvent, temperature and light (Glenny et al., 1993; Schulman & Hughes, 
2002). However, even after submersion during 2 h in the solvent at room temperature and 
unprotected from light, it was possible to recover 100% of the fluorochromes. Some filters show 
an extraction efficiency above 100%, which was attributed to errors when withdrawing very small 
volumes (6 µl) from the original microsphere suspensions for the preparation of the spiking 
suspensions.  
 
In summary, the optimal sample processing procedure includes filtration at a vacuum pressure of 
40 kPa, rinsing of filters with 20 ml distilled water and 20 ml phosphate buffer, and extraction of 
microspheres by immersing the filters in 6 ml Cellosolve® acetate during 2 h. This resulted in total 
recovery percentages between 70 and 80%, with a good repeatability for all microsphere sizes. 
  
As expected, the preliminary in vivo experiments showed that the upper airways of adult 
unanaesthetized layers retained a significantly higher percentage of 5 and 10 µm spheres 
compared to 1 and 3 µm spheres, caused by sedimentation on the eyes and impaction in the 
nose, although some of the larger microspheres were able to reach the lungs. This is in 
accordance with the results of Hayter & Besch (1974), obtained after exposure of adult 
anaesthetized layers, where microspheres of 3.7 to 7 µm were mainly detected in the head and 
the anterior trachea. However, in our preliminary in vivo experiment, both 1 and 3 µm spheres 
were equally divided between upper and lower airways, while Hayter & Besch detected the 1 µm 
spheres mainly in the posterior parts and the 3 µm spheres mainly in the anterior parts of the 
respiratory system. 
  
Comparison of in vivo results obtained after nebulization of 1 and 3 µm spheres with both 
nebulizers in broilers yielded statistically similar conclusions despite the high agglomeration 
tendency after nebulization with the spray-head. Since only 1 and 3 µm spheres could be 
generated with the Pari nebulizer, further experiments will be performed with the Walther Pilot I 
spray-head to study the whole range of microsphere sizes with the same nebulization protocol. 
 
  
5.  Conclusion 
 
The lack of knowledge regarding the deposition pattern of differently sized microspheres in 
unanaesthethized chickens has prompted the optimization of a nebulization system for 
fluorescently-labelled microspheres which was evaluated in vitro and thereafter tested in 
preliminary in vivo experiments. Factors such as the nebulization protocol, the design of the 
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exposure chamber, and the nebulizer type were evaluated. Additionally, a sample processing 
procedure, including filtration and extraction, has been optimized and standardized. The 
preliminary in vivo experiments showed the usefulness of the herein developed nebulization 
system to adequately expose unanaesthetized chickens to microsphere aerosols. The exposure 
chamber allowed the chickens to move freely and the nebulization did not seem to disturb the 
birds, ensuring a normal breathing pattern. In further experiments, described in Chapter 3, the 
influence of age on the deposition pattern of differently sized microspheres was evaluated in 
order to make an estimation of the optimal particle sizes for respiratory powder vaccinations. 
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Chapter 3
DEPOSITION OF DIFFERENTLY SIZED AIRBORNE 
MICROSPHERES IN THE RESPIRATORY TRACT OF 
CHICKENS

Chapter 3 – Deposition of differently sized airborne microspheres in the respiratory tract of chickens 
1.  Introduction 
 
Deposition of aerosolized particles in human airways is well documented (Brain et al., 1985; 
Hatch, 1961; Swift, 1980); however, extrapolation from human data to birds is not possible due 
to the particular characteristics of the avian respiratory system such as air sacs and the flow of air 
through the lungs (Figure 3.1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1. Respiratory system of chickens (Clav. AS = clavicular air sac; Cran. Th. AS = cranial thoracic air sac; Caud. 
Th. AS = caudal thoracic air sac; Abd. AS = abdominal air sac) (Fedde, 1998). 
 
 
The respiratory system of birds consists of three major parts: the conducting airways, the lungs, 
and the air sacs. The air, inhaled through nose and/or beak, enters the trachea through the 
choanal cleft and/or glottis (slit-like openings in upper and lower beak, respectively), and 
continues towards the primary bronchi. Cranial to the lungs, the trachea bifurcates at the syrinx 
(responsible for vocalization in birds) into two short extrapulmonary primary bronchi. The primary 
bronchi extend through the entire lungs in an S-shaped bend (intrapulmonary primary bronchi) 
and end in the abdominal air sacs. In the lungs, the intrapulmonary primary bronchi branch into 3 
major groups of secondary bronchi. The first group contains the medioventral secondary bronchi 
which start from the cranial regions of the intrapulmonary primary bronchi and end in the cranial 
air sacs. The second and third group, the mediodorsal and lateroventral secondary bronchi, 
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originate from the caudal regions of the intrapulmonary primary bronchi and have connections 
with the caudal air sacs.  
 
The primary and secondary bronchi bring the air to the gas exchange regions of the lungs, the 
paleopulmonic and the neopulmonic parabronchi (or paleopulmo and neopulmo). The 
paleopulmo consists of parallel tubes, interconnecting the mediodorsal and the medioventral 
secondary bronchi, while the neopulmo forms a highly branched network of parabronchi, 
originating from the intrapulmonary primary bronchi, the lateroventral secondary bronchi and the 
mediodorsal secondary bronchi, and ending in the caudal air sacs.  
 
The air sacs, which are thin membranous structures, can be divided in a cranial and a caudal 
group. The cranial group contains the cervical air sacs (originating from the first medioventral 
secondary bronchi; not shown in Figure 3.1), the clavicular air sac and the cranial thoracic air 
sacs (both connected to the third medioventral secondary bronchi and the parabronchi). The 
caudal group consists of the caudal thoracic air sacs (connected to the lateroventral and the 
medioventral secondary bronchi) and the abdominal air sacs (attached to the intrapulmonary 
primary bronchi and the neopulmo). All air sacs are paired, i.e. one per lung, except for the 
clavicular air sac which connects both lungs (Figure 3.1) (Fedde, 1980; Fedde, 1998; Powell, 
2000). 
 
During inspiration (Figure 3.2.A), the respiratory muscles expand the body and subsequently the 
air sac volume. This decreases the pressure in the air sacs, and as a result air flows through the 
lungs into the air sacs. More in detail, 50% of the air flows through the intrapulmonary primary 
bronchi and the neopulmo straight into the abdominal and caudal thoracic air sacs, while 50% of 
the air changes direction towards the mediodorsal secondary bronchi and flows into the 
paleopulmo. Upon expiration (Figure 3.2.B), the respiratory muscles contract and reduce the air 
sac volume. Air is then directed from the caudal air sacs through the neopulmo, where the air 
flows either towards the intrapulmonary primary bronchi or to the paleopulmo. Hence, the 
paleopulmo receives air during both inspiration and expiration and in both cases air flows caudal 
to cranial through the parabronchi. The air coming from the cranial air sacs flows into the 
medioventral secondary bronchi and further into the intrapulmonary primary bronchi. This is 
mainly air from the previous inhalation, which was directed from the caudal air sacs to the 
paleopulmo upon expiration, but did not reach the medioventral secondary bronchi at the end of 
expiration. In the following respiration cycle, the air is drawn from the paleopulmo to the cranial 
air sacs due to the pressure difference during inspiration, and the air is only exhaled during 
expiration in this second breathing cycle (Fedde, 1980; Fedde, 1998; Powell, 2000). 
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Figure 3.2. Pathway of airflow in avian respiratory system (Powell, 2000). During inspiration (A), the air sacs expand 
and air is drawn from the outside through the trachea and primary bronchi, partly towards the caudal air sacs and 
partly towards the paleopulmonic parabronchi. During expiration (B), air is directed from the caudal air sacs to the 
paleopulmonic parabronchi and the intrapulmonary primary bronchi, and from the cranial air sacs to the 
intrapulmonary primary bronchi. 
 
 
The fraction of inhaled particles deposited in the respiratory system is governed by three major 
mechanisms: sedimentation, impaction and diffusion (Figure 3.3).  
 
 
  SEDIMENTATION (gravitation) IMPACTION (inertia)
DIFFUSION (Brownian movement)
 
 
 
 
 
 
 
 
 
Figure 3.3. Schematic representation of aerosol particle deposition in airways and the underlying mechanisms of 
deposition (between brackets) (adapted from Brain et al. (1985)). 
 
 
Sedimentation is caused by gravitational settling and is proportional to particle size and transit 
times through the tissue. The second mechanism, impaction, is caused by inertia: particles move 
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further along their original streamline, instead of following a deviating streamline (e.g. at airway 
bifurcations), and impact on airway walls in the streamline. The distance travelled in the original 
direction and thus the probability of reaching an airway wall, increases proportionally to the 
particle size, the air stream velocity and the angle of airway deflection. Submicron particles are 
mainly displaced from their original direction due to Brownian movement, which originates from 
the random collisions between gas molecules and particles, and are only deposited when they 
coincidently reach an airway wall (diffusion controlled deposition) (Brain et al., 1985). However, 
the latter mechanism does not apply for the larger particles used in this study. 
 
As discussed in Chapter 2, the deposition study performed by Hayter & Besch (1974) became the 
main reference in the field and the basis for the difference between spray and aerosol 
vaccination. Six-month-old anaesthetized layers were exposed to particles ranging between 0.1 
and 7 µm. According to this study, particles between 3.7 and 7 µm (polydisperse aerosol) were 
mainly detected in the head and anterior trachea. Particles of 1.1 µm were found in the lungs and 
posterior air sacs, while 0.312 µm particles, which are least influenced by aerosol deposition 
mechanisms such as impaction and diffusion, could reach the anterior air sacs. The smaller 
particles (0.176 and 0.091 µm) were deposited in the caudal regions of the respiratory system by 
diffusion. The study led to the general rule that particles larger than 5 µm are mainly deposited in 
the upper airways, while smaller particles will reach the lower airways.  
 
However, considering the drawbacks described in Chapter 2 (anaesthesia, external detection, 
adult chickens), a new particle deposition study was designed, in which unanaesthetized 
chickens of different ages could be exposed to aerosols of differently sized fluorescent 
microspheres. The deposition of microspheres ranging from 1 to 20 µm was studied after 
inhalation by 1-day-old, 2-week-old and 4-week-old broilers. Microspheres were nebulized using 
the system that was evaluated and optimized in Chapter 2. The analytical procedure, also 
described in Chapter 2, was adapted from the fluorescent microsphere method elaborated by 
Glenny et al. (1993). 
 
 
2.  Materials and methods 
 
2.1.  Exposure chamber and nebulization equipment 
 
The exposure chamber with a volume of 40.6 L (25 x 25 x 65 cm) was constructed of 
polycarbonate. The top of the box was not closed, but covered with a moisture-absorbing cloth 
(Wypall® L40; Kimberly-Clark, Zaventem, Belgium), which acted as a vent filter to prevent 
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excessive air pressure during nebulization. Additionally, the cloth was used to line the walls of the 
box as a measure to control relative humidity (RH) in the exposure chamber. Two inlet holes for 
the nebulization equipment were made in opposite vertical walls at 50 cm above the bottom of 
the box (i.e. about 40 and 30 cm above the head of 1-day-old and 4-week-old chickens, 
respectively), allowing nebulization with a horizontal trajectory (Figure 2.1). A Walther Pilot I spray-
head with a 0.5 mm diameter nozzle (Walther Spritz- und Lackiersysteme, Wuppertal, Germany) 
(Figure 2.2.A) coupled to an air compressor (Airpress Compressor HL 215/25; Fribel, Wilrijk, 
Belgium) was used to nebulize the microspheres. The spray-head was operated at a nebulizing air 
pressure of 0.5 bar and a spray rate of 1.25 ml/min using a 110 s interval between 10 s 
nebulization periods. A counter-current air stream generated by the same pressure as that of the 
nebulizer was introduced in the box at the same height as the nebulizer, creating a turbulent zone 
in the middle of the box when both flows converged. This prevented droplets and microspheres 
from impacting on the opposite wall of the exposure chamber and enhanced droplet evaporation. 
 
 
2.2.  Fluorescent microspheres 
 
Custom-designed monodisperse polystyrene microspheres were obtained from Duke Scientific 
Corporation (Palo Alto, California, USA). The microspheres were supplied as a 2% (w/v) 
suspension and labelled with a high-efficiency fluorochrome, in order to obtain sufficient 
fluorescent intensity in the tissue samples after inhalation. The following microspheres were 
used: 1 µm and 5 µm spheres having a green fluorochrome (excitation and emission wavelength 
of 470 and 508 nm, respectively) and 3 µm, 10 µm and 20 µm spheres having a red 
fluorochrome (excitation and emission wavelength of 560 and 596 nm, respectively). The 
nebulized suspensions were prepared by diluting an aliquot of each microsphere suspension in 
1.5 ml distilled water. One series of suspensions contained 0.16% (w/v) 1 µm spheres and 0.16% 
(w/v) 3 µm spheres, and a second series contained 0.16% (w/v) 5 µm spheres and 0.16% (w/v) 
10 µm spheres. In case of 20 µm spheres, which were nebulized separately, the concentration 
was increased to 0.53% (w/v). 
 
 
2.3.  Experimental design to study in vivo deposition of nebulized microspheres 
 
Broiler chickens (Cobb) were obtained from commercial farms at the age of 2 or 4 weeks. One-
day-old chickens (Cobb) were obtained from a commercial hatchery and exposed to the 
microspheres on the day of hatch. Before exposure, the birds were fasted for at least 12 h. The 
average weight of the 1-day-old (n = 36), 2-week-old (n = 36) and 4-week-old (n = 24) chickens 
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was 46 g (SD, 2 g), 352 g (SD, 111 g) and 1238 g (SD, 81 g), respectively. The 1-day-old and      
2-week-old chickens were exposed to all three microsphere aerosols while the 4-week-old birds 
were only exposed to the 1 and 3 µm spheres aerosol and the 5 and 10 µm spheres aerosol. Per 
aerosol type and age category, two extra chickens, exposed to an aerosol of water droplets 
without microspheres, were used as blank controls. All birds were exposed individually to the 
microsphere aerosols. Complete nebulization of the above described volume with the intermittent 
nebulization protocol lasted 14 min on average. However, the chickens remained in the chamber 
for 20 min, during which they could move freely. All exposures were performed at an average 
ambient temperature of 20°C (SD, 2°C). A summary of the performed experiments is presented 
in Table 3.1. 
 
Birds were handled and treated according to a protocol approved by the Ethical Committee of the 
Faculty of Veterinary Medicine (Ghent University) in agreement with the Belgian regulations on 
protection and welfare of animals. 
 
 
Table 3.1. Overview of performed experiments, with number of exposed chickens and average weight (± SD) per group 
of exposed chickens 
 
Age of chickens Microsphere 
sizes 
Number of exposed 
chickens 
Number of blank 
control chickens 
Average weight of exposed and 
blank chickens (g) 
1 day old 1 & 3 µm 10 2 43 ± 2 
 5 & 10 µm 10 2 48 ± 2 
 20 µm 10 2 46 ± 2 
     
2 weeks old 1 & 3 µm 10 2 480 ± 47 
 5 & 10 µm 10 2 300 ± 43 
 20 µm 10 2 276 ± 44 
     
4 weeks old 1 & 3 µm 10 2                    1295 ± 98 
 5 & 10 µm 10 2                    1180 ± 98 
 
  
 
2.4.  Collection of tissue samples 
 
Tissue samples were collected as described in Chapter 2 (2.6.3. Counting of fluorescent 
microspheres in the birds). The samples collected were: anterior part of the head (further referred 
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to as “nose and eyes”), larynx with trachea, syrinx (with extrapulmonary primary bronchi), left and 
right lung, left and right thoracic air sacs, lower beak with tongue, and oesophagus with crop.  
 
 
2.5.  Sample processing and fluorescence measurements 
 
Sample processing was performed according to the method described in Chapter 2 (2.6.3. 
Counting of fluorescent microspheres in the birds). 
 
 
2.6.  Data analysis 
 
The fluorescent signals of the different microspheres were used to calculate the number of 
microspheres per sample. Per tissue, signals were corrected for background fluorescence by 
subtracting the signals of the corresponding tissue samples harvested from the blank control 
chickens. In addition, the results were corrected for the microsphere loss during sample 
processing (Chapter 2; 3.5. Microsphere recovery during complete sample processing 
procedure). The number of microspheres per tissue sample was expressed as a percentage of the 
total number of microspheres detected in all samples of one chicken. 
  
Statistical analyses (SPSS version 12.0; SPSS, Chicago, Illinois, USA) of the deposition 
percentages were considered significant at P < 0.05. To evaluate the effect of microsphere size 
and the effect of age for microspheres detected in different chickens, a two-way ANOVA was used. 
This allowed comparing the 1, 5 and 20 µm spheres, the 1, 10 and 20 µm spheres, the 3, 5 and 
20 µm spheres, and the 3, 10 and 20 µm spheres. When microsphere sizes measured in one 
chicken (1 vs 3 µm; 5 vs 10 µm) were evaluated for the influence of microsphere size and age, or 
when the different tissue samples were compared per microsphere size and age, a multivariate 
repeated-measures ANOVA design was used. In this model, the microsphere size or the sample 
was the within-subject factor, respectively. The age, which divided the population in subgroups, 
was used as the between-subject factor for these analyses. In all ANOVA analyses, the normality 
of the data was evaluated with the Kolmogorov-Smirnov test. The homogeneity of variances was 
checked with the Levene’s test and the data were transformed if necessary. For the repeated-
measures designs, the Box’s test of Equality of Covariance Matrices was used to evaluate the 
homogeneity of covariance matrices. A Bonferroni correction was used for post hoc investigation 
of the effects. 
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3.  Results 
 
3.1.  Chicken behaviour during exposure 
 
Two-week-old and 4-week-old chickens were sitting quietly in the exposure chamber and showed 
a normal (nose) breathing pattern. The air turbulence created during nebulization did not disturb 
the birds. The 1-day-old chickens were much more active and moved around in the chamber. 
Additionally, they were continuously peeping, and subsequently partly breathing through the 
mouth. This can be considered as normal behaviour, also observed in commercial farms. 
 
 
3.2.  Influence of microsphere size on the in vivo deposition pattern 
 
The influence of microsphere size on the deposition pattern was evaluated by comparing the 
deposition percentage of the different microspheres per tissue sample and per age (Figure 3.4; 
horizontal comparison within each graph). The number of microspheres in each separate tissue 
sample was above detection limit for all microsphere types. 
 
For 1-day-old chickens (Table 3.2; Figure 3.4.A), the deposition percentage in the nose and eyes 
was significantly lower for 1 µm spheres compared with all other microsphere sizes (P = 0.000 in 
all comparisons), while for larger microspheres only 5 and 10 µm spheres had a significant 
different deposition percentage (P = 0.000). Similar, but opposite, differences were seen in the 
trachea samples of 1-day-old chickens. Deposition in the lower airways was clearly influenced by 
microsphere size, as the deposition in the lungs decreased significantly from 17% (1 µm) to 3% 
(20 µm) with increasing microsphere size (P values between 0.000 and 0.047). In contrast, the 
deposition percentage in the thoracic air sacs increased significantly from 6% (1 µm) to 20%    
(20 µm) with increasing microsphere size (P values between 0.000 and 0.002). The only 
deviations from these trends in lower airway deposition are that the 20 µm sphere deposition 
percentage in the lungs did not differ significantly from the deposition percentage of the 10 µm 
spheres, and that the deposition percentage of 1 µm spheres in the air sacs was significantly 
higher than the 3 µm sphere deposition (P = 0.000). 
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Figure 3.4. Average deposition percentages in broilers (n = 10) of different ages (A: 1 day old; B: 2 weeks old;               
C: 4 weeks old) after nebulization of differently sized fluorescent microspheres with a Walther Pilot I spray-head. The 
blue segments represent the deposition in the upper airways (i.e. nose and eyes, larynx with trachea, and syrinx), the 
red segments comprise the deposition in the lower airways (i.e. lungs and thoracic air sacs), and the yellow segments 
show the amount of microspheres in the anterior part of the gastro-intestinal tract (i.e. lower beak with tongue, 
oesophagus with crop). 
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Table 3.2. Deposition percentages (average ± SD) (n = 10) in 1-day-old broilers after nebulization of differently sized 
fluorescent microspheres with a Walther Pilot I spray-head 
 
Tissue sample  Deposition (%) 
  1 µm spheres 3 µm spheres 5 µm spheres 10 µm spheres 20 µm spheres 
Oesophagus + crop  13.9 ± 8.0 12.2 ± 5.9 16.7 ± 11.4    16.8 ± 12.7   13.4 ± 10.4 
Lower beak + tongue     12.4 ± 19.5    10.5 ± 19.9 8.8 ± 7.1  10.7 ± 4.9   7.8 ± 4.5 
Thoracic air sacs     5.7 ± 2.5    2.7 ± 1.6 6.3 ± 1.5    8.8 ± 2.5 20.1 ± 8.1 
Lungs   17.3 ± 6.1    8.5 ± 3.7 7.6 ± 2.5    4.0 ± 0.8   2.9 ± 1.2 
Syrinx     1.5 ± 1.5    0.9 ± 0.7 3.1 ± 1.3    1.7 ± 0.5   0.8 ± 0.4 
Larynx + trachea     24.2 ± 20.0    18.2 ± 19.1 19.9 ± 11.9    5.4 ± 3.0   4.1 ± 1.3 
Nose + eyes     25.1 ± 14.7    47.0 ± 21.9 37.6 ± 16.9    52.4 ± 17.1 50.9 ± 8.1 
 
 
At 2 weeks of age (Table 3.3; Figure 3.4.B), a different deposition pattern was found. The 
deposition percentage in the nose and eyes samples increased significantly from 35 to 84% when 
the microsphere size increased from 1 to 10 µm (P values between 0.000 and 0.007). Opposite 
results were found in the remainder of the respiratory tract. The deposition percentage of 20 µm 
spheres in the nose and eyes was 72%. This result was not significantly different from the 
deposition percentage of 5 and 10 µm spheres. In the lungs, no significant differences in the 
deposition of 5, 10 and 20 µm spheres were detected, the average deposition percentage 
ranging between 1.5 and 2.5%. For microspheres smaller than 5 µm there was a significant 
increase in lung deposition with decreasing particle size (P = 0.001): 19 and 29% for 3 and 1 µm, 
respectively. 
 
 
Table 3.3. Deposition percentages (average ± SD) (n = 10) in 2-week-old broilers after nebulization of differently sized 
fluorescent microspheres with a Walther Pilot I spray-head 
 
Tissue sample  Deposition (%) 
  1 µm spheres 3 µm spheres 5 µm spheres 10 µm spheres 20 µm spheres 
Oesophagus + crop  4.5 ± 5.0 5.2 ± 7.5 8.2 ± 5.8 5.3 ± 7.7 13.5 ± 10.7 
Lower beak + tongue  3.7 ± 2.9 3.5 ± 3.3 3.7 ± 2.9 3.1 ± 4.3 7.8 ± 2.9 
Thoracic air sacs  2.1 ± 0.6 0.6 ± 0.4 1.7 ± 0.9 2.7 ± 4.3 2.5 ± 1.0 
Lungs  29.4 ± 11.8 19.1 ± 15.2 2.5 ± 1.3 1.5 ± 1.1 2.1 ± 1.0 
Syrinx  2.8 ± 3.0 2.8 ± 3.1 0.8 ± 0.6 0.4 ± 0.2 0.3 ± 0.1 
Larynx + trachea  22.1 ± 13.1 23.2 ± 17.0 10.0 ± 13.3 2.8 ± 4.3 2.3 ± 1.1 
Nose + eyes  35.3 ± 16.7 45.7 ± 22.8 72.9 ± 17.1 84.3 ± 18.0 71.5 ± 13.5 
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The deposition patterns in 4-week-old chickens (Table 3.4; Figure 3.4.C) were very similar to 
those found at 2 weeks. However, at this age significant differences were found between all 
microsphere sizes for the deposition percentage in the lungs: the amount of 5 µm spheres 
deposited in the lower airways (lungs and thoracic air sacs) was significantly higher compared to 
10 µm spheres: 12% compared with 2%, respectively (P = 0.000). 
 
 
Table 3.4. Deposition percentages (average ± SD) (n = 10) in 4-week-old broilers after nebulization of differently sized 
fluorescent microspheres with a Walther Pilot I spray-head 
 
Tissue sample  Deposition (%) 
  1 µm spheres 3 µm spheres 5 µm spheres 10 µm spheres 
Oesophagus + crop    1.8 ± 1.0   1.8 ± 1.5 4.7 ± 4.1 5.6 ± 5.2 
Lower beak + tongue      8.1 ± 12.6     9.1 ± 15.3 5.8 ± 4.9 7.0 ± 8.7 
Thoracic air sacs    2.9 ± 2.6   0.8 ± 0.4 2.2 ± 1.6 0.7 ± 0.9 
Lungs  34.3 ± 8.0 24.1 ± 9.9 9.5 ± 6.6 1.0 ± 1.1 
Syrinx    4.1 ± 4.2   5.1 ± 5.7 1.8 ± 2.0 0.6 ± 0.5 
Larynx + trachea    20.0 ± 15.9   23.9 ± 18.6 15.6 ± 13.6 4.0 ± 4.3 
Nose + eyes    28.7 ± 17.4   35.2 ± 20.8 60.6 ± 21.0 81.1 ± 14.4 
 
 
 
3.3.  Influence of age on the in vivo deposition pattern 
 
The influence of the age on the deposition pattern was evaluated by comparing the deposition 
percentages per microsphere size and per tissue sample (Figure 3.4; vertical comparison of 
graphs). 
 
Age did not have a significant influence on the deposition of 1 and 3 µm spheres in the nose and 
eyes sample. For the larger spheres (> 3 µm), a significantly higher deposition was detected in 
this tissue sample of older chickens in comparison to 1-day-old chickens (P values between 
0.000 and 0.006). There was no significant difference between the 2-week-old and 4-week-old 
chickens regarding deposition in the nose and eyes. 
 
For the deposition in the lower respiratory tract, the largest differences were also noticed between 
1-day-old chickens and older chickens, while the percentages in 2-week-old and 4-week-old 
chickens were similar. In 1-day-old chickens, the deposition of 1 and 3 µm spheres in the lungs 
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was significantly lower than in 2-week-old chickens: the deposition percentage increased for the  
1 µm spheres from 17 to 29% and for the 3 µm spheres from 9 to 19% for the 1-day-old and       
2-week-old chickens, respectively (P = 0.043 for both microsphere sizes). In contrast, the lung 
deposition of 5 and 10 µm spheres was significantly higher in 1-day-old chickens: the deposition 
percentages in 1-day-old and 2-week-old chickens were 8 and 3% for the 5 µm spheres               
(P = 0.000), respectively, and 4 and 2% for the 10 µm spheres (P = 0.032), respectively. No 
significant influence of age on the lung deposition of 20 µm spheres was detected. The 
deposition percentage in the thoracic air sacs was clearly higher for 1-day-old chickens compared 
with older chickens (P values between 0.000 and 0.002), and this difference was more 
pronounced for larger microspheres (10-fold difference for 20 µm spheres). The main difference 
between the 2-week-old and 4-week-old chickens regarding the deposition in the lower airways 
was the significantly higher deposition of 5 µm spheres in the lungs of the oldest chickens           
(P = 0.003). 
 
In the gastro-intestinal tract samples, a significant higher deposition percentage of microspheres 
< 20 µm was found in the 1-day-old chickens compared with other birds (P values between 0.000 
and 0.020 for oesophagus + crop samples). The sum of the deposition percentages in the lower 
beak, oesophagus and crop ranged for the different microsphere sizes between 23 and 28% for 
the 1-day-old chickens, while the percentages ranged between 8 and 12% for the 2-week-old 
chickens and between 10 and 13% for the 4-week-old birds. 
 
 
3.4.  Microsphere distribution throughout the respiratory system 
 
The distribution of the deposition percentages in the different sections of the respiratory system 
with age and with microsphere size can be derived from Figure 3.4 by comparing the tissue 
samples per column. 
 
The nose and eyes samples contained significantly more microspheres of at least 5 µm in size at 
all ages compared to the remaining caudally located tissues (P = 0.000 in all comparisons). The 
smaller microspheres (1 and 3 µm) were more homogeneously distributed in the respiratory 
system as in most comparisons no significant differences were seen between the nose and eyes 
sample and the lungs. The only significant difference was a higher deposition of 3 µm spheres in 
the nose and eyes of 1-day-old chickens compared with the lungs (P = 0.003). 
 
The syrinx only retained low amounts of large fluorescent microspheres, ranging between 0.4 and 
3% for the 5, 10 and 20 µm spheres. For the smaller 1 and 3 µm spheres, deposition in the syrinx 
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was somewhat larger (ranging between 1 and 5%); however, these percentages were still 
significantly lower compared to the deposited amounts in the caudally located lungs (P values 
from 0.000 to 0.001). 
 
When the deposition in the lungs and thoracic air sacs was compared, microspheres smaller than 
3 and 5 µm were detected in significantly higher amounts in the lungs compared with the air sacs 
in 2-week-old and 4-week-old chickens, respectively (P = 0.000 in all cases). In 1-day-old 
chickens, microspheres smaller than 5 µm were also detected in higher amounts in the lungs (P = 
0.000). However, for microspheres larger than 5 µm the opposite result was found; that is, the 
deposition in the lungs was significantly lower compared with the air sacs (P = 0.000 in all 
comparisons).  
 
 
4.  Discussion 
 
Overall, the deposition pattern of microspheres in the upper and lower airways of 
unanaesthetized 2-week-old and 4-week-old broilers was similar to the results obtained by Hayter 
& Besch (1974). However, accurate comparison between both studies is not possible as Hayter & 
Besch did not analyse the different tissue samples separately. Instead, they externally detected 
the inhaled radioactive aerosol in transverse sections of the body using a Na-I scintillation 
detector (with possible overlap of different tissues). Even so, they assigned the upper respiratory 
tract as the main deposition site for particles between 3.7 and 7 µm (polydisperse aerosol) in 
adult, anaesthetized layers. The present study shows that, independent of age, the deposition of 
microspheres ≥ 5 µm is significantly higher in the nose and eyes compared with other tissues. 
Additionally, there was a significant increase in deposition in the nose and eyes of 2-week-old and 
4-week-old chickens with increasing microsphere size. The smaller microspheres (1 and 3 µm) 
are more homogeneously distributed throughout the respiratory system, which confirms the 
homogeneous distribution of 1.1 µm spheres in the study of Hayter & Besch. These results clearly 
illustrate the importance of sedimentation and impaction as the main deposition mechanisms in 
the upper respiratory tract, as the contribution of these mechanisms increases proportionally to 
particle mass. Particle deposition in the nose by mentioned mechanisms is in agreement with the 
physiological function of the nose in protecting the vulnerable lower airways from dust and 
infectious agents. Moreover, sedimentation of large aerosol microspheres on the nose, and 
specifically the eyes, will have contributed to their higher deposition percentages in the nose and 
eyes samples of 2-week-old and 4-week-old chickens when compared with the smaller sized 
microspheres (1 and 3 µm). This process is important for inducing adequate local and humoral 
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immunity, which will be elicited when vaccine virus reaches the Harderian gland behind the third 
eyelid in sufficient quantities (Cargill, 1999; Glick, 2000; Sharma, 1999). 
 
Similar to the nose, the syrinx of the trachea was expected to retain a high number of 
microspheres as airway bifurcations are generally known to capture large inhaled particles due to 
impaction (Brain et al., 1985). However, in this study, deposition in the syrinx was significantly 
lower compared with anterior and posterior tissue samples, which suggests that the angle of 
deflection at the syrinx of chickens is not large enough to induce considerable impaction. 
 
When a low percentage of microspheres are retained in the upper airways, a high percentage of 
microspheres are able to reach the lower airways. As a consequence, the deposition of 1 µm 
spheres in the lungs of 2-week-old and 4-week-old chickens was higher than the deposition 
percentage of 3 µm spheres. Lower airway deposition of 5 µm and larger microspheres was 
reduced to about 5% of the total deposited number of microspheres for the 2-week-old chickens, 
independent of microsphere size. In 4-week-old chickens, 5 µm spheres were also deposited in 
the lower airways in considerable amounts, while only microspheres of 10 µm showed negligible 
deposition percentages in lungs and air sacs. This coincides with theoretical predictions of 
particle deposition in upper and lower airways of humans as described by Hatch (1961): when 
particles become larger than 2 µm, their deposition in the lungs decreases and, for 10 µm 
spheres, the probability of escaping deposition in the upper respiratory tract is essentially zero. 
However, in the present study, this cut-off size for deposition in upper or lower respiratory tract is 
additionally influenced by age and subsequent increasing airway dimensions. The wider 
conducting airways allowed larger microspheres to penetrate into the lungs, explaining the 
increase in cut-off size for deposition in upper and lower respiratory tract from 5 µm for                  
2-week-old chickens to 10 µm for 4-week-old chickens. 
 
Whereas the present results for 2-week-old and 4-week-old chickens are consistent with the 
findings of Hayter & Besch (1974), different conclusions can be drawn for the 1-day-old chickens. 
Although some significant differences were encountered when nose and eyes samples were 
compared for the influence of microsphere size, the expected increase of deposited microspheres 
with increasing microsphere size was not seen. Additionally, the total deposition percentages in 
the lower airways (sum of lungs and air sacs) of 1-day-old chickens did not differ for small and 
large microspheres. Significantly higher percentages of microspheres ≥ 5 µm were found in the 
lower airways of 1-day-old chickens compared with older birds, whereas the conducting airways of 
the 1-day-old birds are much narrower. These findings were probably due to mouth breathing 
during the exposure to the microsphere aerosols. These young chickens were constantly peeping, 
during which the beaks were opened. Due to the mouth breathing, the nose is partly bypassed 
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and this allows more and larger particles to reach the lower airways as has been shown by others 
in humans (Brain et al., 1985) and in chickens (Riddell et al., 1998). 
 
For 1 and 3 µm spheres, no significant differences were found between the deposition 
percentage in the nose and eyes sample of 1-day-old chickens compared to the older chickens. 
However, the deposition of 5, 10 and 20 µm spheres in this sample was higher for older chickens 
than for 1-day-old chickens. It can be assumed that the major part of detected particles in the 
nose and eyes of 1-day-old chickens originated from sedimentation (air stream does not pass the 
nose upon mouth breathing) and that the same percentage sedimented on the nose and eyes of 
older chickens; therefore, these results suggest that 1 and 3 µm spheres were less sensitive to 
impaction in the nose than 5, 10 and 20 µm spheres.  
 
Due to the higher percentage of microspheres reaching the lower airways in 1-day-old chickens, it 
was possible to evaluate for all microsphere sizes the main deposition site (i.e. lungs or air sacs). 
In 2-week-old and 4-week-old chickens only the small microspheres reached the lower airways, 
and in all cases the deposition in the lungs was significantly higher than in the thoracic air sacs. 
The same was seen for microspheres smaller than 5 µm in 1-day-old chickens; however, the 
opposite was true for microspheres larger than 5 µm. When microsphere sizes were compared in 
1-day-old chickens, an increase of microsphere size reduced the deposition in the lungs, but led 
to a higher percentage of microsphere deposition in the thoracic air sacs. These observations are 
consistent with the airflow pattern in the respiratory system of chickens (Figure 3.1 and 3.2). Only 
small microspheres (1 and 3 µm) seem to follow the deviating streamline from the 
intrapulmonary primary bronchi towards the paleopulmonic parabronchi in the lungs, resulting in 
higher deposition percentages of small microspheres in the paleopulmo. Inertial impaction in the 
branched neopulmonic parabronchi will contribute to the deposition in the lungs as well. 
However, the larger microspheres, which have a higher inertia, continue along their original 
streamline through the intrapulmonary primary bronchi and the lateroventral secondary bronchi 
into the caudal air sacs, instead of deviating towards the parabronchi. Consequently, 
microspheres larger than 5 µm that are able to avoid deposition in the upper airways will 
preferentially be deposited in the air sacs. It should be noted that, although in Figure 3.1 and 3.2 
the air seems to flow to the caudal thoracic air sacs in a 90° angle, this angle is probably much 
larger. In case of a 90° angle, no microspheres larger than 5 µm would be detected in the 
thoracic air sacs due to impaction where the air flow deviates.  
 
It is not likely that microspheres of the sizes used in this study are deposited in the lungs during 
expiration. When the respiratory muscles reduce the air sac volume, the air flow reverses and this 
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180° change in direction of air flow will cause microspheres to deposit in the air sacs due to 
sedimentation when their velocity drops or due to inertial impaction. 
 
Although the gastro-intestinal tract was not our main focus, its cranial part was sampled in order 
to estimate the amount of swallowed microspheres. Only the anterior part of the gastro-intestinal 
tract was sampled as it was assumed that the microspheres would not pass through the empty 
crop during the 20 min exposure period. The mouth breathing of 1-day-old chickens contributed 
to the significantly higher deposition of microspheres in their gastro-intestinal tract compared to 
older chickens. Microspheres may also have reached the GI-tract due to clearance from the 
mucus layer of the nose and the ciliated and non-ciliated regions of trachea and lungs (Mensah & 
Brain, 1982). However, these mechanisms are valid for all age categories and therefore, only the 
larger extent of mouth breathing can explain the significantly higher deposition of microspheres in 
the gastro-intestinal tract of 1-day-old chickens. 
 
The 5 µm cut-off size for deposition of microspheres in the lower airways, as determined on 
anaesthetized adult layers by Hayter & Besch (1974) also applied to the unanaesthetized 2-week-
old broilers of our study. For broilers close to the slaughter age, the cut-off size, as derived from 
the current aerosol experiments, is 10 µm. Thus, for these two ages our results agree with the 
previously reported deposition data despite the fact that we did not use anaesthesia and broiler 
chickens were used instead of layers. In contrast, in day-old chickens, microspheres of even up to 
20 µm were found to penetrate into the lower airways probably due to mouth breathing and the 
subsequent partial bypass of the nose filter.  
 
It is important to realise that viable vaccine virus particles will replicate and may migrate towards 
the lower airways even if completely deposited in the upper airways (Hatch, 1961). Therefore, it 
might be very difficult to completely prevent strong post-vaccination reactions in primary spray 
vaccinations when there is the probability of particles (or droplets in the current applications) 
being inhaled. Currently, this is solved by spraying large droplets close to the 1-day-old chickens 
in the hatchery, increasing the deposition of droplets onto the birds and decreasing the risk of 
evaporation and inhalation of smaller particles (Cargill, 1999; Jorna, 1999). In view of the proven 
inhalation of large microspheres, this might also be recommended when using dry powder 
vaccines.  
 
 
 
 
 
- 90 - 
Deposition of differently sized airborne microspheres in the respiratory tract of chickens 
5.  Conclusion 
 
Knowledge on the deposition pattern of differently sized particles in the respiratory system of 
chickens as presented here is essential if an effective dry powder aerosol vaccine is to be 
developed. For secondary vaccinations, a powder vaccine with a narrow particle size distribution 
of 3 to 5 µm, which will target the whole respiratory system, should be aimed for. In contrast, in 1-
day-old chickens, mouth breathing during the experiment allowed 20 µm spheres to reach the 
lower airways, which should be prevented during primary vaccination. Therefore, a powder 
vaccine composed of coarser particles (> 20 µm) applied over a short distance to chickens, as in 
the current hatchery vaccination, seems necessary in order to prevent post-vaccination reactions 
in these birds. 
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Picture: Measurement of droplet sizes of a nebulized liquid with
Mastersizer laser diffraction equipment
Chapter 4
ESTIMATION OF EFFECTIVENESS OF COMMERCIAL 
NEBULIZERS FOR SPRAY AND AEROSOL 
VACCINATION OF POULTRY

Chapter 4 – Estimation of effectiveness of commercial nebulizers for spray and aerosol vaccination of poultry 
1.  Introduction 
 
In poultry industry, a spray is defined as a dispersion of coarse droplets that sediment rapidly, 
while an aerosol consists of droplets that remain airborne during longer periods of time. Spray 
vaccination is generally performed for primary vaccination at young ages (deposition on nostrils 
and eyes), whereas aerosol vaccination with inhalable droplets is only done after a basic level of 
immunity has been developed in order to avoid strong post-vaccination reactions (Gough & Allan, 
1973; Guittet et al., 1997; van Eck & Goren, 1991; Yadin & Orthel, 1978).  
 
The droplet size generated by several nebulizers has been characterized in order to evaluate the 
influence of different diluents for the freeze-dried vaccine cake, to evaluate the immune response 
elicited by different nebulizers and/or to determine the virus survival after nebulization. For 
example, Gough & Allan (1973) found that the induction of a serological immune response in 
chickens was faster when nebulizers produced finer droplets, and that the use of distilled water in 
comparison to tap water or gelatine as diluent for the vaccine cake resulted in finer and therefore 
more immunogenic droplets after evaporation of the diluent. In contrast, Villegas & Kleven 
(1976a; 1976b) did not find a significant difference between the antibody titres in chickens after 
aerosol vaccination, neither when using nebulizers that generate different droplet size 
distributions, nor when using different diluents. Yadin & Orthel (1978) suggested that 
reconstitution of a Newcastle disease (ND) vaccine cake in distilled water and subsequent 
nebulization with an Atomist nebulizer provided an optimal immune response after secondary 
vaccination in contrast to other nebulizers and diluents. However, with this optimal system they 
still detected an initial loss of vaccine concentration between 1 and 3 log10 50% Egg Infectious 
Doses (EID50) and a further loss between 0.2 and 3.4 log10 EID50 per hour, caused by 
sedimentation and evaporation of the generated droplets. 
 
In the current study, the generated droplet size distributions of a hand-held spray generator and 
two aerosol generators (Atomist and Spray Fan) have been measured and physical principles 
have been applied to estimate the efficiency of both spray and aerosol vaccination in relation to 
the deposition patterns obtained in Chapter 3. Additionally, an experiment has been performed to 
estimate the influence of shear forces on the infectivity of a virus during droplet generation. 
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2.  Materials and methods 
 
2.1.  Commercial nebulization equipment 
 
A manually activated hand-held spray bottle (Figure 4.1) (Ypma Plastics, Harskamp, the 
Netherlands), which is regularly applied for spray vaccination of small groups of 1-day-old birds, 
has been characterized as an example of a coarse spray generator. 
 
 
 
 
Figure 4.1. Hand-held spray bottle. 
 
 
Commercially applied secondary aerosol vaccination equipment was kindly provided by Desvac® 
(Angers, France). Two different aerosol generators were included in the study: a 1026BP Atomist 
(RL Corporation, Lowell, Michigan, USA) (Figure 4.2.A) and a Spray Fan (1.5 mm nozzle; Micron 
Sprayers, Herefordshire, Great Britain) (Figure 4.2.B). 
 
 
                 
 
 
 
 
 
 
 
 
 
A. B. 
Figure 4.2. A: 1026BP Atomist; B: Spray Fan. 
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2.2.  Measurement of droplet size distribution 
 
The volume droplet size distribution generated by the different nebulizers was measured by laser 
diffraction (Mastersizer-S long bed; Malvern Instruments, Malvern, UK). The Mastersizer was used 
in the open bench configuration and an air stream, parallel with the liquid stream direction, was 
generated in front of the lens in order to avoid droplet deposition on the lens (related to the broad 
spray angle of Atomist and Spray Fan). 
 
The spray originating from the hand-held spray bottle was measured at 4 cm from the laser beam, 
while the outlet of the Atomist and the spinning disc of the Spray Fan were held at 0.5 m from the 
laser beam. The distance to the laser beam was the minimal distance between the outlet of the 
hand-held spray bottle and the Atomist and the break-up of the liquid film into droplets. Droplets 
were immediately formed at the spinning disc of the Spray Fan, but a large part of the droplets 
was ejected sidewards and deposited on the lens when the nebulizer was close to the laser 
beam, despite the air stream in front of the lens. To avoid this, the minimal distance between disc 
and laser beam was 0.5 m.  
 
The droplet size distribution of the Atomist was evaluated with the air inlet regulator open and 
closed, which generated a light (‘fine’ setting) and a more dense (‘heavy’ setting) aerosol, 
respectively. It was not possible to make adjustments in the spray pattern of the other nebulizers. 
 
All measurements were repeated five times and demineralised water was used as nebulization 
liquid. During the measurements, the environmental temperature and relative humidity (RH) were 
20.5°C and 35%, respectively. Together with the short distance between outlet and laser beam, 
these conditions allowed to measure the originally generated droplet size (i.e. without substantial 
evaporation). The droplet size distributions were described by the 10th, 50th and 90th percentile 
(i.e. D[v,0.1], D[v,0.5] and D[v,0.9]) of the distribution. Additionally, span was calculated as 
(D[v,0.9] - D[v,0.1]) / D[v,0.5] and represents the width of the droplet size distribution. 
Furthermore, the average cumulative droplet size distribution was divided in 3 size ranges: 
droplets smaller than 50 µm, ranging between 50 and 100 µm, and larger than 100 µm. 
 
 
2.3.  Evaluation of spray rate 
 
Spray rate was evaluated for the hand-held spray bottle by spraying in a graduated cylinder and 
relating the sprayed volume to the number of actuations. 
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The aerosol generated with the Atomist was collected in a recipient closed with a vent filter during 
a 1 min nebulizing period. The spray rate was determined with the air inlet regulator at ‘fine’ and 
‘heavy’ setting and expressed in ml/min. 
 
The spray rate of the Spray Fan was evaluated without actually nebulizing the liquid. Since the 
liquid is fed to the nozzle by gravity, it was possible to determine the spray rate by holding the 
Spray Fan in nebulizing position (feed bottle on top) and allowing water to flow through the nozzle 
into a graduated cylinder during 1 min. The spray rate was expressed in ml/min. 
 
All spray rate evaluations were performed in triplicate with demineralised water. 
 
 
2.4.  Evaluation of virus infectivity in function of shear 
 
A Delta Spray® gravity feed manual spray gun (Figure 4.3) with a 1.4 mm nozzle diameter (Graco, 
Maasmechelen, Belgium), kindly provided by Euromat (Ghent, Belgium), was used to evaluate the 
influence of shear on the infectivity of a live virus.  
 
Shear applied on the liquid was controlled via the nebulizing air pressure of the Delta Spray® gun. 
The influence of nebulizing air pressure on the generated droplet size was monitored by 
nebulizing demineralised water at 0.3, 0.8 and 1.5 bar nebulizing air pressure through the laser 
beam of the Mastersizer (with nozzle held at 4 cm from the laser beam). 
 
 
 
Figure 4.3. Delta Spray® gravity feed manual spray gun.  
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The same air pressures (0.3, 0.8, and 1.5 bar) were subsequently used to nebulize a suspension 
of Porcine Respiratory Corona Virus (PRCV, family of Coronaviridae) in phosphate buffered saline 
(PBS; Sigma-Aldrich, Steinheim, Germany). PRCV is an enveloped virus of which the infective dose 
can be determined in cell cultures. As this is a more economical procedure than the dose 
determination of ND in embryonated eggs, PRCV was used as a model for enveloped viruses. The 
suspension contained 106.5 50% Tissue Culture Infective Doses (TCID50) per ml and 5 ml of this 
virus suspension was nebulized in a sealed container (volume: 1000 ml) equipped with a vent 
filter. After nebulization, 500 µl of the collected suspension was stored at -80°C until further 
processing. As blank control, an aliquot of the original virus suspension was subjected to the 
same freeze and thawing steps as the nebulized suspensions but was not nebulized (i.e. no shear 
forces were applied on the blank suspension). 
 
To determine the PRCV titre in the nebulized suspensions, ten-fold dilution series (100 to 10-6) of 
the defrosted suspensions were prepared in a PBS-medium containing 100 IU/ml penicillin and 
0.1 µg/ml streptomycin. Fifty µl of each dilution was inoculated in four wells of a microtitre plate 
with swine testicle (ST) cells. After inoculation, the microtitre plates were placed in a CO2 
incubator during 1 h to allow attachment of the viruses to the cells and afterwards, an additional 
100 µl of the PBS-medium was added to each well. The plates were subsequently placed in the 
CO2 incubator during 1 week. Wells that contained death cells (PRCV causes cell lysis) were 
considered positive and the reciprocal of the dilution that caused cell lysis in 50% of the wells 
was used as virus titre. When this 50% endpoint occurred between two dilutions (i.e. more and 
less than two wells with cell lysis in two consecutive dilutions), the formula of Reed and Muench 
(1938) was applied to calculate the exact titre. The detection limit, which is one infected well with 
the undiluted suspension, is calculated by assuming a maximal effect (i.e. cell lysis in four wells) 
when a 10-fold concentrated suspension would be inoculated. This resulted in a detection limit of 
10-0.3 TCID50 per inoculum (50 µl) and thus 101.0 TCID50 per ml. 
 
 
3.  Results 
 
3.1.  Measurement of droplet size distribution 
 
Table 4.1 presents the average droplet size distribution parameters (n = 5) of the different 
nebulizers, while Figure 4.4 shows the cumulative droplet size distributions. 
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Table 4.1. Average droplet size distribution parameters (± SD) of different commercially applied spray and aerosol 
vaccination equipment (n = 5) 
 
Nebulizer Distance to 
laser beam (m) 
 D[v,0.1]      
(µm) 
D[v,0.5]      
(µm) 
D[v,0.9]      
(µm) 
Span 
Hand-held spray bottle 0.04  65.5 ± 2.4    222.2 ± 12.3    509.6 ± 30.0 2.0 ± 0.1 
Atomist (‘fine’ setting) 0.5  35.6 ± 1.3    89.3 ± 4.0    188.9 ± 16.5 1.7 ± 0.2 
Atomist (‘heavy’ setting) 0.5  41.6 ± 1.1  111.1 ± 6.7    246.4 ± 17.8 1.8 ± 0.1 
Spray Fan 0.5  47.1 ± 1.8    87.2 ± 2.5  146.4 ± 2.6 1.1 ± 0.1 
 
 
The hand-held spray bottle clearly produced large droplets: the median droplet size D[v,0.5] was 
2 to 2.5 times larger than D[v,0.5] of the aerosol generators. Additionally, the sprayer generated a 
broader droplet spectrum than the aerosol nebulizers. 
 
A clear difference was detected between the droplet size generated by the Atomist at ‘fine’ and 
‘heavy’ setting, with an increase of D[v,0.5] from 89.3 to 111.1 µm, respectively. However, the 
span of the droplet size distribution did not considerably change in function of the setting of the 
air inlet regulator. 
 
The Spray Fan generated a droplet size spectrum with a D[v,0.5] that was similar to the D[v,0.5] 
of the Atomist at ‘fine’ setting (± 90 µm), but with a more narrow distribution (span of 1.1 
compared to 1.7). 
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Figure 4.4. Average droplet size distribution (n = 5) generated by nebulizing demineralised water with different 
commercially applied spray and aerosol vaccination equipment. The results are expressed as a cumulative volume 
distribution (i.e. percentage of droplets below a certain volume are plotted in function of their diameter). 
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Figure 4.5 shows the volume percentages of droplets contained in the size ranges < 50 µm,      
50 - 100 µm and > 100 µm for the different nebulizers. It was again clear that the hand-held 
spray bottle generated the largest droplets: only 5% of droplets was smaller than 50 µm, while 
81% of the droplets were larger than 100 µm. With the Atomist at ‘fine’ setting, 60% of droplets 
was smaller than 100 µm of which 18% was smaller than 50 µm, while these percentages 
decreased to 45% and 13%, respectively, at the ‘heavy’ setting. In comparison to the Atomist, the 
Spray Fan produced a larger fraction of droplets in the size range below 100 µm, but a smaller 
fraction of droplets < 50 µm was generated. As a result, the Spray Fan generated a larger fraction 
of droplets between 50 and 100 µm in comparison to the Atomist. 
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Figure 4.5. Average volume percentage of droplets contained in the size ranges < 50 µm, 50 - 100 µm, and > 100 µm, 
after nebulization of demineralised water with commercially applied spray and aerosol vaccination equipment. 
 
 
 
3.2.  Evaluation of spray rate 
 
The hand-held spray bottle nebulized on average 10 ml of water per 13 actuations. Since the 
maximum actuation rate per minute is about 60, the spray rate is approximately 50 ml per min. 
The average spray rate of the Atomist was 407 (SD, 6) and 503 (SD, 6) ml/min at ‘fine’ and 
‘heavy’ setting, respectively. With the Spray Fan, a volume of 97 (SD, 4) ml was collected within   
1 min. 
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3.3.  Evaluation of virus infectivity in function of shear 
 
The calculation of TCID50 with the method of Reed and Muench (1938) is illustrated in Table 4.2 
for nebulization of PRCV at a nebulizing air pressure of 0.3 bar with the Delta Spray® manual 
spray gun.  
 
 
Table 4.2. Calculation of titre of a PRCV suspension after nebulization of the suspension at 0.3 bar with the Delta 
Spray® manual spray gun, according to the method of Reed and Muench (1938) 
 
Dilution  Number of 
infected wells 
Number of non-
infected wells 
Cumulative 
number of 
infected wells 
Cumulative 
number on non-
infected wells 
Percentage of 
infected wells 
100  4 0 19 0 19/19 = 100% 
10-1  4 0 15 0 15/15 = 100% 
10-2  4 0 11 0 11/11 = 100% 
10-3  4 0 7 0      7/7 = 100% 
10-4  3 1 3 1         3/4 = 75% 
10-5  0 4 0 5  0/5 = 0% 
10-6  0 4 0 9  0/9 = 0% 
 
 
The second and third column represent the number of wells per dilution where cell lysis was 
detected or where cells were intact, respectively. Based on these data the 50% endpoint (two 
infected wells) is obtained by a dilution between 10-4 and 10-5. In column 4, the cumulative 
number of infected wells (in column 2) is calculated starting from the largest dilution (10-6) to the 
undiluted suspension. In column 5, the same is done for the non-infected wells (in column 3), but 
starting from the undiluted suspension and working down to the 10-6 dilution. In column 6, the 
percentage of infected wells is determined per dilution via the ratio of the cumulative number of 
infected cells and the sum of the cumulative number of infected and non-infected cells. This also 
confirms that the 50% endpoint is obtained with a dilution between 10-4 and 10-5 (75% and 0% of 
infected wells, respectively). 
  
The formula of Reed and Muench calculates the 50% endpoint as follows: 
 
(% of infected wells above 50%) - 50% 
(% of infected wells above 50%) – (% of infected wells below 50%) 
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Based on the example, this results in a value of 0.3 (i.e. (75% - 50%) / (75% - 0%)). Hence, the 
dilution causing an infection in half of the wells is 10-4.3 (i.e. 10-4.0-0.3). The titre of the inoculum 
(50 µl) is obtained by taking the reciprocal of this dilution, i.e. 104.3, and when expressing this 
result per ml, a PRCV titre of 105.6 TCID50 was detected in the suspension after nebulization at  
0.3 bar. 
 
Increasing the energy and shear on the liquid at higher nebulizing air pressure caused a decrease 
of the median droplet size (Figure 4.6). In the original virus suspension (not nebulized) the virus 
titre was 106.3 TCID50 per ml. Upon nebulization, the infectivity of the aerosol decreased 0.5 to   
0.7 log10, without a visible trend in function of the nebulizing air pressure (Figure 4.6). 
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Figure 4.6. 50% Tissue Culture Infectious Doses (TCID50) per ml of Porcine Respiratory Corona Virus (PRCV) suspended 
in phosphate buffered saline (PBS) and median droplet sizes (D[v,0.5]) in function of increasing nebulizing air 
pressures (Delta Spray® gravity feed manual spray gun). The blank was treated identical to the other suspensions, but 
no nebulizing air pressure was applied on this suspension. 
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4.  Discussion 
 
Ideally, for primary respiratory vaccination, the birds should be targeted directly rather than to 
expose them to an inhalable aerosol. In general, it is suggested that droplets should be larger 
than 100 µm to avoid that the droplets are being inhaled (Cargill, 1999; Gough & Allan, 1973; 
Jorna, 1999; van Eck, 1990), which is supported by the finding that 1-day-old birds can inhale    
20 µm particles due to mouth breathing (Chapter 3). Moreover, spraying as close as possible to 
the birds is also recommended in order to increase the probability of immediate deposition of 
droplets on the eyes (immune response via the Harderian glands) or the feathers of the birds 
(immune response via the gastro-intestinal tract after oral uptake of the vaccine) (Cargill, 1999; 
Jorna, 1999). Together with the large droplet size of a coarse spray this should ensure fast 
deposition on the birds, without chance of droplet size reduction by evaporation. For example, 
sedimentation speeds of 0.2, 0.7 and 2.0 m/s have been described for 100, 200 and 500 µm 
droplets, respectively (Holterman, 2003). When spraying with the hand-held spray bottle at a 
recommended distance of 25 cm above the birds (Jorna, 1999), 72% of the vaccine volume (72% 
of the droplets in the 100 - 500 µm range) is deposited on the birds after 0.125 (500 µm droplet) 
to 1.25 s (100 µm droplet), assuming that the droplets sediment in still air. In addition, the kinetic 
energy of the droplets when they exit the nozzle at high speed, forces them towards the chickens. 
As droplets with a certain speed also have a certain inertia, it might be difficult for these droplets 
to be drawn into the lower respiratory system of young chickens. However, the droplet size 
distribution produced by the hand-held spray bottle showed that approximately 20% of the 
volume was nebulized as droplets smaller than 100 µm, which might pose a risk of strong post-
vaccination reactions. To avoid the presence of a considerable fraction of small droplets, it would 
be necessary to use a nebulizer that produces even larger droplets than the hand-held spray 
bottle. However, this might affect the efficiency of the vaccination as such large droplets would 
have a lower probability of reaching birds that are further away from the vaccination apparatus 
due to their extremely fast sedimentation. The recommendation to crowd the birds together 
during spray vaccination (Cargill, 1999; Gough & Allan, 1973; Jorna, 1999; van Eck, 1990) would 
then become a prerequisite for an efficient vaccination. Another approach to improve the safety 
of a primary vaccination is the development of systems that disperse the vaccine with a more 
narrow size distribution, thereby avoiding the presence of the undesired small particles. 
 
For secondary vaccinations, the aim is to generate droplets < 50 µm which evaporate to inhalable 
dry particles (Cargill, 1999; Gough & Allan, 1973; Jorna, 1999; van Eck, 1990). The manufacturer 
of the Atomist claims that the average droplet size at ‘fine’ and ‘heavy’ setting is 22 and 46 µm, 
respectively. The difference in particle size originates from the aspiration of a different volume of 
liquid. The liquid is drawn from the tank of the Atomist towards the outlet by the Venturi-principle. 
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To generate the aspiration force, an electrical motor produces an airflow that is directed over the 
aspiration tube. However, the air inlet regulator allows to adjust the amount of air that passes 
over the aspiration tube: at the ‘fine’ setting (air inlet regulator open), part of the air flow escapes 
from the Atomist and a lower volume is drawn to the outlet. In contrast, at ‘heavy’ setting (air inlet 
regulator closed), a higher liquid volume is aspirated, resulting in a larger output. As a larger 
number of droplets is dispersed in a spray cone with the same dimensions, the aerosol is more 
dense, the chance of collision of droplets is higher, and a larger droplet size is obtained in 
comparison with the ‘fine’ setting. The differences in spray rate and particle size for ‘fine’ and 
‘heavy’ setting were confirmed in the current measurements, but the measured droplet sizes 
differed from the specification of the manufacturer. For example, at the ‘fine’ setting, the 
measured D[v,0.5] was 89 µm, and only 18% of the droplets was smaller than 50 µm. Other 
authors also found larger droplet sizes (50% of droplets between 80 and 159 µm) but by 
converting the obtained volume distribution to a number distribution, their results (50% of the 
droplets between 20 and 39 µm) approached the manufacturer’s claim (Yadin & Orthel, 1978). 
However, expressing the droplet size distribution as a number distribution is misleading for the 
application of a vaccine, as not the number of inhaled droplets but the inhaled volume 
(corresponding to a specific vaccine dose) is proportional to the immune response. 
 
The droplet formation of a spinning disk aerosol generator such as the Spray Fan, occurs at the 
edge of a spinning disk, forming uniform primary droplets due to the interaction of centrifugal 
forces and surface tension (Leong, 1992; Swift, 1985). The narrow droplet size distribution 
claimed for this aerosol generator is considered to be a major advantage for secondary aerosol 
vaccination of poultry in comparison to the aerosols originating from pressurised nebulization 
devices (e.g. Atomist) (Cargill, 1999). The manufacturer of the Spray Fan claims a homogeneous 
droplet size of approximately 70 µm. This is in reasonable agreement with our particle size 
measurements: D[v,0.5] of 87.2 µm with a span of 1.1. Additionally, the span of the distribution is 
indeed smaller in comparison to the droplet size distribution of the Atomist, resulting in a larger 
fraction of 50 - 100 µm droplets. 
 
To correlate the droplet size data with the deposition patterns obtained in Chapter 3, the 
evaporation of aerosol droplets has to be taken into consideration. Based on the evaporation 
kinetics of droplets at specific conditions (21°C/75% RH), the lifetime of differently sized droplets 
was calculated by van Eck (1990). These data in combination with the average sedimentation 
rate of evaporating droplets (evaporation means continuous size reduction and decreasing 
sedimentation rate) allowed to determine the distance travelled by a droplet until it had 
completely evaporated (Table 4.3). Since the recommended temperatures in poultry houses of   
2-week-old and 4-week-old chickens are 27 and 23°C, respectively (Hybro PG+ broiler 
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management, www.hybro.com), these values can be used to estimate how droplets generated by 
Atomist (‘fine’ setting) and Spray Fan are behaving in a poultry house. 
 
 
Table 4.3. Distance travelled by droplets with different diameters until complete evaporation in function of evaporation 
and average sedimentation rate at 21°C and 75% relative humidity (van Eck, 1990) 
 
Droplet size   
(µm) 
 Lifetime of droplet             
(s) 
Average sedimentation rate 
(cm/s) 
Distance travelled until 
complete evaporation (cm) 
20  1.7 0.6 1 
50  10.4 3.6 37 
100  41.7 14.4 600 
 
 
It is advised to nebulize the vaccine droplets approximately 50 cm above the chickens           
(Guittet et al., 1997). Based on the data in Table 4.3, all droplets smaller than 50 µm will 
therefore completely evaporate before reaching the chickens. This means that 18 and 11% of the 
droplets generated by the Atomist and Spray Fan, respectively, will evaporate to dry particles. 
However, evaporation was calculated at 21°C while temperatures in poultry houses are generally 
higher, resulting in faster evaporation during sedimentation. Additionally, the values in Table 4.3 
are calculated under ‘ideal’ conditions, i.e. droplets settling vertically in still air. In reality, this 
situation will not occur during vaccination (turbulent air flow, generation of droplets with high 
kinetic energy). Therefore, it is safe to assume that also the major part of the 50 - 100 µm 
droplets (42% and 54% for Atomist and Spray Fan, respectively) will have evaporated completely 
before reaching the chickens: the high velocity of the droplets when emitted from the nebulizer 
stimulates evaporation and the horizontal trajectory increases the distance between the outlet of 
the nebulizer and the chickens, thereby extending the time available for evaporation. For 
example, Atomist droplets can be carried up to 10 m from the outlet, while the droplets from the 
Spray Fan can travel 5 m before sedimentation (manufacturer’s specifications).  
 
The diameter of a dry particle after complete evaporation of the liquid in the droplet from which 
the dry particle originates, can be calculated from the droplet diameter and the solid 
concentration of the nebulized liquid via the following equations: 
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V solid = 4/3 x π x (r solid)³  
V solid = π/6 x (d solid)³  
d solid = (6/π)1/3 x (V solid)1/3    
d solid = (6/π)1/3 x (V solid / V liquid)1/3 x (V liquid)1/3 
d solid = (6/π)1/3 x (V solid / V liquid)1/3  x (π /6 x (d liquid)³)1/3 
d solid = (V solid / V liquid)1/3 x d liquid
 
 with  V solid = volume of completely evaporated particle 
r solid = radius of completely evaporated particle 
d solid = diameter of completely evaporated particle 
  V liquid = volume of generated droplet 
  d liquid = diameter of generated droplet 
 
 
The average dry matter content of a vial of a Clone 30 lyophilized commercial ND vaccine 
(containing 1000 doses) was 220 mg (van Eck & Goren, 1991). In veterinary practice it is 
recommended to nebulize 1000 doses of vaccine within 3 min (Guittet et al., 1997), hence the 
volume used to reconstitute the vaccine cake depends on the spray rate of the nebulizer, being 
1200 ml for the Atomist at ‘fine’ setting (407 ml/min) and 300 ml for the Spray Fan                
(100 ml/min). Assuming a density of 1 g/ml for the solid vaccine particles, the droplets generated 
by the Atomist will be reduced to approximately 1/18 of their original size: 50 and 100 µm 
droplets will evaporate to particles of approximately 3 and 6 µm, respectively. Due to the higher 
solids content of suspensions nebulized with the Spray Fan, the dry particles will be about 1/11 
of the original droplet size, i.e. approximately 5 and 9 µm for 50 and 100 µm droplets, 
respectively. 
 
As established in Chapter 3, the maximal particle size for deposition in the lower airways (and 
thus for an efficient immune response after secondary vaccination) is 5 and 10 µm for 2-week-old 
and 4-week-old birds, respectively. Based on droplet size distribution and evaporation rates, the 
efficiency of delivering an aerosol with the Atomist ranges between 20 and 60% at the ‘fine’ 
setting, depending on the age of the chickens. The efficiency of the Spray Fan is 11 and 65% for 
the vaccination of 2-week-old and 4-week-old chickens, respectively. Despite the similar D[v,0.5] 
of Atomist and Spray Fan, the latter nebulizer produced less dry particles below 5 µm. Droplets 
larger than 100 µm will most likely not completely evaporate and will be larger than 10 µm when 
reaching the chickens. However, these droplets might still contribute to the immune response by 
deposition in the upper airways or by sedimentation on the eyes, as is the case for coarse spray 
vaccination.  
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Whereas a decrease of efficiency can be expected due to non-optimal droplet sizes, the efficiency 
of liquid aerosol vaccination with live vaccine virus depends considerably more on the reduction 
of the virus titre during evaporation and thermal stress. For example, evaporation caused a 
decrease of virus titre of 2 to 3 log10 EID50 within 15 min after nebulization of a La Sota ND 
vaccine (20°C; RH between 50 and 60%) (van Eck, 1990). Due to these phenomena, droplets 
that evaporate to an inhalable particle size will contain a reduced virus titre, thereby substantially 
decreasing the efficiency of vaccination procedures using the Atomist and Spray Fan. To 
compensate for the loss of virus titre during nebulization, high doses are nebulized: for example, 
ND vaccines contain at least 106 EID50 per dose (BCFI, Belgisch Centrum voor 
Farmacotherapeutische Informatie) (2006), while a dose of 102 - 103 EID50 deposited in the lower 
airways already results in an efficient immune response (van Eck & Goren, 1991). 
 
Upon nebulization of liquids, energy is required to overcome the surface tension in the liquid and 
to form smaller droplets. Increasing the energy input (e.g. higher atomizing air pressures) 
decreases the droplet size (Swift, 1985), as confirmed in Figure 4.6, and could therefore be 
beneficial in liquid aerosol vaccination. However, several hydrophobic biological components are 
known to be sensitive to increasing shear forces and/or to the creation of a larger air-liquid 
interface when droplet size is reduced: hydrophobic components tend to migrate to the air-liquid 
interface at the droplet surface but exposure to air might inactivate these components (e.g. 
unfolding of proteins) (Ip et al., 1995; Lengsfeld & Anchordoquy, 2002; Maa & Hsu, 1997). As 
enveloped viruses such as PRCV and ND contain lipoproteins in their envelope (Alexander, 1991), 
they could be sensitive to shear and reduction of droplet size. Although the infectivity titre 
decreased by approximately 0.5 log10 upon nebulization of PRCV, this reduction was independent 
of the atomizing air pressure, when ranging between 0.3 and 1.5 bar. Based on these data, the 
sensitivity of an enveloped virus to the degree of shear forces or to the air-liquid interface seems 
limited. 
 
 
5.  Conclusion 
 
The major issue of spray equipment is the presence of small droplets in the generated spray that 
can be inhaled into the lower airways, thereby increasing the risk of undesired post-vaccination 
reactions. The problems identified during the evaluation of aerosol vaccination equipment are a 
large fraction of non-inhalable droplets and inactivation during evaporation, which will both 
reduce the vaccination efficiency. Therefore, to compensate for this inactivation, much more 
vaccine virus than actually required for an active immune response is currently administered 
under practical circumstances. Optimizing the particle size distribution of the aerosol and the 
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stability of the virus in the aerosol particles could therefore considerably improve the efficiency of 
aerosol vaccination. 
 
 
 
- 111 - 
Chapter 4 
6.  References 
 
Alexander D.J. (1991). Newcastle disease and other paramyxovirus infections. In Diseases of 
Poultry, (Calnek B.W., Ed.), pp. 496-519. Iowa State University Press, Ames. 
 
BCFI. (Belgisch Centrum voor Farmacotherapeutische Informatie) (2006). Gecommentarieerd 
Geneesmiddelenrepertorium voor Diergeneeskundig Gebruik. 
 
Cargill P.W. (1999). Vaccine administration in poultry. In Practice 21, 323-328. 
 
Gough R.E. & Allan W.H. (1973). Aerosol vaccination against Newcastle disease: the influence of 
vaccine diluent. The Veterinary Record 93, 458-461. 
 
Guittet M., Meulemans G., Vindevogel H. & Duchatel J.P. (1997). Avian vaccines. In Veterinary 
Vaccinology, (Pastoret P.P., Blancou J., Vannier P. & Verschueren C., Eds.), pp. 395-405. 
Elsevier Science B.V., Amsterdam. 
 
Holterman H.J. (2003). Kinetics and evaporation of water drops in air. Wageningen UR, Instituut 
voor Milieu- en Agritechniek (IMAG), Wageningen. 
 http://idefics.holsoft.nl/idefics/pdf/kinevap.pdf. 
 
Ip A.Y., Arakawa T., Silvers H., Ransone C.M. & Niven R.W. (1995). Stability of recombinant 
consensus interferon to air-jet and ultrasonic nebulization. Journal of Pharmaceutical 
Sciences 84, 1210-1214. 
 
Jorna A. (1999). Vaccination requires the right technology. World Poultry 15(7). 
 
Lengsfeld C.S. & Anchordoquy T.J. (2002). Shear-induced degradation of plasmid DNA. Journal of 
Pharmaceutical Sciences 91, 1581-1589. 
 
Leong K.H. (1992). Theoretical principles and devices used to generate aerosols for research. In 
Pharmaceutical Inhalation Aerosol Technology, (Hickey A.J., Ed.), pp. 129-154. Marcel 
Dekker Inc., New York. 
 
Maa Y.F. & Hsu C.C. (1997). Protein denaturation by combined effect of shear and air-liquid 
interface. Biotechnology and Bioengineering 54, 503-512. 
 
- 112 - 
Estimation of effectiveness of commercial nebulizers for spray and aerosol vaccination of poultry 
Reed L.J. & Muench H. (1938). A simple method of estimating fifty percent endpoints. American 
Journal of Hygiene 27, 493-497. 
 
Swift D.L. (1985). Aerosol characterization and generation. In Aerosols in Medicine: Principles, 
Diagnosis and Therapy, (Morén F., Newhouse M.T. & Dolovich M.B., Eds.), pp. 53-76. 
Elsevier Science B.V., Amsterdam. 
 
van Eck J.H.H. (1990). Spray- en aerosolentingen: principes en uitvoering. 
Pluimveegezondheidszorg: Informatieblad voor Dierenartsen. 42, PHI Doorn. 
 
van Eck J.H.H. & Goren E. (1991). An Ulster 2C strain-derived Newcastle disease vaccine: vaccinal 
reaction in comparison with other lentogenic Newcastle disease vaccines. Avian 
Pathology 20, 497-507. 
 
Villegas P. & Kleven S.H. (1976a). Aerosol vaccination against Newcastle disease. I. Studies on 
particle size. Avian Diseases 20, 179-190. 
 
Villegas P. & Kleven S.H. (1976b). Aerosol vaccination against Newcastle disease. II. Effect of 
vaccine diluents. Avian Diseases 20, 260-267. 
 
Yadin H. & Orthel F.W. (1978). A study of Newcastle disease vaccine virus in sprays and aerosols. 
Avian Pathology 7, 357-371. 
 
 
- 113 - 

Chapter 5
DEVELOPMENT OF A DRY POWDER VACCINE FOR 
MASS VACCINATION OF POULTRY
“Development of a dry powder vaccine for mass vaccination of 
poultry”. E.A. Corbanie, J.P. Remon, K. Van Reeth, W.J.M. 
Landman, J.H.H. van Eck, C. Vervaet. Submitted (Vaccine).
Picture: Scanning Electron Microscope picture of spray-dried
trehalose particles

Chapter 5  -  Development of a dry powder vaccine for mass vaccination of poultry 
1.  Introduction 
 
The efficiency of liquid spray and aerosol vaccinations with live attenuated organisms is rather 
low due to several reasons. As illustrated in Chapter 4, a first problem is the broad droplet size 
distribution generated by the nebulizers currently used for liquid spray and aerosol vaccination: 
the presence of small, inhalable droplets in a coarse spray for primary vaccination often results in 
undesired post-vaccination reactions (Gough & Allan, 1973; van Eck & Goren, 1991; Yadin & 
Orthel, 1978), and a large fraction of non-inhalable droplets generated by fine aerosol nebulizers                          
(e.g. 10 - 1000 µm (Cargill, 1999)) reduce the efficiency of secondary aerosol vaccinations. 
Furthermore, the efficiency of vaccines administered by air might be jeopardized due to the use of 
tap water for reconstitution (often containing virucidal agents, such as chlorines) (Guittet et al., 
1997), and most importantly, due to inactivation of the vaccine virus by evaporation of droplets 
after generation (Gough & Allan, 1973; Landman & van Eck, 2001; Yadin & Orthel, 1978). These 
harmful effects can be circumvented by formulating the vaccine as a dispersible dry powder with 
defined narrow particle size.  
 
As described in Chapter 1, spray drying is an attractive technique to produce the dry powder 
vaccines, even though high process temperatures are used. Nevertheless, stabilizing excipients 
are added to proteins before spray drying to prevent degradation under the influence of process 
and storage stresses (Bosquillon et al., 2004; Broadhead et al., 1994; Costantino et al., 1998a; 
Forbes et al., 1998). Disaccharides are amongst the most used excipients, with trehalose being 
particularly successful (Cordone et al., 2005; Crowe et al., 2001). However, polyvinylpyrrolidone 
(PVP) is sometimes added when formulating proteins as a dry powder to prevent re-crystallization 
of stabilizing sugars during storage (Mahlin et al., 2006; Zeng et al., 2001; Zhang & Zografi, 
2001). Also proteins such as albumins have been shown to prevent crystallization of spray-dried 
and freeze-dried excipients (Bosquillon et al., 2004; Hawe & Friess, 2006). An additional 
advantage of bovine serum albumin (BSA) in an inhaled powder vaccine, is that it can elicit a non-
specific mucosal immune response (Ameiss et al., 2006; Gutierro et al., 2002). 
 
In this part of the project, the usefulness of spray drying to formulate an attenuated live ND dry 
powder vaccine was investigated. Firstly, placebo formulations were characterized for their 
protein stabilizing potential and for their particle size distribution. The assessment of the protein 
stabilizing potential was based on residual moisture content, glass transition temperature, water 
uptake and crystallization rate (Hinrichs et al., 2001) and the particle size was compared with the 
optimal particle size required for vaccination of differently aged chickens (Chapter 3). 
Subsequently, an attenuated Newcastle disease (ND) vaccine virus was spray dried with the 
different formulations and the loss of virus infectivity upon drying and storage was evaluated. 
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2.  Materials and methods 
 
2.1.  Spray drying 
 
An experimental spray dryer with a 30 µm piezo-actuated nozzle, kindly provided by Niro A/S 
(Soeborg, Denmark), was used to produce particles with an extremely narrow size distribution. 
The feed solutions were prepared in distilled water, with a total concentration of solids of 5% 
(w/w). Five different feed solutions were prepared: 5% mannitol (C*Mannidex 16700; Cerestar, 
Mechelen, Belgium), 5% trehalose dihydrate (C*Ascend 16400; kindly provided by Cerestar, 
Mechelen, Belgium), 4% trehalose dihydrate with 1% polyvinylpyrrolidone (PVP) (Kollidon®30; 
BASF, Ludwigshaven, Germany), 4% trehalose dihydrate with 1% bovine serum albumin (BSA) 
(Sigma-Aldrich, Steinheim, Germany), and 3% trehalose dihydrate with 1% PVP and 1% BSA. The 
feed solutions were filtered (paper filter 595, Schleicher & Schuell, Dassel, Germany) to remove 
remaining particulates in order to avoid clogging of the nozzle. Then, a feed solution was pumped 
to the nozzle (feed rate: 30 ml/h) where a droplet generation frequency of 50 kHz was applied on 
the feed solution by the piezo-actuator. The inlet temperature was set at 90°C and the drying gas 
flow rate at 25 kg/h, resulting in an outlet temperature of 70°C. The powder was separated from 
the drying air using a cyclone. After production, the powders were stored at 25°C in glass vials 
closed with silica-containing stoppers. 
 
After drying and evaluating the placebo powders, the formulations were used to produce the 
powder vaccines. For this purpose, the attenuated Clone 30 strain of the ND virus, developed by 
Intervet International (Boxmeer, the Netherlands), was harvested from the allantoic fluid of 
specified-pathogen-free (SPF) embryonated eggs and added to the feed solution in a 
concentration of 107 50% Egg Infectious Doses (EID50) per ml of feed solution. As 100 ml of a 
feed solution with 5% solids was dried, a maximum titre of 109 EID50 was incorporated in 5 g 
powder. The collection vessel was regularly exchanged during production to prevent heating of 
the vaccine particles. The same drying conditions as described before were used and the powder 
vaccines were stored in sealed aluminium bags at 6°C and at 25°C. 
 
 
2.2.  Solid-state characterization 
 
2.2.1.  Dynamic Vapour Sorption (DVS) 
 
Water sorption isotherms of the powder formulations were determined gravimetrically at 25°C 
(SD, 0.1°C) using a DVS Advantage 1 with a Cahn D200 microbalance (Surface Measurement 
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Systems, London, UK). Between 10 and 20 mg powder was weighed in the sample cup of the 
instrument, subjected to a drying step in order to bring the sample to a constant weight and 
subsequently exposed to increasing relative humidity (RH) (using 10% increments up to 90% RH). 
Following the sorption phase, the samples were exposed to a decreasing RH (in steps of 10% until 
0% RH). Each step continued until equilibrium was reached (i.e. when the change of mass was 
smaller than 0.002% per minute during at least 10 min) or until 6 h had passed. The mass 
change was recorded every minute with a resolution of ± 0.1 µg. 
 
 
2.2.2.  Karl Fischer titration 
 
The residual moisture content after spray drying and the water content after 1 year storage were 
evaluated by Karl Fischer titration. The samples (± 50 mg) were heated in a Mettler DO337 oven 
(Mettler-Toledo, Beersel, Belgium) at 130°C during 10 min. During this period the water vapour 
from the samples was transferred by a dry nitrogen flow to the titration vessel of the Karl Fischer 
titrator (Mettler DL35; Mettler-Toledo, Beersel, Belgium), containing absolute, dry methanol 
(Biosolve, Valkenswaard, the Netherlands). After these 10 min, the titration with Hydranal® 
Composite 2 (Sigma-Aldrich, Steinheim, Germany) started automatically. All titrations were 
performed in triplicate. 
 
 
2.2.3.  Differential Scanning Calorimetry (DSC) 
 
The thermodynamic behaviour of the powders was determined on a DSC 2920 calorimeter        
(TA Instruments, Ghent, Belgium), operated in the modulated mode. The DSC was calibrated with 
indium (temperature calibration) and with sapphire (heat capacity and cell constant calibration). 
The sample cell was purged with a nitrogen flow of 25 ml/min. The samples (5 to 10 mg) were 
loaded in sealed aluminium pans (TA Instruments, Ghent, Belgium), equilibrated at -20°C and 
heated to 200°C with a scanning rate of 2°C/min and modulation amplitude of ± 0.318°C every 
60 s. The glass transition temperature (Tg) was recognised on the reversing heat flow curve as an 
endothermic shift of the baseline and determined as the midpoint of this transition. Melting was 
seen as endothermic peaks, where the melting temperature Tm was determined after 
extrapolation on the baseline (onset melting temperature). Crystallization temperatures (Tc) were 
determined as the peak temperatures of the exothermic crystallization peaks. 
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2.3.  Particle characterization 
 
2.3.1.  Scanning Electron Microscopy (SEM) 
 
A thin layer of powder was dispersed on a sample holder and coated with platinum in an Auto 
Fine Coater (JFC-1300; Jeol, Zaventem, Belgium). A Jeol JSM 5600 LV scanning electron 
microscope (Jeol, Zaventem, Belgium) was used to evaluate the particle morphology. Powders 
were evaluated immediately after production and after 1 year storage. 
 
 
2.3.2.  Particle size distribution 
 
Particle size distributions were measured by laser diffraction (Mastersizer-S long bed; Malvern 
Instruments, Malvern, UK). To obtain the size distribution of individual particles, the powders were 
suspended in Miglyol 812N (capric triglyceride; Sasol, Witten, Germany) with 0.2% Tween™80. 
Additionally, the particle size distribution of dispersed powders was determined to verify if the 
powders could be de-agglomerated into individual particles during air-assisted dispersion. The 
experimental powder dispersion device was constructed from a vacuum flask (Figure 5.1), in 
which air (10 L/min; 2.5 bar) was blown with an Omron CX3 compressor (Omron, Hoofddorp, the 
Netherlands).  
 
 
 
 
Figure 5.1. Experimental dispersion device for powders, constructed from a vacuum flask. The air blown into the flask 
carries the air-suspended particles through the outlet. 
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The airflow suspended the particles in air and carried them through the outlet of the flask into the 
particle sizing equipment. The environmental conditions during powder dispersion were 21°C and 
35% RH. An additional experiment was performed for the trehalose-PVP-BSA formulation with dry 
air (dried using silica gel) to disperse the powder. All measurements were performed in triplicate. 
The particle size distributions were characterized via D[v,0.1], D[v,0.5] and D[v,0.9]. The span of 
the distribution is defined as (D[v,0.9] – D[v,0.1]) / D[v,0.5]. 
 
 
2.3.3.  Particle density 
 
A helium pycnometer (AccuPyc 1330; Micromeritics, Brussels, Belgium) was used to evaluate the 
true density of the spray-dried powders. 
 
 
2.4.  Evaluation of vaccine virus stability 
 
Virus titration of the feed solution and corresponding powders were performed immediately after 
production. Additionally, titrations were performed on powders stored for 1, 5 and 10 months at  
6 and 25°C in order to evaluate the ability of the different formulations to stabilize the vaccine 
during storage.  
 
For titration, tenfold dilution series were prepared in phosphate buffered saline (PBS) with 1% 
penicillin-streptomycin. Subsequently, 100 µl of each dilution was inoculated in the allantoic 
cavity of five 10-11 days old embryonated SPF chicken eggs. After 72 h incubation at 37°C, 
allantoic fluids were tested for haemagglutination activity (HA), caused by the haemagglutinin 
antigen of ND viruses. Fifty µl of the allantoic fluid of each egg was pipetted in a U-bottomed 
microtitre plate (containing 50 µl PBS per well) and twofold dilutions were made across the plate. 
Afterwards, 50 µl of a 0.5% chicken red blood cells (RBCs) suspension was added to each well, 
the fluids in the well plate were gently mixed and RBCs were allowed to settle during 1 h at room 
temperature. When haemagglutinin antigens were present, they interconnected the 
haemagglutinin receptors of RBCs, resulting in a network that covered the bottom of the well. In 
the absence of haemagglutinin, the separate RBCs settled to a distinct button at the lowest point 
of the well. The virus titre was calculated from the 50% endpoint as described in Chapter 4      
(2.4. & 3.3. Evaluation of virus infectivity in function of shear). However, undiluted virus 
suspensions were not inoculated during these experiments, which increased the detection limit to 
100.7 EID50 per inoculum (100 µl). This resulted in a detection limit of 102.7 EID50 per gram 
powder, as 10% solutions were made when dissolving the powders (100 mg powder in 1 ml PBS).  
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2.5.  Statistical analysis 
 
Water content, as determined by Karl Fischer titration, was evaluated by two-way ANOVA testing 
(SPSS version 12.0; SPSS, Chicago, Illinois, USA) for the influence of storage time and 
formulation.  
 
The particle size data were also analysed using two-way ANOVA tests: a first analysis evaluated 
the influence of dispersion method and formulation, while in a second analysis the influence of 
storage time and formulation was evaluated. Four particle size parameters were evaluated in 
each analysis, namely D[v,0.1], D[v,0.5], D[v,0.9], and span.  
 
True densities were compared statistically for the influence of formulation type by a one-way 
ANOVA. 
 
In all analyses, the normality of the data was evaluated with the Kolmogorov-Smirnov test. The 
homogeneity of variances was checked and the data were transformed where necessary. For the 
evaluation of water content, the main effect of the formulation ignoring the effect of storage time 
or the main effect of the storage time ignoring the formulation effect was investigated when no 
significant interaction was present. When the interaction between both factors was significant, 
the simple effects of the formulation within each storage time or the simple effects of the storage 
time within each formulation was investigated with a Bonferroni post hoc test. The same 
procedure was followed when analysing the particle size data. 
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3.  Results 
 
3.1.  Solid-state characterization 
 
3.1.1.  Dynamic Vapour Sorption (DVS) 
 
The water sorption and desorption profiles at 25°C are shown in Figure 5.2. Mannitol was the 
least hygroscopic powder, absorbing only 1% of water when exposed to 90% RH. The other 
formulations had a similar water sorption up to 50% RH and absorbed about 5% and 11% water 
at 30 and 50% RH, respectively. Below 30% RH the water sorption rate was lower in comparison 
to the sorption rate above 30% RH, resulting in an inflection point in the absorption curves. Above 
50% RH, the influence of the composition of the formulation was evident. Pure trehalose did not 
sorb additional water when exposed to higher RH and did not release water during the desorption 
phase. When PVP and/or BSA were added to trehalose, no plateau in water sorption was 
observed and the water content increased up to maximum values of 23, 17 and 27% for 
trehalose-PVP, trehalose-BSA and trehalose-PVP-BSA, respectively.  
 
At a specific RH (correlated with a specific water content), the raw DVS data (Table 5.1) of these 
combined powders showed a decrease in mass during the sorption phase: for trehalose-PVP this 
occurred at 70% RH (18% water content decreased to 15%), for trehalose-BSA at 60% RH (15% 
water content decreased to 11%), and for trehalose-PVP-BSA at 80% RH (22% water content 
decreased to 19%). The desorption phase of these powders was similar and water evaporated 
from the samples. However, hysteresis occurred and 3 to 5% water was still present in the 
samples at the end of the sorption/desorption cycle. 
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Figure 5.2. Water sorption (red) and desorption curves (green) obtained from Dynamic Vapour Sorption experiments.   
A: mannitol; B: trehalose; C: trehalose-PVP; D: trehalose-BSA; E: trehalose-PVP-BSA. 
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Table 5.1. Decrease of water content (%) at specific formulation-related RH during the sortion phase in Dynamic 
Vapour Sorption experiments, indicating crystallization of the formulation. The RH step ended after 285, 180, and 360 
min for trehalose-PVP, trehalose-PVP-BSA, and trehalose-PVP-BSA, respectively. 
 
Time elapsed after 
start of RH step         
(min) 
 Water content of            
trehalose-PVP               
(at 70% RH)                 
(%) 
Water content of           
trehalose-BSA               
(at 60% RH)                 
(%) 
Water content of          
trehalose-PVP-BSA           
(at 80% RH)                 
(%) 
0  16.2 10.4 20.7 
15  17.6 12.8 22.1 
30  18.3 13.8 21.9 
45  18.0 14.3 21.6 
60  17.1 14.5 21.4 
75  16.5 14.4 21.1 
90  16.1 13.6 21.0 
105  15.8 11.7 20.8 
120  15.6 11.4 20.6 
135  15.5 11.3 20.5 
150  15.4 11.2 20.4 
165  15.3 11.2 20.3 
180  15.2 11.2 20.1 
195  15.1 - 20.0 
210  15.1 - 20.0 
225  15.0 - 19.9 
240  15.0 - 19.8 
255  15.0 - 19.7 
270  14.9 - 19.7 
285  14.9 - 19.6 
300  - - 19.6 
315  - - 19.6 
330  - - 19.5 
345  - - 19.5 
360  - - 19.4 
 
 
 
3.1.2.  Residual moisture content and moisture uptake during storage 
 
Table 5.2 shows the residual moisture content (Karl Fischer titration) after spray drying and after 
1 year storage of the powders in glass vials with silica-containing stoppers. 
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Table 5.2. Average moisture content (± SD) (n = 3) and glass transition temperature (n = 1) immediately after 
production and after 1 year storage at 25°C in glass vials closed with silica-containing stoppers. The moisture content 
immediately after production represents the residual moisture content after spray drying 
 
Formulation  Immediately after production 1 year after production 
  Moisture content 
(%) 
Glass transition 
temperature (°C) 
Moisture content  
(%) 
Glass transition 
temperature (°C) 
Mannitol          0.7 ± 0.1 -         1.4 ± 0.1 a - 
Trehalose          3.1 ± 0.1 71.6         7.9 ± 0.0 a 38.3 
Trehalose-PVP          3.4 ± 0.1 b 75.8         8.9 ± 0.1 a, c 41.1 
Trehalose-BSA          3.4 ± 0.1 b 76.8         7.2 ± 0.1 a 48.0 
Trehalose-PVP-BSA          3.3 ± 0.1 b 82.1         8.8 ± 0.1 a, c 47.4 
 
a Water content of all formulations increased significantly after 1 year storage in glass vials 
b, c Formulations with the same superscript have similar water contents (no significant difference). 
 
 
Mannitol retained significantly less water during production (< 1.0%) compared to the other 
formulations (3.0 - 3.5%). No significant differences were detected between trehalose-PVP, 
trehalose-BSA and trehalose-PVP-BSA. Storage during 1 year significantly increased the moisture 
content of the mannitol formulation to 1.4%, while the other formulations contained 7 to 9% 
water. The PVP-containing formulations showed similar (± 9%), but significantly higher results 
than those of the other formulations. 
 
 
3.1.3.  Thermodynamic properties 
 
Glass transition temperatures (Tg) of the amorphous powders, determined immediately after 
production and after 1 year storage, are shown in Table 5.2. The Tg of pure spray-dried trehalose 
(72°C) increased to values between 76 and 82°C with the addition of other excipients. After       
1 year storage at 25°C, Tg values decreased, the PVP-containing powders having the largest 
reduction (35°C). At both time points, the BSA-containing powders had the highest Tg values. The 
spray-dried mannitol powder was crystalline with a melting temperature of 163°C. 
 
Upon heating of pure trehalose, a crystallization peak was observed at 55°C above Tg. This 
crystallization peak was delayed to 70 and 90°C above Tg for trehalose-PVP and trehalose-BSA, 
respectively. The trehalose-PVP-BSA powder did not show non-isothermal crystallization within the 
scanned temperature range. 
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3.2.  Particle characterization 
 
3.2.1.  Scanning Electron Microscopy (SEM) 
 
The different powder particles are visualised in Figure 5.3.  
 
 
       A.                                                                B. 
 
 
 
 
 
 
       C.         D. 
 
 
 
 
 
 
          E.       
 
 
 
 
 
 
 
Figure 5.3. Morphology of the different formulations immediately after production.                                                             
A: mannitol; B: trehalose; C: trehalose-PVP; D: trehalose-BSA; E: trehalose-PVP-BSA. 
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Most of the mannitol particles were regular shaped, but some of the particles seemed to be 
fragmented. In contrast, trehalose particles were nearly perfect spheres. The addition of PVP to 
trehalose formed raisin-like, wrinkled spherical particles, with the indentations becoming more 
pronounced when additionally BSA was included in the formulation. Combining trehalose with 
BSA (but without PVP) resulted in completely collapsed particles. In general, all powders showed a 
very homogeneous size distribution. 
 
 
3.2.2.  Dispersibility of spray-dried powders 
 
In Table 5.3, the particle size distribution parameters after suspending the powders in Miglyol 
(primary particle size) are compared with the distribution after air-assisted dispersion with the 
experimental powder dispersion device. Figure 5.4 shows the cumulative particle size 
distributions.  
 
 
Table 5.3. Average particle size distribution (± SD) (n = 3) of powders measured after suspension in Miglyol 812N + 
0.2% Tween™ 80, compared to the particle size distribution after air-assisted dispersion with the experimental powder 
dispersion device 
 
Formulation Dispersion 
method 1
 D[v,0.1]          
(µm) 
D[v,0.5]        
(µm) 
D[v,0.9]             
(µm) 
Span 
Mannitol Susp.       19.5 ± 0.8      28.2 ± 0.2         37.8 ± 0.4       0.7 ± 0.0 
 AAD       22.8 ± 0.3 a      29.3 ± 1.0 a         43.2 ± 3.7 a       0.7 ± 0.1 
       
Trehalose Susp.         4.1 ± 0.7      24.8 ±0 .6         37.0 ± 1.0       1.3 ± 0.4 
 AAD       20.4 ± 0.2 a      24.1 ± 0.4         29.4 ± 1.3 a       0.4 ± 0.0 a
       
Trehalose-PVP Susp.         3.2 ± 0.1      25.8 ± 0.1         30.3 ± 0.0       1.1 ± 0.0 
 AAD       21.8 ± 0.5 a      26.5 ± 1.1         32.6 ± 1.6 a       0.4 ± 0.0 a
       
Trehalose-BSA Susp.       16.1 ± 0.3      28.2 ± 0.0         36.2 ± 0.2       0.7 ± 0.0 
 AAD       20.6 ± 0.6 a      27.9 ± 0.1         38.3 ± 0.7       0.6 ± 0.0 
       
Trehalose-PVP-BSA Susp.       19.5 ± 0.9      29.0 ± 0.0         36.1 ± 0.5       0.6 ± 0.0 
 AAD       25.3 ± 0.2 a      34.1 ± 1.3 a       305.3 ± 258.5 a       8.1 ± 7.5 a
 
1 Dispersion method: Susp. = suspended in wet dispersion cell of Mastersizer with Miglyol 812N + 0.2% Tween™ 80 as 
medium; AAD = air-assisted disperion with experimental powder dispersion device into dry powder cell of Mastersizer 
a Significant difference (P < 0.05) between the primary and dispersed particle size. 
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A.                B. 
 
 
 
 
 
 
 
 
C.                D. 
 
 
 
 
 
 
 
        E.  
 
 
 
 
 
 
 
 
 
Figure 5.4.  Average cumulative particle size distribution (n = 3) of powders measured after suspension in            
Miglyol 812N + 0.2% Tween™ 80, compared to the particle size distribution after air-assisted dispersion with the 
experimental powder dispersion device. A: mannitol; B. trehalose; C. trehalose-PVP; D. trehalose-BSA;                            
E. trehalose-PVP-BSA. 
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Most particle size distribution parameters were similar after suspension in Miglyol and after air-
assisted dispersion (although the small differences were in some cases statistically different 
related to the good reproducibility of the measurements). Only for mannitol and trehalose-PVP-
BSA, all three size parameters increased significantly. These differences were small, except for 
D[v,0.9] of trehalose-PVP-BSA which increased from 36 to 305 µm upon dispersion, thereby 
increasing the span value significantly. However, when the powder was dispersed with a dry air 
stream (Figure 5.5), D[v,0.1], D[v,0.5] and D[v,0.9] were 21, 29 and 37 µm, respectively. 
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Figure 5.5. Average cumulative particle size distribution (n = 3) of trehalose-PVP-BSA measured after suspension in 
Miglyol 812N + 0.2% Tween™ 80, compared to the particle size distribution after dispersion with the experimental 
powder dispersion device using dried air. 
 
 
 
3.2.3.  Influence of storage time on particle size distribution 
 
The particle size distribution parameters (determined in Miglyol) immediately after production and 
after storing the powders for 1 year in glass vials with silica-containing stoppers are shown in 
Table 5.4. Similar to the evaluation of the dispersibility, most differences were small and not 
relevant from a practical point-of-view (even if statistically different). Only pure trehalose showed 
a clear shift towards larger particle sizes after 1 year storage. This was confirmed by SEM pictures 
as the trehalose particles agglomerated due to the formation of solid bridges between the primary 
particles (Figure 5.6). No particle agglomeration was observed on SEM pictures of the other 
powders. The cumulative particle size distributions are compared per formulation in Figure 5.7. 
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Table 5.4. Average particle size distribution (± SD) (n = 3) of powders measured after suspension in Miglyol 812N + 
0.2% Tween™ 80 immediately after production and after 1 year storage at 25°C in glass vials with silica-containing 
stoppers 
 
Formulation Storage 
time 
 D[v,0.1]         
(µm) 
D[v,0.5]           
(µm) 
D[v,0.9]           
(µm) 
Span 
Mannitol -       19.5 ± 0.8      28.2 ± 0.2      37.8 ± 0.4       0.7 ± 0.0 
 1 year       19.9 ± 1.4      28.7 ± 0.3      39.9 ± 0.5 a       0.7 ± 0.0 
       
Trehalose -         4.1 ± 0.7      24.8 ± 0.6      37.0 ± 1.0       1.3 ± 0.4 
 1 year       14.9 ± 0.4 a      38.1 ± 2.6 a      97.4 ± 3.4 a       2.2 ± 0.1 a
       
Trehalose-PVP -        3.2 ± 0.1      25.8 ± 0.1      30.3 ± 0.0       1.1 ± 0.0 
 1 year        4.1 ± 0.0 a      26.9 ± 0.2 a      37.4 ± 1.7 a       1.2 ± 0.0 a
       
Trehalose-BSA -      16.1 ± 0.3      28.2 ± 0.0      36.2 ± 0.2       0.7 ± 0.0 
 1 year      12.9 ± 5.5      29.7 ± 0.0 a      40.9 ± 0.3 a       0.9 ± 0.2 a
       
Trehalose-PVP-BSA -      19.5 ± 0.9      29.0 ± 0.0      36.1 ± 0.5       0.6 ± 0.0 
 1 year        6.1 ± 2.1 a      29.3 ± 0.0      37.9 ± 0.0 a       1.1 ± 0.0 a
 
a Significant differences (P < 0.05) between the particle size immediately after production and after 1 year storage at 
25°C. 
 
 
 
 
.  
                                          
 
Figure 5.6. Agglomerate of trehalose particles, formed after 1 year storage at 25°C in glass vials with silica-containing 
stoppers. 
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Figure 5.7. Average cumulative particle size distribution (n = 3) of powders measured after suspension in Miglyol 812N 
+ 0.2% Tween™ 80 immediately after production and after 1 year storage at 25°C in glass vials with silica-containing 
stoppers. 
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3.2.4.  Particle density 
 
The true density of the formulations, with significant differences between all formulations, was 
influenced by the incorporated excipients. The pure components mannitol and trehalose had a 
density of 1.42 g/cm³ and 1.52 g/cm³, respectively. The addition of PVP or BSA to trehalose 
lowered the density to 1.45 and 1.47 g/cm³, respectively, and the additive effect of PVP and BSA 
resulted in the lowest density for the trehalose-PVP-BSA formulation (1.40 g/cm³). 
 
 
3.3  Evaluation of vaccine virus stability 
 
The effect of spray drying on the infectivity of the Clone 30 ND vaccine virus can be derived from 
Table 5.5, where the titre before drying (in the total volume of feed solution, i.e. in approximately 
100 ml) is compared with the titre after drying (in the total amount of resulting spray-dried solids, 
i.e. in approximately 5 g). Three formulations retained the vaccine activity completely: trehalose, 
trehalose-BSA and trehalose-PVP-BSA. The addition of PVP to trehalose decreased the vaccine 
titre with 0.8 log10 EID50, but the largest loss of activity was seen in the mannitol formulation, as 
the titre was reduced with 4.1 log10 EID50. 
 
 
Table 5.5. Inactivation of Clone 30 live attenuated ND vaccine virus during the spray drying process 
 
Formulation   Log10 EID50 in total amount of feed Log10 EID50 in total amount of powder 
Mannitol   9.0 4.9 
Trehalose  8.5 8.3 
Trehalose-PVP  8.0 7.2 
Trehalose-BSA  8.5 8.3 
Trehalose-PVP-BSA  8.5 8.7 
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Table 5.6 shows the titres detected per gram powder immediately after production and when the 
different formulations were stored during 1, 5 and 10 months at 6 and 25°C. Figure 5.8 shows 
the loss of titre (calculated per gram of powder) in function of storage time, taking the titre 
immediately after production as a reference.  
 
 
Table 5.6. Infectivity of Clone 30 live attenuated ND vaccine virus in dry powder formulations during storage                       
at 6 and 25°C 
 
Formulation  Log10 EID50 per gram powder 
  Storage at 6°C (in months) Storage at 25°C (in months) 
  
Immediately after 
production 1 5 10 1 5 10 
Mannitol  4.3 4.3 3.6 4.0 3.3 < 2.7 < 2.7 
Trehalose  7.6 7.1 6.4 5.5 5.3 3.3 3.0 
Trehalose-PVP  6.5 6.0 5.0 3.4 3.0 < 2.7 < 2.7 
Trehalose-BSA  7.7 7.5 6.5 6.5 6.3 5.2 4.3 
Trehalose-PVP-BSA  8.0 7.0 6.1 6.0 6.5 5.1 4.7 
 
 
In general, the vaccine titre decreased at higher storage temperature and longer storage time. 
However, the degree of inactivation depended on the excipients of the formulation. Although 
mannitol was not able to stabilize the vaccine during the drying process, the reduction of titre was 
only 0.3 log10 EID50 when stored at 6°C for 10 months. In contrast, the reduction of titre in the 
other formulations ranged between 1.2 (trehalose-BSA) and 3.1 (trehalose-PVP) log10 EID50 under 
the same storage conditions. The titre of trehalose-BSA and trehalose-PVP-BSA vaccines 
stabilized during the last 5 months of storage at 6°C. Storage at 25°C resulted in a large 
decrease of titre in the trehalose and trehalose-PVP formulations, while the loss of titre in 
trehalose-BSA and trehalose-PVP-BSA formulations was lower. Additionally, the resulting titres 
after 10 months storage at 25°C of the trehalose-BSA and trehalose-PVP-BSA formulation were 
only approximately 2 and 1 log10 EID50 lower in comparison to storage at 6°C. The incorporation 
of the Clone 30 vaccine in trehalose-BSA and trehalose-PVP-BSA thus resulted in the highest 
retention of viral activity, with residual virus titres of 106.5  and 106.0 EID50, respectively, when 
stored for 10 months at 6°C and 104.3 and 104.7 EID50, respectively, after 10 months storage at 
25°C. 
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Figure 5.8. Loss of infectivity titre of Clone 30 live attenuated ND vaccine virus in dry powder formulations in function 
of storage temperature (A: storage at 6°C; B: storage at 25°C) and time in comparison to the titres obtained 
immediately after production. Results are expressed as log10 EID50 per gram of powder. The dotted bars indicate that 
the titre was below detection limit (i.e. below 102.7 EID50 per gram of powder); these results should therefore be 
considered as minimal losses. 
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4.  Discussion 
 
When developing an inhalable dry powder vaccine, the interaction between powder properties 
such as water uptake, glass transition temperature and particle characteristics largely influences 
the potential application of a formulation. The water sorption profiles obtained from the DVS 
experiments indicated clear differences between the formulations, which are mainly related to 
different thermodynamic properties. The mannitol powder, which was crystalline after spray 
drying, hardly absorbed water, while the amorphous trehalose-containing formulations were 
hygroscopic even at low RH. The larger water uptake of amorphous formulations is due to bulk 
absorption of water, while crystalline materials only adsorb water on readily accessible water 
binding sites at the surface (Kontny & Conners, 2002). This also explains why mannitol had a 
much lower residual moisture content after spray drying compared to the other formulations. The 
amount of water absorbed by amorphous materials depended on the excipients used: the 
addition of the hydrophilic high molecular weight PVP increased the amount of water incorporated 
in the trehalose matrix after exposure to 90% RH (DVS experiments) and after 1 year storage 
(Karl Fischer titration).  
 
The non-isothermal Tg, as determined from the DSC thermograms, showed that the high-
molecular weight additives PVP and BSA were able to maintain the glass transition temperature 
at a higher level after 1 year storage, even when larger amounts of plasticizing water were 
absorbed. Additionally, crystallization of the formulation was delayed to higher temperatures 
when PVP and/or BSA were added to trehalose. This delay of crystallization was also detected in 
the water sorption profiles: although all components passed their isothermal glass transition at 
30% RH (detected as an inflection point in the water sorption isotherm (Burnett et al., 2004; 
Kontny & Conners, 2002; Sitaula & Bhowmick, 2006)), the moisture-induced crystallization 
(identified by a reduction of water content (Burnett et al., 2004; Kontny & Conners, 2002; Sitaula 
& Bhowmick, 2006)) occurred at higher RH for the formulations containing PVP and/or BSA. 
Hence, these formulations can be exposed to higher temperature and RH, and can absorb more 
water without their molecules reaching the mobility necessary for crystallization. Several authors 
have used PVP to stabilize the amorphous state and explained this effect by limiting the 
molecular mobility in the system due to the addition of high molecular weight molecules (Mahlin 
et al., 2006; Zeng et al., 2001; Zhang & Zografi, 2001). Proteins have been described to limit the 
molecular mobility of sugars and prevent crystal nucleation and growth due to strong hydrogen 
bonds between protein and sugar (Costantino et al., 1998b; Forbes et al., 1998; Sarciaux & 
Hageman, 1997). 
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Pure trehalose crystallized with the formation of trehalose dihydrate (Costantino et al., 1998b; 
Hinrichs et al., 2001), as can be derived from the constant water content during the desorption 
phase. This hydrate formation was largely prevented by the addition of PVP and/or BSA. However, 
not all absorbed water could be removed after the final drying step of these formulations, which 
was previously related to the formation of small quantities of hydrate molecules during the 
sorption phase (Burnett et al., 2004). Therefore, the additives apparently could not completely 
prevent the hydrate formation of trehalose upon exposure to increasing humidity. 
 
The evaluation of water sorption is essential in the formulation of dry powder aerosols due to the 
influence of water on the aerosolisation properties. Moisture sorption can induce cohesion by 
liquid bridging during dispersion, and agglomeration via crystallization and formation of solid 
bridges during storage (Broadhead et al., 1996; Van Campen & Venthoye, 2002). The first 
phenomenon can explain the increase in particle size of the trehalose-PVP-BSA powder upon air-
assisted dispersion since vapour sorption from the air used to disperse the powder during the 
measuring period most probably caused cohesion of the powder. This was confirmed by repeating 
the experiment with dried air (using silica gel): the particle size distribution of the dispersed 
powder was similar to its primary particle size distribution. The other formulations were not as 
sensitive to this short term moisture effect as their moisture sorption was slower compared to 
trehalose-PVP-BSA. For example, after exposing the samples for 5 min to 30% RH (comparable to 
the environmental RH (35%) during the powder dispersion tests), the trehalose-PVP-BSA and 
trehalose powder absorbed 0.4 and 0.1% water, respectively (derived from the raw DVS data).  
 
However, the median particle size of trehalose-PVP-BSA did not increase significantly upon 
storage, while trehalose showed largely increased particle sizes. This was explained by the long 
term effect of water on the particle size, i.e. agglomeration by induction of crystallization or 
dissolving of the outer layer of the particles and subsequent formation of solid bridges (as 
confirmed for trehalose in Figure 5.6). A surface enrichment with PVP and BSA is suggested by 
the morphology of the particles: the raisin-like and collapsed appearance of the formulations 
containing PVP and BSA, respectively, have both been described previously and related to highly 
viscous forces that hinder particle smoothening due to surface enrichment of these components 
when combined with sugars (Adler et al., 2000; Mahlin et al., 2006). As crystallization has been 
described to start at the surface (Mahlin et al., 2006), and as PVP and BSA have a higher Tg and 
lower solubility than trehalose, the particles were better protected against crystallization or 
dissolution and subsequent agglomeration compared to pure trehalose. 
 
Although only minor deagglomeration forces were applied, the powders were easily dispersed, as 
only minimal differences were seen between the particle size distribution in Miglyol and the 
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particle size distribution after air-assisted dispersion. This can be explained by the homogeneous 
particle size distribution and the sphericity of particles. Therefore, a monodisperse particle size 
distribution and shielding the powders from environmental humidity during storage and 
dispersion are the main requirements to ensure easy dispersion of these dry powders. 
 
The powders manufactured with the experimental spray dryer had a median particle size of about 
30 µm, depending on the design of the ultrasonic nozzle. These particles are well suited for 
primary respiratory vaccination of poultry where deposition in the lower airways should be avoided 
to prevent strong post-vaccination reactions in the more vulnerable lungs (Gough & Allan, 1973; 
van Eck & Goren, 1991; Yadin & Orthel, 1978). To obtain this, vaccination of 1-day-old chickens 
should be performed with particles larger than 20 µm, as determined in Chapter 3. When 
designing powders for secondary vaccination (where the lower airways are targeted), the particle 
size should be reduced below 5 and 10 µm for 2-week-old and 4-week-old chickens, respectively 
(Chapter 3). However, hygroscopic formulations, such as the amorphous powders, can be subject 
to hygroscopic growth in the airways (Morrow, 1986). This could reduce the probability that 
particles reach the lower airways, even if they are theoretically small enough. Hence, a non-
hygroscopic powder, such as mannitol, could be beneficial for a secondary powder vaccination by 
avoiding particle growth due to moisture sorption. 
 
Spray drying of the Clone 30 vaccine virus with the above evaluated excipients did not result in 
loss of vaccine activity, except when the virus was incorporated in crystalline mannitol. In 
contrast, during storage at 6°C, the loss of infectivity titre was lower in the mannitol matrix than 
in the amorphous formulations. These findings suggest that the ND virus did not behave like 
single proteins when incorporated in dry powder formulations. Water replacement with hydrogen 
bonding between stabilizing sugars and proteins is considered to be responsible for the 
stabilization during dehydration (Carpenter & Crowe, 1988; Pikal, 2002). However, enveloped 
viruses such as ND virus contain a large amount of lipoproteins in their envelope (Alexander, 
1991), so that water replacement is an unlikely mechanism of stabilization. Immobilization in an 
amorphous matrix (Green & Angell, 1989; Pikal, 2002) does stabilize the virus better during the 
drying process, but less during storage. This may be due to the different structure of single 
proteins versus viruses. Virus particles, being a complex organization of proteins, might already 
have an intrinsic stability as is also described for enzymes consisting of several monomers 
(Anchordoquy et al., 2001). As in freeze drying, a possible inactivation mechanism for the viruses 
during spray drying and storage might be aggregation (Precausta et al., 1980); however, 
additional research, which was out of the scope of the current project, should be performed to 
support this. 
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5.  Conclusion 
 
A stable dry powder vaccine for mass vaccination of poultry against Newcastle disease was 
developed by means of a one-step spray drying process. The addition of PVP and/or BSA to 
trehalose formulations revealed several advantages in solid-state and particle characteristics. 
When formulating the vaccine in these excipients, the combination of trehalose with BSA (both in 
the binary trehalose-BSA combination or in the ternary trehalose-PVP-BSA combination) was 
beneficial for the maintenance of vaccine titres during 10 months storage at 6 and 25°C. 
Although mannitol crystallized during spray drying and did not have a good process stability, it 
was able to stabilize the vaccine virus particles during storage at 6°C. Combining the latter with 
its low hygroscopicity, mannitol might overcome the disadvantage of loss of titre during 
production. This will be investigated by evaluating the immune response after vaccinating 
chickens with the different formulations. 
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Landman”. Manuscript in preparation.
Picture: Dispersion of dry powder vaccine in isolator
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1.  Introduction 
 
In this study, preliminary proof-of-principle experiments with dry powder Newcastle disease (ND) 
vaccines, developed in Chapter 5, for primary (> 20 µm) and secondary vaccination (< 5 µm for   
2-week-old and < 10 µm for 4-week-old chickens) (optimal particle size determined in Chapter 3) 
were performed. In vitro experiments were carried out to evaluate the dispersion of the powders 
in air, with particular attention to the particle size and virus concentration. Subsequently, the dry 
powder formulations were administered to broiler chickens to evaluate the elicited immune 
response. As a reference, a commercial freeze-dried vaccine, nebulized as a reconstituted liquid 
spray or aerosol, was included in the in vitro and in vivo part of the study.  
 
 
2.  Materials and methods 
 
2.1.  Spray drying of vaccines 
 
To prepare a coarse powder for primary vaccination, an experimental spray dryer with a 30 µm 
piezo-actuated nozzle, kindly provided by Niro A/S (Soeborg, Denmark), was used (further referred 
to as Monodisperse Spray Dryer, MSD). A commercial Mobile Minor D-2000 pilot plant dryer with 
a two-fluid nozzle (Niro A/S, Soeborg, Denmark) was used to produce fine powders intended for 
secondary vaccination. 
 
Two different formulations were produced with each spray dryer. For the first formulation, a feed 
solution with 3% (w/w) trehalose dihydrate (C*Ascend 16400; kindly provided by Cerestar, 
Mechelen, Belgium), 1% (w/w) polyvinylpyrrolidone (PVP) (Kollidon®30; BASF, Ludwigshaven, 
Germany), and 1% (w/w) bovine serum albumin (BSA) (Sigma-Aldrich, Steinheim, Germany) was 
prepared in distilled water. For the second formulation, mannitol (C*Mannidex 16700; Cerestar, 
Mechelen, Belgium) was dissolved in distilled water at a concentration of 5% (w/w). Two batches  
of each formulation were prepared with each dryer: a first batch for the in vitro experiments, and 
a second batch for the in vivo experiments. In the trehalose-PVP-BSA feed, 107 50% Egg 
Infectious Doses (EID50) Clone 30 vaccine virus (attenuated strain of the ND virus, developed by 
Intervet International; Boxmeer, the Netherlands; harvested from the allantoic fluid of specified-
pathogen-free (SPF) embryonated eggs), was added per ml feed solution, which resulted in a 
maximal titre of 108.3 EID50 per gram spray-dried powder. For the mannitol feed solutions, the 
added virus dose was increased to 109 EID50 per ml, resulting in a maximal titre of 1010.3 EID50 
per gram spray-dried powder. 
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Spray drying with the MSD was performed at an inlet temperature of 90°C. Together with a feed 
rate of 30 ml/h and a drying gas flow rate of 25 kg/h this resulted in an outlet temperature of 
70°C. The piezo-actuator applied a droplet generation frequency of 50 kHz on the feed solution 
when passing through the nozzle. 
 
A 1 mm two-fluid nozzle with an atomizing air pressure of 2 bar was used in the Mobile Minor. The 
drying gas rate was 80 kg/h and the inlet temperature was set at 160°C. The feed rate was 
adjusted to ± 25 ml/min, resulting in the same outlet temperature as with the MSD (70°C). After 
production, all powders were stored in sealed aluminium bags at 6°C (± 1 week). 
 
 
2.2.  Particle/droplet size distribution of the dispersed/nebulized vaccines 
 
The particle size distribution of the dispersed powder vaccines was determined by laser 
diffraction (Mastersizer-S long bed; Malvern Instruments, Malvern, UK). An experimental device 
for powder dispersion described in Chapter 5 (Figure 5.1) was used to disperse the powders with 
dried air into the particle sizing equipment. 
 
For the application of the liquid vaccine suspension, two different nebulizers were characterized: 
a Walther Pilot I spray-head with 0.5 mm nozzle (decribed in Chapter 2, Figure 2.2.A) and a hand-
held spray bottle (described in Chapter 4, Figure 4.1). The generated droplet size distributions 
were measured by nebulizing demineralised water through the laser beam of the Mastersizer 
(open bench configuration) with the nozzle opening at 4 cm distance from the laser beam. The 
Walther Pilot I spray-head was connected to an air compressor (Mecha Concorde type 7SAX, 
1001, SACIM, Verona, Italy) which was set at an air pressure of 2 bar. The spray rate was              
5 ml/min. The hand-held spray bottle was manually actuated with a spray rate of approximately 
50 ml/min (65 actuations per min).  
 
All measurements were performed in triplicate and the environmental conditions during 
dispersion/nebulization were 20°C and 31% relative humidity (RH). 
 
 
2.3.  Titration of the vaccines 
 
At the day of the experiments, an aliquot of the powders was used to determine the vaccine titre. 
The powder was dissolved in distilled water and 0.2 ml of tenfold dilutions (10-3 – 10-8) prepared 
in Hanks Balanced Salt Solution (HBSS; Gibco®, Invitrogen, Paisley, UK) with 0.3 mg NaHCO3 
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(Invitrogen, Paisley, UK), 3800 IE sodium benzyl penicillin (Eurovet Animal Health, Bladel, the 
Netherlands), 4 mg streptomycin (Alfasan Diergeneesmiddelen BV, Utrecht, the Netherlands) and 
2 µl fungizone (Bristol-Myers Squibb, Princeton, New Jersey, USA) per ml HBSS was inoculated in 
five 9-day-old SPF eggs per dilution. A haemaggutination assay (HA) was performed to quantify 
the vaccine titre after 7 days incubation and the formula of Reed and Muench (1938) was used 
to calculate the exact titre. 
 
Additionally, a commercial Clone 30 vaccine (Nobilis ND Clone 30, 1000 doses, Intervet 
International, Boxmeer, the Netherlands) was dissolved in 2 ml (in vitro experiments) or in 5 ml  
(in vivo experiments) of distilled water. An aliquot of each suspension was used to prepare a 
tenfold dilution series (10-3 – 10-8) for determining the vaccine titre as described for the dry 
powder vaccines. 
 
 
2.4.  In vitro dispersion/nebulization of the vaccines 
 
The in vitro experiments were performed in an empty isolator (Beyer & Eggelaar, Utrecht,           
the Netherlands) with a volume of 1.31 m³ (1.40 m long, 0.75 m wide and 1.25 m high). The 
ventilation of the isolator was switched off during the experimental period, but was switched on 
during 30 min after each experiment to remove remaining vaccine. The ventilation capacity was 
approximately 40 m³/h and the ventilation efficiency was evaluated by air sampling after each 
ventilation period, as described further. 
 
Four different vaccines were evaluated: a coarse trehalose-PVP-BSA vaccine (produced on MSD), 
a fine trehalose-PVP-BSA vaccine (produced on Mobile Minor), a coarse liquid spray vaccine 
(generated by the hand-held spray bottle), and a fine liquid aerosol vaccine (generated by the 
Walther Pilot I spray-head). The dry powder vaccines were dispersed during 10 min and the 
dispersed powder mass was determined via the weight loss of the powder dispersion device. 
Liquid vaccines were prepared by reconstituting the Clone 30 freeze-dried pellet (containing 
minimal 109 EID50 vaccine virus) in 2 ml distilled water. Subsequently, distilled water was added 
to 1280 µl of the reconstituted vaccine until a total volume of 200 ml (resulting in a minimal titre 
of 106.5 EID50 per ml). With the Walther Pilot I spray-head, 50 ml of this final dilution was 
nebulized within 10 min. The same volume was nebulized with the hand-held spray bottle via 65 
actuations performed within 1 min. 
 
In all cases, care was taken to disperse/nebulize the vaccines equally throughout the isolator. 
Each type of vaccine was evaluated twice. Temperature and RH were measured at regular points 
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in time during the experimental periods with a humidity logger (Testostor 171-2; Testo, Ternat, 
Belgium). 
 
 
2.5.  Exposure of chickens to dispersed/nebulized vaccines 
 
The vaccination of 4-week-old SPF broiler chickens was performed in isolators (Beyer & Eggelaar, 
Utrecht, the Netherlands) with a volume of 1.34 m³ (1.94 m long, 0.73 m wide and 0.95 m high). 
A group of approximately 20 chickens was exposed to each vaccine, while a group of 10 chickens 
served as non-vaccinated blank control group. Six different vaccine formulations were applied: 
coarse trehalose-PVP-BSA (n = 20), coarse mannitol (n = 19), coarse liquid spray (n = 20), fine 
trehalose-PVP-BSA (n = 18), fine mannitol (n = 20), and fine liquid aerosol (n = 19). 
 
The powder vaccines were dispersed with the experimental powder dispersion device during        
1 min, with exception of the fine mannitol powder which was dispersed during 10 min. The 
dispersed powder mass was determined via the weight loss of the powder dispersion device. 
 
The coarse liquid vaccine was generated with the hand-held spray bottle. The nebulized liquid was 
prepared by reconstitution of a Clone 30 freeze-dried pellet in 5 ml distilled water and 60 µl of 
this suspension was diluted to a total volume of 20 ml (resulting in a minimal virus titre of 105.8 
EID50 per ml). Ten ml of this dilution was nebulized over a period of 30 s (13 actuations).  
 
The Walther Pilot I spray-head was used to nebulize a fine liquid aerosol over the chickens. Here, 
distilled water was added to 30 µl of the reconstituted vaccine until a total volume of 5 ml, which 
was nebulized within 1 min (spray rate 5 ml/min). 
 
Ventilation was switched off at the start of vaccine dispersion/nebulization for a period of 1 h. 
Temperature and RH were monitored every 20 s with the humidity logger. 
  
Birds were housed, handled and treated following approval by the Animal Experimental 
Committee of the Animal Health Service in Deventer, the Netherland, in accordance with the 
Dutch regulations on experimental animals. 
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2.6.  Air sampling 
 
Air sampling was performed with a Sartorius MD8 airscan sampling device (Sartorius, 
Nieuwegein, the Netherlands) as described previously (Landman et al., 2004; Landman & van 
Eck, 2001). Sterile gelatine filters of 3 µm pore size and 80 mm diameter (type 17528-80-ACD; 
Sartorius, Nieuwegein, the Netherlands) were used and samples were taken during 2 min at 
2000 L/h (i.e. sampling of 67 L air). The filter device was held at a height of 15 cm (i.e. at the 
level of the head of a 4-week-old chicken) during the complete sampling period. 
 
During the in vitro experiments, air sampling was performed midcourse the 10 min 
dispersion/nebulization period, immediately, 10 and 20 min after the end of the 
dispersion/nebulization period. No samples were taken during the nebulization period when using 
the hand-held spray bottle. During the in vivo experiments, air samples were taken immediately 
and 20 min after ending the dispersion/nebulization period. Filters were removed from the air 
sampling device and stored for a maximal period of 24 h in sterile recipients at 4°C until further 
processing. 
 
 
2.7.  Assessment of the Newcastle disease vaccine virus concentration in the air 
 
The gelatine filters were carefully removed from their plastic holders and placed in Petri dishes. 
Ten ml of the same solution as used for the virus titration, added at a temperature of 37°C, was 
used to dissolve the filters. After 15 min, the filter solution was transferred to sterile test tubes, 
which were stored at minus 70°C until virus titrations were performed as described above 
(dilution series 100–10-6). The obtained virus titres, expressed per ml filter solution, were 
converted to virus doses per m³ isolator air, taking the volume in which the filters were dissolved 
(10 ml) and the sampled air volume (67 L) into account. The detection limit per m³ air in the 
isolators was 102.6 EID50, as calculated from the detection limit of the titration (100.4 EID50 per 
ml). The obtained virus doses per m³ air in the isolator at the different sampling moments were 
used to calculate the loss of virus from the air with time in comparison to the dispersed/nebulized 
concentrations. 
 
 
2.8.  Evaluation of the humoral immune response in serum 
 
The humoral immune response was evaluated by determining the haemagglutination inhibition 
(HI) antibodies (formed in response to the haemagglutinin antigen of the ND virus) in the serum of 
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the broilers, taken at 2 and 4 weeks after vaccination. As control, serum samples taken before 
vaccination and serum samples originating from the non-vaccinated control group were used. All 
samples were analysed in one run. The HI assay was performed in a microtitre system with 
twofold diluted sera and 8 haemagglutinating units (HAU) from the Ulster strain of the ND virus. 
The HI titre was determined from the highest dilution of serum causing complete inhibition of 
haemagglutination of the 8 HAU added to the wells and was expressed as the log2 values of the 
reciprocal of the endpoint dilution. Titres were considered positive when higher than 3 (de Jong, 
1978). 
 
 
2.9.  Statistical analysis 
 
The serum antibody titres in the different groups were compared statistically by a multivariate 
repeated-measures ANOVA design (SPSS version 12.0; SPSS, Chicago, Illinois, USA). The time of 
serum sampling (i.e. 2 or 4 weeks post-vaccination) was the within-subject factor and the vaccine 
type was the between-subject factor. The normality of the data was evaluated with the 
Kolmogorov-Smirnov test, while the homogeneity of variances was checked with the Levene’s test 
and the data were transformed if necessary. Additionally, the Box’s test of Equality of Covariance 
Matrices was used to evaluate the homogeneity of covariance matrices. A Bonferroni correction 
was used for post hoc investigation of the effects. 
 
 
3.  Results 
 
3.1.  Particle/droplet size distribution of the dispersed/nebulized vaccines 
 
Table 6.1 shows the size distribution parameters D[v,0.1], D[v,0.5], D[v,0.9], and span (calculated 
as (D[v,0.9]-D[v,0.1])/D[v,0.5]) after dispersion and nebulization of the dry powder and liquid 
vaccines, respectively. The volume distribution was used and the cumulative particle and droplet 
size distributions are shown in Figure 6.1. 
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Table 6.1. Average particle/droplet size distribution parameters (± SD) (n = 3) of dispersed powder and nebulized 
liquid vaccines  
 
Vaccine type   D[v,0.1] (µm) D[v,0.5] (µm) D[v,0.9] (µm) Span 
Coarse trehalose-PVP-BSA  20.9 ± 2.6 28.7 ± 0.7 37.2 ± 1.7   0.6 ± 0.1 
Coarse mannitol  22.8 ± 0.3 29.3 ± 1.0 43.2 ± 3.7   0.7 ± 0.1 
Coarse liquid spray  65.5 ± 2.5 222.2 ± 12.3 509.6 ± 30.0   2.0 ± 0.1 
Fine trehalose-PVP-BSA    2.7 ± 0.1   7.2 ± 0.3 367.4 ± 66.6 50.5 ± 7.3 
Fine mannitol    2.7 ± 0.3   8.7 ± 2.0 628.1 ± 39.1    74.4 ± 14.7 
Fine liquid aerosol    6.5 ± 0.3 24.4 ± 0.1 49.6 ± 1.6    1.8 ± 0.1 
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Figure 6.1. Average cumulative particle/droplet size distribution (n = 3) of dispersed powder and nebulized liquid 
vaccines. 
 
 
The coarse powders showed a narrow distribution (span < 1) around a median particle size of 
approximately 30 µm. Only 4.5 and 1.0% of the volume consisted of particles smaller than 10 µm 
for trehalose-PVP-BSA and mannitol, respectively. The coarse liquid spray, generated by the hand-
held spray bottle, contained droplets that were mainly larger than 50 µm. Only 20% of the 
droplets was smaller than 100 µm, as described in Chapter 4. 
 
The size distribution patterns of fine trehalose-PVP-BSA and mannitol powders were similar, but in 
contrast to the coarse powders the distributions were broad: 66 and 64% of the particles were 
smaller than 10 µm for trehalose-PVP-BSA and mannitol, respectively, whereas a considerable 
portion of the particles were not de-agglomerated during dispersion (the 100 - 900 µm fraction 
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contributed 17 and 20% of the dispersed volume of trehalose-PVP-BSA and mannitol, 
respectively). The droplet size distribution generated by the Walther Pilot I spray-head (fine liquid 
aerosol) contained 17% droplets below 10 µm and only 3% droplets in the 100 - 900 µm fraction. 
 
 
3.2. Temperature and relative humidity in the isolators   
 
The average temperature in the isolator during the in vitro experiments was 27.1°C (SD, 0.7°C). 
RH data during the experiments are shown in Figure 6.2. During all powder dispersion 
experiments, RH in the isolator was constant with an average value of 65.5% (SD, 4.7%). 
However, when nebulizing both types of liquid vaccines, RH increased to about 100% within 5 min 
and remained on this level throughout the complete experimental period. 
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Figure 6.2. Relative humidity measured in the isolator at regular points in time during and after the nebulization of 
different vaccine formulations (in vitro experiments). The red line is representative of all powder dispersion 
experiments. The same pattern was found in both experiments performed per liquid nebulization method. 
 
 
The average temperature during the in vivo experiments was 28.7°C (SD, 0.7°C). RH data during 
the experimental periods are shown in Figure 6.3. The presence of chickens resulted in an 
increase of RH in all experiments. There was a continuous and steady increase of RH during 
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dispersion of the powder vaccines, reaching saturation within 10 min after the start of the 
dispersion period. RH also increased during nebulization of the liquid vaccines. However, after 
nebulization of the coarse liquid spray, 100% RH was reached within a few minutes after starting 
nebulization, while saturation was only reached after 20 min with the fine liquid aerosol.  
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Figure 6.3. Relative humidity in isolators measured at regular points in time during the exposure of 4-week-old broilers 
to different vaccine formulations (in vivo experiments). 
 
 
 
3.3.  Evaluation of the dispersed/nebulized vaccine concentration 
 
The dispersed/nebulized dose of the different Clone 30 vaccine formulations per m³ of air in the 
isolators was calculated from the dispersed mass or nebulized volume and the virus content per 
unit (g or ml) of powder or liquid vaccine, respectively. The dispersed/nebulized virus 
concentration in the in vitro (n = 2) and in vivo (n = 1) dispersion/nebulization periods are shown 
in Table 6.2. 
 
During the in vitro experiments, similar concentrations were dispersed for both powder 
formulations (approximately 108 EID50 per m³ air), whereas a higher concentration (approximately 
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1 log10 EID50 per m³) was nebulized for both liquid formulations. Titration of the control filters, i.e. 
the air samples taken after the 30 min ventilation period, resulted in values below the detection 
limit of the titration procedure. The dispersed/nebulized concentrations were approximately 107 
EID50 per m³ air during the in vivo experiments, except with coarse trehalose-PVP-BSA and coarse 
mannitol where approximately 108 and 105 EID50 per m³, respectively, was dispersed. 
 
 
Table 6.2. Dispersed/nebulized virus concentration of the different vaccine formulations in the in vitro experiments               
(average, n = 2) and in vivo experiments (n = 1) 
 
Vaccine type  Total dispersed mass or 
nebulized volume per 
isolator                  
(g or ml)a
Virus concentration in 
vaccine formulation 
(log10 EID50/g or ml)b
Dispersed/nebulized 
virus concentration 
(log10 EID50/m³ air in 
isolatorc) 
In vitro experiments     
Coarse trehalose-PVP-BSA  10.3 7.4 8.3 
Coarse liquid spray  50.0 7.5 9.1 
Fine trehalose-PVP-BSA  8.8 7.3 8.1 
Fine liquid aerosol  50.0 7.5 9.1 
In vivo experiments     
Coarse trehalose-PVP-BSA  5.9 7.3 7.9 
Coarse mannitol  0.9 5.5 5.3 
Coarse liquid spray  10.0 6.5 7.4 
Fine trehalose-PVP-BSA  0.4 7.1 6.6 
Fine mannitol  11.3 5.7 6.6 
Fine liquid aerosol  5.0 6.8 7.4 
 
a Dispersed amount of vaccine expressed in g for the powder vaccines and in ml for the liquid vaccines 
b Per g for the powder vaccines and per ml for the liquid vaccines 
c Volume of isolator is 1.31 m³ during in vitro experiments and 1.34 m³ during in vivo experiments. 
 
 
 
3.4.  Loss of vaccine concentration in the air with time 
 
The average (n = 2) vaccine virus concentration in the air during the in vitro experiments per type 
of vaccine and the detected virus concentration during the in vivo experiments are shown in     
Table 6.3. The loss of vaccine virus concentration in the air with time, calculated by subtracting 
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the sampled virus concentration from the dispersed/nebulized concentration, is depicted in 
Figure 6.4 and Figure 6.5 for the in vitro and in vivo experiments, respectively. As some of the air 
samples of the in vivo experiments (liquid spray and aerosol at both sampling moments, coarse 
trehalose-PVP-BSA and mannitol 20 min after dispersion) did not contain sufficient virus to reach 
the detection limit of 102.6 EID50 per m³, the losses indicated for these samples in Figure 6.5 
should be considered as minimum values. 
 
In both experimental series, an increasing loss of concentration with time was seen for the 
powder vaccines and the coarse liquid vaccines. However, between 10 and 20 min after the end 
of the dispersion, the vaccine concentration did not decrease further during the in vitro 
experiments. In general, the concentration loss of coarse vaccines from the air was considerably 
larger than that of their fine counterparts. The virus concentration in the air after in vitro 
nebulization of the fine liquid aerosol did not decrease with time; however, during the in vivo 
experiments losses were higher and comparable to the coarse liquid spray. 
 
 
Table 6.3. Vaccine virus concentration in the air obtained after air sampling with gelatine filters at different points in 
time during the in vitro experiments (average, n = 2) and in vivo experiments (n = 1) 
 
Vaccine type 
 
Virus concentration in the air at different points in time                         
(log10 EID50/m³ air in isolator) 
  
During 
dispersion/ 
nebulization 
Immediately after 
dispersion/ 
nebulization 
10 min after 
dispersion/ 
nebulization 
20 min after 
dispersion/ 
nebulization 
In vitro experiments      
Coarse trehalose-PVP-BSA  6.5 5.0 3.5 3.6 
Coarse liquid spray  - 5.4 3.9 4.0 
Fine trehalose-PVP-BSA  7.5 6.1 5.2 5.2 
Fine liquid aerosol  6.7 6.8 6.8 6.4 
In vivo experiments      
Coarse trehalose-PVP-BSA  - 4.2 - < 2.5 
Coarse mannitol  - 3.7 - < 2.9 
Coarse liquid spray  - < 2.4 - < 2.4 
Fine trehalose-PVP-BSA  - 6.1 - 3.5 
Fine mannitol  - 5.2 - 4.1 
Fine liquid aerosol  - < 2.4 - < 2.7 
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Figure 6.4. Average (n = 2) loss of vaccine virus concentration from the air after dispersion/nebulization of different 
vaccine formulations in an empty isolator (in vitro experiments), obtained by subtracting the sampled concentration at 
different points in time from the dispersed/nebulized virus concentration. 
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Figure 6.5. Loss of vaccine virus concentration from the air during exposure of 4-week-old broilers to different vaccine 
formulations (in vivo experiments), obtained by subtracting the sampled concentration at different points in time from 
the dispersed/nebulized virus concentration. 
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3.5.  Humoral immune response after exposure of chickens to the different vaccines 
 
The average humoral immune response per type of vaccine is shown in Figure 6.6. Statistical 
analysis showed a significant increase of HI titres from 2 to 4 weeks post-vaccination for each 
vaccine formulation. 
  
When comparing the immune response elicited by the different vaccines at 2 weeks post-
vaccination, the coarse mannitol powder induced a significantly lower immune response in 
comparison with the other vaccines. The individual results only showed positive antibody titres in 
2 out of 19 chickens (with HI titres of 23 and 24). On the other hand, the fine trehalose-PVP-BSA 
powder elicited the highest average HI titre, which was significantly higher than the HI titres 
obtained with the other vaccines, with exception of the fine liquid aerosol.  
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Figure 6.6. Average Newcastle disease virus antibody titres in serum at 2 and 4 weeks after exposure of 4-week-old 
broilers (n = ± 20) to different vaccine formulations as determined by a haemagglutination inhibition assay. The error 
bars represent the standard deviations. 
 
 
At 4 weeks after vaccination, the different vaccines reached similar HI titres (ranging from 26.0 to 
27.3). The antibody titre induced by the coarse mannitol powder was significantly lower than with 
the fine vaccine formulations, but no further significant differences were detected when 
comparing the immune response elicited by the different vaccines.  
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Serum samples from all chickens before vaccination and all serum samples from non-vaccinated 
birds did not show HI antibodies. No undesired post-vaccination reactions were seen in the 
vaccinated chickens. 
 
 
4.  Discussion 
 
In general, the loss of dispersed/nebulized virus doses in the air depends on particle size 
distribution, particle density, and RH in the isolators, as confirmed in the present studies. During 
the in vitro experiments with the dry powders, the loss of virus concentration from the air seemed 
largely influenced by sedimentation, with faster sedimentation of the coarse formulation. 
However, between 10 and 20 min after dispersion, no further losses were detected, even for the 
coarse vaccine, suggesting that only very small particles were present in the air at that time. This 
was confirmed as follows: according to Stokes’ law (valid for particles < 40 µm (Brain et al., 
1985)) 5 µm particles with a density of 1.4 g/cm³ (as determined in Chapter 5) sediment 65 cm 
per 10 min. As the dispersion device was held at approximately 30 cm above the level of the filter 
device, it can be assumed that only particles smaller than 5 µm remain airborne until 10 min 
after the end of the dispersion period. According to the cumulative size distributions (Figure 6.1), 
a volume of 31 and 2% is smaller than 5 µm for fine and coarse trehalose-PVP-BSA, respectively. 
The maximal virus concentration in the air at 10 min after the end of the dispersion period can 
subsequently be calculated from the virus concentration immediately after the dispersion period: 
31% of 106.1 EID50 per m³ (i.e. 105.6 EID50 per m³) for fine trehalose-PVP-BSA, and 2% of          
105.0 EID50 per m³ (i.e. 103.3 EID50 per m³) for coarse trehalose-PVP-BSA. These theoretical values 
were close to the detected virus concentrations at 10 min after the end of the dispersion period 
as 105.2 and 103.5 EID50 was detected per m³ air for fine and coarse trehalose-PVP-BSA, 
respectively. 
 
These findings underline the importance of avoiding the presence of small particles in a coarse 
vaccine formulation intended for primary respiratory vaccination, as they can remain airborne 
long enough to allow inhalation. The risk of too strong post-vaccination reactions is high whenever 
a primary vaccine is deposited in the lower airways, especially in case other pathogens affecting 
the respiratory tract (e.g. Mycoplasma) are present in the birds (Guittet et al., 1997; van Eck & 
Goren, 1991). 
 
During nebulization of the fine liquid aerosol vaccine, the loss of virus concentration from the air 
will also be influenced by evaporation of the droplets (Gough & Allan, 1973; Landman & van Eck, 
2001; Yadin & Orthel, 1978). However, during the in vitro experiments, humidity saturation 
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occured during the first 5 min of the nebulization, making complete evaporation of 50 ml 
nebulized liquid impossible. In contrast, during vaccinations in the field humidity saturation does 
not occur, enabling complete evaporation of aerosol droplets (Gough & Allan, 1973; Yadin & 
Orthel, 1978). Therefore, in order to mimic the field situation, smaller volumes were nebulized 
during the in vivo experiments. The air in the isolators can contain approximately 40 g water at 
28.7°C (average temperature measured at start of the in vivo experiments) before saturation 
occurs, as derived from the Mollier diagram. At the start of the nebulization of the fine liquid 
vaccine, RH was 55%, so that the air contained 22 g of water at the time. Subsequently, an 
additional 5 ml of water, nebulized with the Walther Pilot I spray-head would evaporate 
completely. RH indeed remained below 100% during the experimental period, but it was 
remarkable that RH increased slower when nebulizing the liquid aerosol vaccine than when 
dispersing powder vaccines. However, this particular isolator was heated to approximately 33°C 
prior to gradual cooling to the experimental temperature, whereas this did not occur in the 
remaining isolators. This could have resulted in a drier isolator interior compared to the others.  
 
As expected, the evaporation of the fine aerosol droplets during the in vivo experiments resulted 
in a large reduction of virus concentration in the air: immediately after nebulization, the 
concentration was below detection limit, representing a loss larger than 5 log10 EID50 per m³ air. 
Previously, the inactivation of a La Sota ND vaccine after complete evaporation at 30°C was also 
estimated to be larger than 5 log10 EID50 (van Eck, 1990). 
 
The obtained antibody response after exposure of 4-week-old broilers to the different vaccines is 
in the range of what is generally obtained after a single vaccination with a live lentogenic ND 
vaccine (HI titres of 24 to 26 (Alexander, 1991)). The HI titres reached 27 with all fine vaccine 
formulations, indicating that also with dry powders very good humoral immune responses can be 
obtained. Similarly, high titres were obtained after a single vaccination of 3-week-old chickens 
with a freeze-dried micronized La Sota vaccine (dispersion of 108.1 EID50 per m³) (Gaudry et al., 
1976). 
 
Coarse and fine formulations were included in the study to differentiate the immune response 
originating from a vaccine deposited in the upper and lower airways, respectively. Although not 
significant, the antibody titres obtained with fine formulations deposited in the lower airways were 
faster induced and slightly higher compared to the antibody titres obtained with coarse 
formulations deposited in the upper airways. This is expected due to a higher concentration of 
immune cells in the lower respiratory tract compared to the upper airways (van Eck, 1990) and a 
higher immune response following vaccination with smaller particles has been shown previously 
(Gough & Allan, 1973). Non-hygroscopic mannitol formulations were included, despite the lower 
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suitability of the carrier to stabilize the ND virus during spray drying (Chapter 5), as preliminary 
experiments with trehalose-PVP-BSA showed difficulties for dispersion at 75% RH due to the high 
hygroscopicity of the powder. Hygroscopic growth of such particles in the trachea (RH values up to 
95 and 99% RH suggested for humans) (Morrow, 1986) could therefore reduce the ability of fine 
trehalose-PVP-BSA particles to reach the lower airways. However, no differences could be 
detected between the immune response induced by hygroscopic and non-hygroscopic fine 
formulations.  
 
The results obtained with the different coarse formulations illustrate the importance of directly 
targeting the birds during primary vaccination. In practice, it has been recommended to spray as 
close as possible to the birds in order to increase the probability of immediate deposition of 
droplets on the eyes (immune response via the Harderian glands) or the feathers of the birds 
(immune response via the gastro-intestinal tract after oral uptake of the vaccine) (Cargill, 1999; 
Jorna, 1999). The lower immune response at 2 weeks post-vaccination obtained with coarse 
mannitol compared to coarse trehalose-PVP-BSA is therefore related to the dispersed 
concentration and not to the concentration detected in the air immediately after the dispersion 
period. Whereas the latter concentrations were similar (103.7 and 104.2 EID50 per m³ air for 
mannitol and trehalose-PVP-BSA, respectively), the dispersed concentration was approximately 
2.5 log10 EID50 lower for mannitol. Similarly, the concentration after nebulization of the coarse 
liquid spray was below detection limit, but the nebulized virus concentration was high. 
 
In contrast, the efficiency of fine aerosol vaccines depends on the virus dose available for 
inhalation from the air. Despite the extensive inactivation of virus during the evaporation of 
droplets, antibody titres were still high after vaccination with a fine liquid aerosol. Obviously, the 
size reduction of droplets associated with evaporation allowed a deeper penetration in the 
airways and therefore a higher immune response (Gough & Allan, 1973). Taking the droplet 
volume and the dry matter content (220 mg per flacon commercial Clone 30 vaccine, (van Eck & 
Goren, 1991)) of the nebulized virus suspension in consideration, droplets of 24 µm (D[v,0.5]) or 
50 µm (D[v,0.9]) evaporated to dry particles of 1.6 and 3.3 µm, respectively. It was previously 
shown that 34 and 24% of 1 and 3 µm polystyrene microspheres, respectively, are able to reach 
the lungs of 4-week-old chickens, whereas only 10% of 5 µm spheres was detected in the lungs 
(Chapter 3). Therefore, the smaller size and lower deposition site of the dried particles of an 
evaporated nebulized liquid aerosol might have compensated for the lower virus concentration in 
the air. 
 
The good immune response when exposing chickens to the low virus concentration in the air 
obtained with the fine liquid aerosol suggests that the dispersed dose of sufficiently fine powder 
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vaccines can be reduced, as inactivation during and after dispersion is unlikely. The formulation 
of vaccines as dry powders would then offer more possibilities for the aerosol application of 
vaccines with lower virus titres. For example, vaccines against infectious bronchitis (IB) contain at 
least 103 EID50 per dose while an ND vaccine contains at least 106 EID50 per dose (BCFI, Belgisch 
Centrum voor Farmacotherapeutische Informatie) (2006). However, both vaccines require a 
minimal dose of 102 to 103 EID50 in the lower airways (van Eck, 1990) for a good immune 
response. Therefore, the extensive inactivation during evaporation of a liquid aerosol implies a 
higher risk for an inefficient IB vaccination as the margin between dose concentration and 
minimal effective dose is smaller. Subsequently, it has been recommended to apply vaccines with 
low virus titres only by spray or by individual vaccination methods (van Eck, 1990). The possibility 
of dose reduction with powder vaccines needs to be investigated by performing dose-response 
studies. In this respect, it is important to optimize the experimental powder dispersion device to 
allow dispersion of predetermined vaccine doses, as the powder output was currently less 
reproducible due to the large influence of powder flowability (e.g. high for coarse trehalose-PVP-
BSA, where the output was almost 15 times higher than with the cohesive fine trehalose-PVP-BSA 
particles).  
 
 
5.  Conclusion 
 
This preliminary study showed the induction of a good immune response after vaccination with 
powder vaccines. For coarse powder vaccines, the obtained particle size should be further 
optimized with respect to the presence of particles in the small size range, to further reduce the 
risk of strong post-vaccination reactions. Furthermore, the powder dispersion device should be 
optimized to obtain a constant output in order to enable the dispersion of predetermined vaccine 
concentrations. Dose-response experiments should then show if the required vaccine virus dose 
can be reduced by using powder vaccines instead of liquid vaccines, as the current data suggest. 
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GENERAL CONCLUSION 
AND FUTURE PERSPECTIVES

General conclusion and future perspectives 
Spray and aerosol vaccination are common techniques for mass vaccination of poultry. A coarse 
spray, targeted to the upper airways, is used when exposing chickens for the first time to a 
vaccine (primary vaccination), while a fine aerosol, targeted to the lower airways is used for 
subsequent re-vaccinations (secondary vaccinations). However, several problems, such as broad 
droplet size distributions and inactivation of vaccine virus after generation of the droplets, are 
connected with nebulizing liquid vaccines. This reduces the efficiency of the technique and the 
here presented research was performed to solve these issues by formulating a readily dispersible 
dry powder vaccine via spray drying.  
 
In a first step, the optimal particle size for targeting the upper or the lower respiratory tract was 
determined in a deposition study where unanaesthetized chickens of 1 day old, 2 weeks old and 
4 weeks old were exposed to fluorescent microspheres. The study showed that for a primary 
vaccination of 2-week-old chickens the particles should be larger than 5 µm, whereas primary 
vaccination immediately after hatching, should be performed with particles larger than 20 µm due 
to mouth breathing of 1-day-old chickens. For secondary vaccinations, where the lower airways 
are targeted, the vaccine particles should be smaller than 5 and 10 µm for 2-week-old and 4-
week-old chickens, respectively. When comparing these optimal particle sizes with the droplet 
sizes measured in liquid sprays and aerosols originating from commercial nebulizers, it was 
confirmed that these droplet sizes were sub-optimal. 
 
In a second part of the study, a dry powder vaccine was developed by spray drying, which allowed 
the production of powders with narrow size distributions where the optimal particle sizes for 
targeting the upper and lower respiratory tract were approached. Additionally, it was found that 
excipients that are commonly used for the preservation of protein activity in powder formulations 
are also able to maintain the infectivity of a live vaccine virus during spray drying. The vaccination 
of chickens with these powder vaccines induced high levels of antibodies in the blood of the 
chickens, providing proof of principle of the dry powder vaccination concept.  
 
This project was a first step towards a new method of performing poultry vaccinations. However, 
future research is needed to confirm the full value of dry powder vaccines. In a first step it will be 
necessary to further optimize the storage stability of the vaccine virus in the powder formulations 
by screening different excipient compositions. Additional work should be performed to optimize 
the obtained particle sizes and particle size distributions. More in detail, it will be necessary to 
develop a primary vaccine without particles smaller than 20 µm, whereas for an efficient 
secondary vaccination of 2-week-old chickens the median particle size needs to be reduced below 
5 µm to allow high deposition in the lower airways. 
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Next to optimizing the formulation, performing additional in vivo experiments will also be 
necessary. As suggested during the last phase of this research project, it might be possible to 
decrease the dispersed dose of vaccine virus when using powder vaccines. To confirm this, dose-
response studies in chickens should be performed. This implies that the powder dispersion 
device should be replaced by an apparatus that allows the dispersion of separate particles in 
predetermined doses. One option to obtain this can be found in painting industry where powder 
dispersion guns are used for powder coating with fine paint particles. Furthermore, in vivo 
experiments should be performed to evaluate if undesired post-vaccination reactions after 
primary vaccinations are reduced using these dry powders. This is currently one of the problems 
associated with coarse spray vaccination, especially when chickens have underlying respiratory 
diseases, and is caused by a fraction of small droplets present in the generated spray clouds.  
 
In summary, the current results indicate that mass application of vaccines as dispersible dry 
powders might be more efficient compared to liquid spray and aerosol vaccination, but further 
optimization of the formulation and additional in vivo experiments are needed to confirm the 
value of this new vaccination strategy. 
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Summary 
As discussed in Chapter 1, veterinary vaccines should be pure, potent, safe, 
efficacious, and cheap. Especially in low-profit sectors such as poultry industry, 
cost and efficacy are very important. Although a number of new approaches for 
vaccination have emerged from the interplay between vaccinology, immunology 
and biotechnology, the classical live attenuated and inactivated vaccines still represent the 
primary choice for veterinary vaccination as the production and administration of the new 
vaccines is often expensive. In poultry industry, the possibility of mass application via the mucosal 
surfaces represents an additional advantage of live attenuated vaccines. Although good results 
are obtained with currently applied mass spray and aerosol vaccination (nebulization of 
reconstituted vaccines), there is room for improvement. This thesis presents a method to 
increase the efficiency and safety of classical live attenuated vaccines by reformulation of the 
vaccines as dispersible dry powders. 
 
Firstly, the optimal particle size for targeting the different parts of the 
respiratory system had to be determined. Therefore, Chapter 2 focused on the 
development and optimization of a method for the nebulization of differently 
sized fluorescently labelled polystyrene microspheres and the detection of 
these microspheres in the respiratory system of chickens. A first part concerned the optimization 
of the aerosol administration method: the influence of different nebulizers and nebulizing 
protocols on the relative humidity in the exposure chamber, the particle size distributions, the 
microsphere output and the single microsphere percentage were determined. In a second part, a 
sample processing procedure was optimized for recovery of microspheres from suspensions and 
extraction of fluorochromes from the microspheres. Finally, the method was applied in preliminary 
in vivo experiments with adult layer fowl. In the optimized method, microspheres (1 µm combined 
with 3 µm spheres, 5 µm combined with 10 µm spheres; 20 µm spheres separately) were 
nebulized with a Walther Pilot I spray-head with 0.5 mm nozzle diameter. The spray-head was 
placed in an inlet hole at 50 cm above the bottom of the exposure chamber (25 x 25 x 65 cm) 
and the suspensions were nebulized with a nebulizing air pressure of 0.5 bar, a spray rate of  
1.25 ml/min, and nebulization periods of 10 s with intervals of 110 s in between. This resulted in 
the generation of dry microspheres and minimal agglomeration of microspheres. The optimized 
and repeatable sample processing procedure implied filtration of tissue samples (digested in 
KOH) with glass fibre filters by vacuum pressure (40 kPa), rinsing of the filters with 20 ml water 
and 20 ml phosphate buffer (pH 7.4), and extraction of fluorochomes with 6 ml 2-ethoxyethyl 
acetate during 2 h. The intensity of the extracted fluorochromes was measured with a 
fluorescence spectrophotometer and correlated with the number of microspheres present in the 
sample. The preliminary in vivo experiments proved the applicability of the developed method. 
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The method developed in Chapter 2 was in Chapter 3 applied for the 
evaluation of deposition patterns of differently sized microspheres after 
inhalation by unanaesthetized broiler chickens of increasing ages (1 day old,   
2 weeks old, 4 weeks old). Respiratory and gastro-intestinal tract tissue 
samples were collected and the number of fluorescent microspheres per sample was determined. 
In 2-week-old and 4-week-old chickens, microspheres of 5 and 10 µm, respectively, were too 
large for deposition in the lungs and air sacs as less than 5% of these microspheres penetrated 
into the lower airways. The larger size of microspheres reaching the lower airways of 4-week-old 
chickens was explained by increasing airway dimensions with age. For 1-day-old chickens, 
deposition in the lungs decreased from 17 to 3% with increasing microsphere size (1 to 20 µm), 
but increased in the air sacs from 6 to 20%. The total deposition percentage in the lower airways 
of 1-day-old chickens was independent of microsphere size and even 20 µm spheres were able to 
penetrate into the lower airways. This was attributed to mouth breathing of the 1-day-old 
chickens. 
 
In Chapter 4, the particle deposition patterns in chickens were used to 
estimate the effectiveness of currently applied spray and aerosol vaccination 
equipment. The droplet size distributions generated by a hand-held spray 
bottle (for spray vaccination) and an Atomist and Spray Fan (both for aerosol 
vaccination) were measured by laser diffraction and related to the optimal particle sizes for 
targeting of upper and lower respiratory airways, i.e. the desired deposition sites for spray and 
aerosol vaccination, respectively. Additionally, the influence of shear (created when transforming 
a liquid into droplets) on the infectivity of a live enveloped virus (Porcine Respiratory Corona Virus, 
PRCV) was evaluated with a small scale spray-head. The broad droplet size distribution generated 
by the hand-held spray bottle showed that reduced efficiency of spray vaccination partly 
originates from a large fraction of fast sedimenting droplets that do not reach the chickens. 
However, the deposition of 20 µm polystyrene microspheres in the lower airways of 1-day-old 
chickens and the considerable fraction of droplets in this size range represent the major concern 
with this sprayer as inhalation of droplets into the lower airways during primary vaccination 
implies a high risk of strong post-vaccination reactions. For secondary aerosol vaccinations, it is 
necessary to take evaporation during sedimentation of small droplets into account. Therefore, the 
measured droplet sizes of Atomist and Spray Fan were converted to the particle size of dried 
particles. For 2-week-old chickens, where inhalable particles are smaller than 5 µm, only 20 and 
11% of droplets generated by Atomist and Spray Fan, respectively, resulted in dry particles 
inhalable into the lower airways. For 4-week-old chickens, that can inhale particles smaller than 
10 µm, these percentages increased to 60 and 65%, but still a substantial fraction of particles is 
too large to be inhaled in the lower airways, thereby decreasing the efficiency of liquid aerosol 
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vaccinations. The nebulization of PRCV did not indicate a negative influence of shear on the 
infectivity of an enveloped virus.  
 
The development of a dispersible dry powder vaccine in a one-step spray drying 
process is described in Chapter 5. A live attenuated Newcastle disease (ND) 
vaccine virus (Clone 30, harvested from embryonated eggs) was spray dried 
with potential stabilizers (mannitol, trehalose, or trehalose combined with 
polyvinylpyrrolidone (PVP) and/or bovine serum albumin (BSA)) using an experimental spray dryer 
with 30 µm piezo-actuated nozzle. Thermodynamic properties, water sorption, dispersion 
properties, density and morphology of the powders were evaluated. Virus infectivity in feed 
solutions and corresponding powders was determined by titration in embryonated eggs and 
subsequent haemagglutination assay. Titrations were also performed to evaluate the stability of 
vaccine virus after 1, 5 and 10 months storage at 6 and 25°C. Solid-state characterization 
showed that spray-dried mannitol was non-hygroscopic and crystalline, whereas the other 
powders were hygroscopic and amorphous. The median particle size ranged between 24 and    
29 µm and the distribution was narrow after air-assisted dispersion of the powders. Combined 
with a density of 1.4 to 1.5 g/ml, these powders are suitable for primary respiratory vaccination of 
1-day-old chickens (targeting of the upper airways). The mannitol vaccine formulation showed the 
largest reduction of infectivity during spray drying (4 log10 50% Egg Infectious Doses or EID50), 
while trehalose-PVP-BSA fully protected the virus. However, during storage at 6°C, the virus 
concentration in mannitol remained stable. Addition of BSA was beneficial for storage of 
amorphous powders: in trehalose-BSA and trehalose-PVP-BSA the virus concentration decreased 
only 2 and 3 log10 EID50 per gram powder after 10 months storage at 6 and 25°C, respectively, 
whereas these losses increased to 3 and 5 log10 EID50 per gram powder when trehalose and 
trehalose-PVP vaccines were stored at 6 and 25°C, respectively. Overall, powder vaccines with 
good dispersion characteristics and virus stabilization capacity during spray drying and storage 
were obtained. 
 
In Chapter 6, the dispersion of dry powder vaccines was compared with the 
nebulization of commercial liquid vaccines, in in vitro experiments as well as in 
in vivo experiments. Here, the Clone 30 ND virus was added to a 5% (w/w) 
mannitol or trehalose-PVP-BSA (3:1:1) solution and spray dried on the 
experimental spray dryer or on a Mobile Minor spray dryer. Additionally, a commercial freeze-dried 
Clone 30 vaccine was reconstituted in distilled water for application as a coarse liquid spray or 
fine liquid aerosol. Laser diffraction was used to determine the sizes of dispersed/nebulized 
particles/droplets and the virus concentrations in the air were determined by air sampling on 
gelatine filters and subsequent titration of the dissolved filters in embryonated eggs. The in vivo 
- 175 - 
Summary 
experiments were performed with 4-week-old broilers housed in isolators (18 to 20 birds per 
vaccine type) and the humoral immune response (haemagglutination inhibition (HI) antibodies) in 
serum was determined at 2 and 4 weeks post-vaccination. The spray dryers produced powders 
with median size of 28 µm (experimental dryer) and 7 µm (Mobile Minor), suitable for targeting 
upper and lower airways of 4-week-old broilers, respectively. The median droplet size of nebulized 
coarse and fine liquid vaccines was 222 and 24 µm, respectively. The virus concentration in the 
air decreased fast for the coarse vaccines due to sedimentation and for the liquid fine aerosol 
vaccine due to inactivation during evaporation of droplets. The coarse vaccines induced high 
average HI titres of 25 and 27 at 2 and 4 weeks post-vaccination, respectively, except for coarse 
mannitol where only after 4 weeks an average HI titre of 25 was detected. This was related to the 
lower dispersed concentration. The fine powder vaccines induced higher average HI titres and did 
this faster as titres were already between 26 and 27 at 2 weeks post-vaccination, which is 
explained by a deeper penetration of these fine particles in the respiratory system. Although 
hygroscopic growth was expected to reduce the deposition of the hygroscopic trehalose-PVP-BSA 
particles in the lower airways, the detected antibody titres were not different from those elicited 
by the non-hygroscopic mannitol vaccine. The fine liquid aerosol induced similar antibody levels 
as the fine powders, despite inactivation of virus during evaporation of the droplets. This 
suggested that powder formulations, where this inactivation does not occur, might allow a 
significant reduction of vaccine dose.  
 
These preliminary in vivo results showed the induction of a good immune response after 
vaccination with dry powders. Future research should optimize the particle size distribution of the 
spray-dried powders, especially when the vaccines are intended for secondary vaccination at the 
age of 2 weeks where particles should be smaller than 5 µm. Additionally, the possibility of dose 
reduction with the powder vaccines should be investigated. Furthermore, it will be important to 
investigate if the frequent occurrence of strong post-vaccination reactions after primary liquid 
spray vaccination (caused by a considerable fraction of small inhalable droplets) can be avoided 
with narrow sized dry powder vaccines. In conclusion, the current results indicate that the 
dispersion of respiratory vaccines as a dry powder might indeed be a more safe and efficient 
alternative compared to liquid spray and aerosol vaccination, but further research is needed to 
optimize this vaccination strategy.  
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Samenvatting 
Zoals besproken in Hoofdstuk 1 moeten veterinaire vaccins zuiver, veilig, 
doeltreffend en goedkoop zijn. Vooral in sectoren met lage winstmarges zoals 
pluimveeteelt zijn de laatste twee aspecten van groot belang. Hoewel een 
aantal nieuwe mogelijkheden voor vaccinatie zijn ontstaan uit de interactie 
tussen vaccinologie, immunologie en biotechnologie, vormen de levend geattenueerde en 
geïnactiveerde vaccins nog steeds de eerste keuze voor veterinaire vaccins aangezien de 
productie en toediening van de nieuwe vaccins vaak duur is. In de pluimveeteelt heeft het gebruik 
van levend geattenueerde vaccins als bijkomende voordeel dat massa-toediening via de mucosa 
mogelijk is. Hoewel goede resultaten worden bekomen met de huidige massa-vaccinatie via spray 
en aërosol (verneveling van een gereconstitueerd vaccin) is er nog ruimte voor verbetering. Dit 
proefschrift introduceert een methode waarbij de efficiëntie en veiligheid van klassieke levend 
geattenueerde vaccins kan worden verbeterd door herformulatie van de vaccins als verstuifbare 
droge poeders. 
 
In eerste instantie moest de optimale deeltjesgrootte voor een doelgerichte 
afzetting van deeltjes in verschillende delen van het ademhalingsstelsel 
worden bepaald. Daarom werd in Hoofdstuk 2 een methode ontwikkeld en 
geoptimaliseerd voor de verneveling van fluorescent gemerkte polystyreen 
microsferen van verschillende groottes en voor de detectie van deze microsferen in het 
ademhalingsstelsel van kippen. Een eerste deel bestond uit de optimalisatie van een methode 
voor toediening van de aërosol waarbij de invloed van verschillende vernevelaars en 
vernevelingsprotocols op de relatieve vochtigheid in de blootstellingskamer, de 
deeltjesgroottedistributie, de hoeveelheid vernevelde microsferen en het percentage niet 
geagglomereerde microsferen werd bepaald. In een tweede deel werd een methode voor analyse 
van de stalen geoptimaliseerd met aandacht voor de recuperatie van de microsferen uit de stalen 
en de extractie van de fluorescente merkers uit de microsferen. Uiteindelijk werd de methode 
aangewend in preliminaire in vivo experimenten met volwassen legkippen. In de geoptimaliseerde 
methode werden de microsferen (1 µm gecombineerd met 3 µm sferen, 5 µm gecombineerd met 
10 µm sferen; 20 µm sferen afzonderlijk) verneveld met een Walther Pilot I sproeikop waarvan de 
diameter van de spuitopening 0,5 mm bedroeg. De sproeikop werd in een opening geplaatst op 
50 cm boven de bodem van de blootstellingskamer (25 x 25 x 65 cm) en de suspensies werden 
verneveld met een vernevelingsdruk van 0,5 bar, een debiet van 1,25 ml/min, en 
vernevelingsperiodes van 10 s met intervallen van 110 s. Dit resulteerde in droge microsferen en 
een minimale agglomeratie van de microsferen. In de geoptimaliseerde en herhaalbare 
procedure voor analyse van de stalen werden weefselstalen (opgelost in 4N KOH) gefiltreerd over 
glasvezelfilters bij een vacuumdruk van 40 kPa, werden de filters gespoeld met 20 ml water en 
20 ml fosfaatbuffer (pH 7,4), en werden de fluorescente merkers geëxtraheerd met 6 ml              
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2-ethoxyethylacetaat gedurende 2 u. De intensiteit van de geëxtraheerde fluorescente merkers 
werd gemeten met een fluorescentie-spectrofotometer en gecorreleerd met het aantal 
microsferen aanwezig in het staal. De preliminaire in vivo experimenten bewezen de 
toepasbaarheid van de ontwikkelde methode. 
 
De methode ontwikkeld in Hoofdstuk 2 werd in Hoofdstuk 3 gebruikt voor de 
evaluatie van het depositiepatroon van microsferen van verschillende groottes 
na inhalatie door niet-verdoofde vleeskuikens van verschillende leeftijden      
(1 dag, 2 weken en 4 weken oud). Het aantal fluorescente microsferen in 
weefselstalen van het ademhalingsstelsel en het spijsverteringsstelsel werd bepaald. In 2 weken 
en 4 weken oude kippen waren respectievelijk 5 en 10 µm sferen te groot voor depositie in de 
longen en luchtzakken aangezien minder dan 5% van deze microsferen kon doordringen tot de 
diepe luchtwegen. De grotere microsferen die de diepe luchtwegen van 4 weken oude kippen 
bereikten, waren het gevolg van de grotere diameter van de luchtwegen in functie van de leeftijd. 
Voor de 1-dags kuikens daalde de depositie in de longen van 17 tot 3% voor grotere microsferen 
(1 tot 20 µm), maar de depositie in de luchtzakken nam toe van 6 tot 20%. Daardoor was de 
totale depositie in de diepe luchtwegen onafhankelijk van de deeltjesgrootte, en zelfs 20 µm 
deeltjes waren in staat om door te dringen tot de diepe luchtwegen. Dit werd toegeschreven aan 
de bekademhaling van 1-dags kuikens. 
 
In Hoofdstuk 4 werden de depositiepatronen in de kippen gebruikt om de 
effectiviteit van de momenteel aangewende spray- en aërosolvaccinatie 
apparatuur in te schatten. De druppelgroottedistributies geproduceerd door 
een manuele vernevelaar (toegepast voor sprayvaccinatie) en een Atomist en 
Spray Fan (beide voor aërosolvaccinatie) werden gemeten met laserdiffractie en gerelateerd aan 
de optimale deeltjesgroottes vereist voor depositie in de voorste en diepere luchtwegen (i.e. de 
doelwitten bij respectievelijk spray- en aërosolvaccinatie. Bovendien werd de invloed van 
wrijvingskrachten (die ontstaan als een vloeistof in druppels wordt verdeeld) op de infectiviteit 
van een levend omhuld virus (Porcine Respiratoir Coronavirus, PRCV) geëvalueerd. De brede 
druppelgroottedistributie geproduceerd met de manuele vernevelaar toonde aan dat bij 
sprayvaccinatie de efficiëntie daalt door een grote fractie van snel sedimenterende druppels die 
niet in staat zijn om de kippen te bereiken. Aangezien 20 µm deeltjes de diepe luchtwegen van   
1-dags kuikens kunnen bereiken, betekent de aanzienlijke fractie van druppels < 20 µm dat er 
een groot risico op sterke post-vaccinale reacties is indien deze manuele vernevelaar wordt 
toegepast voor primaire vaccinatie. Voor secundaire aërosolvaccinaties is het nodig om de 
verdamping van druppels tijdens sedimentatie van de kleine druppels in rekening te brengen. 
Daarom werden de gemeten druppelgroottes van Atomist en Spray Fan omgerekend tot de 
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corresponderende deeltjesgroottes van ingedroogde partikels. Bij 2 weken oude kippen (waar 
deeltjes kleiner dan 5 µm inhaleerbaar zijn) kon slechts 20 en 11% van de druppels 
geproduceerd door respectievelijk Atomist en Spray Fan na indrogen ingeademd worden tot in de 
diepe luchtwegen. Bij 4 weken oude kippen (die deeltjes kleiner dan 10 µm kunnen inademen) 
namen deze percentages toe tot 60 en 65%, maar nog steeds bleek een behoorlijke fractie van 
de druppels na indroging te groot om door te dringen tot de diepe luchtwegen, wat de efficiëntie 
van vloeibare aërosolvaccinaties reduceert. De verneveling van PRCV toonde geen negatieve 
invloed van wrijvingskrachten op de infectiviteit van een omhuld virus aan. 
 
De ontwikkeling van een verstuifbaar droog poedervaccin in een éénstaps 
sproeidroog proces is beschreven in Hoofdstuk 5. Een levend geattenueerd 
Newcastle disease (NCD, pseudovogelpest) vaccinvirus (Clone 30, verkregen na 
kweek in bebroede eieren) werd gesproeidroogd met mogelijke stabiliserende 
stoffen (mannitol, trehalose, of trehalose gecombineerd met polyvinylpyrrolidone (PVP) en/of 
bovine serum albumine (BSA)) in een experimentele sproeidroger met 30 µm piëzo-aangedreven 
spuitkop. De thermodynamische eigenschappen, wateropname, verstuivingseigenschappen, 
dichtheid en morfologie van de poeders werden geëvalueerd. De infectiviteit van het virus in de te 
sproeidrogen oplossingen en de resulterende poeders werd bepaald door titratie in bebroede 
eieren en een daaropvolgende haemagglutinatie test. Titraties werden ook uitgevoerd om de 
stabiliteit van het vaccinvirus tijdens 1, 5 en 10 maanden bewaring bij 6 en 25°C te evalueren. 
De vaste stof karakterisatie toonde aan dat gesproeidroogd mannitol niet-hygroscopisch en 
kristallijn was, terwijl de andere poeders hygroscopisch en amorf waren. De mediane 
deeltjegrootte varieerde van 24 tot 29 µm en de distributie was nauw na verstuiving van de 
poeders. Gecombineerd met een densiteit van 1,4 tot 1,5 g/ml zijn deze poeders geschikt voor 
primaire respiratoire vaccinatie van 1-dags kuikens (vaccin gericht naar voorste luchtwegen). De 
vaccinformulatie met mannitol vertoonde het grootste verlies van infectiviteit tijdens het 
sproeidroogproces (4 log10 50% Ei-Infecterende Dosis of EID50), terwijl trehalose-PVP-BSA het 
virus volledig beschermde. Evenwel bleef de virusconcentratie in mannitol stabiel tijdens 
bewaring bij 6°C. De toevoeging van BSA was gunstig voor de bewaring van de amorfe poeders: 
in trehalose-BSA en trehalose-PVP-BSA daalde de virusconcentratie slechts 2 en 3 log10 EID50 per 
gram poeder na 10 maanden bewaring bij respectievelijk 6 en 25°C, terwijl deze verliezen 
toenamen tot 3 en 5 log10 EID50 per gram poeder bij bewaring van de trehalose en trehalose-PVP 
vaccins bij respectievelijk 6 en 25°C. In het algemeen werden poedervaccins bekomen met 
goede verstuivingseigenschappen en aanvaardbare stabilisatiecapaciteit voor het virus tijdens 
sproeidrogen en bewaring. 
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In Hoofdstuk 6 werd de verstuiving van droge poedervaccins vergeleken met de 
verneveling van commerciële vloeibare vaccins, zowel tijdens in vitro als tijdens 
in vivo experimenten. Het Clone 30 NCD vaccin werd toegevoegd aan een 5% 
(g/g) mannitol en trehalose-PVP-BSA (3:1:1) oplossing en gesproeidroogd in de 
experimentele sproeidroger of in een Mobile Minor sproeidroger. Bovendien werd een 
commercieel gevriesdroogd Clone 30 vaccin gereconstitueerd in gedestilleerd water voor 
toediening als grove spray of fijne aërosol. Laserdiffractie werd gebruikt om de deeltjes- of 
druppelgroottes te meten en de virusconcentraties in de lucht werden bepaald via 
luchtbemonstering met gelatinefilters en daaropvolgende titratie van de opgeloste filters in 
bebroede eieren. Voor de in vivo experimenten werden 4 weken oude vleeskuikens gebruikt die in 
isolatoren werden gehuisvest (18 tot 20 kippen per vaccin type) en de humorale immuunrespons 
(haemagglutinatie remmende (HAR) antilichamen) in het bloed werd 2 en 4 weken na vaccinatie 
bepaald. De sproeidrogers produceerden poeders met een mediane deeltjesgrootte van 28 µm 
(experimentele droger) en 7 µm (Mobile Minor), zodat deze geschikt zijn voor depositie in 
respectievelijk de voorste en diepe luchtwegen. De mediane druppelgrootte van de vernevelde 
grove en fijne vloeibare vaccins was respectievelijk 222 en 24 µm. De virusconcentratie in de 
lucht daalde snel bij de grove applicaties door sedimentatie en bij de fijne vloeibare aërosol door 
inactivatie tijdens verdamping van de druppels. De grove applicaties resulteerden in hoge 
gemiddelde HAR titers van 25 en 27 respectievelijk 2 en 4 weken na vaccinatie, behalve voor het 
grove mannitol vaccin waar pas na 4 weken een gemiddelde HAR titer van 25 werd gedetecteerd. 
De fijne poedervaccins induceerden nog hogere HAR titers en bereikten deze waarden sneller 
(titers na 2 weken: 26 en 27). Dit werd verklaard doordat deze fijne deeltjes dieper doordrongen in 
het ademhalingsstelsel. Hoewel verwacht werd dat hygroscopische groei de depositie van 
hygroscopische trehalose-PVP-BSA deeltjes in de diepe luchtwegen zou reduceren, waren de 
antilichaamtiters niet verschillend van de door het niet-hygroscopische mannitol vaccin 
geïnduceerde titers. Het fijne vloeibare aërosolvaccin induceerde gelijkaardige antilichaamtiters 
als de fijne poeders, ondanks de inactivatie van virus gedurende indampen van de druppels. Dit 
suggereert dat poederformulaties (waar deze inactivatie niet optreedt) een significante reductie 
van de toegediende virusdosis toelaten. 
 
Deze preliminaire in vivo resultaten tonen aan dat een goede immuunrespons kan worden bereikt 
na vaccinatie met droge poeders. Verder onderzoek moet de deeltjesgroottedistributie van de 
gesproeidroogde poeders optimaliseren, zeker indien de vaccins moeten worden aangewend voor 
secundaire vaccinatie op een leeftijd van 2 weken aangezien in dat geval de deeltjes kleiner dan 
5 µm moeten zijn. Bovendien moet de mogelijkheid tot dosisreductie met de droge poedervaccins 
verder onderzocht worden. Daarenboven is het ook belangrijk om na te gaan of het frequent 
optreden van sterke post-vaccinale reacties bij primaire vaccinatie met vloeibare spray (door de 
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aanwezigheid van een aanzienlijke fractie van kleine inhaleerbare druppels) kan worden 
verhinderd door gebruik te maken van een droog poeder met nauwe deeltjesgroottedistributie. In 
conclusie geven de huidige resultaten aan dat de verstuiving van respiratoire vaccins als droog 
poeder inderdaad een efficiënt alternatief kan zijn voor de vloeibare spray- en aërosolvaccinatie, 
maar verder onderzoek is vereist om deze nieuwe vaccinatietechniek te optimaliseren. 
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Dankwoord 
Zo, het verhaal van 4,5 jaar onderzoek is opgeschreven. Maar in dat verhaal figureren een aantal 
mensen (in hoofd- en bijrollen) die ik hierbij van harte wil bedanken. Aangezien ik nog wat in de 
‘roes’ van het KISS-principe zit (Keep It Short and Simple) volgt nu een tabellarisch overzicht 
(‘Simple’) van iedereen die op een of andere manier heeft bijgedragen aan dit proefschrift. Of het 
‘Short’ wordt, valt nog te bezien… 
 
Prof. Vervaet Chris, heel erg bedankt voor alles wat ik van je mocht leren en voor de  
“all-round” begeleiding: 
• De talloze besprekingen van kleine praktische problemen, die een vrij 
hoge frequentie kenden tijdens het opzetten van de depositiestudie. Al 
leken die problemen toen soms erg groot (‘ik hou mijn hart vast als jij 
hier binnenkomt’), gezien dit proefschrift geschreven is, kunnen we 
ervan uitgaan dat de meeste zijn opgelost en nu dus als klein kunnen 
aanzien worden.  
• De leerrijke discussies over resultaten, toestellen, opstellingen, 
achterliggende theorie… 
• Het nalezen van manuscripten en proefschrift, de taalkundige 
suggesties en de commentaren (nogal vaak: ‘niet zo uitgebreid’, ‘hou 
het kort’, maar ook wel eens ‘pure veterinaire poëzie’). 
• Uitleg allerhande. 
• Etcetera, etcetera (om het kort te houden…). 
  
Prof. Remon Professor, bedankt om me over dit onderzoek te vertellen. Zo’n 6 jaar 
geleden kwam ik eigenlijk informeren over onderzoek doen in Utrecht. Maar 
naast een antwoord op mijn vraag, gaf u in 1 adem ook nog een korte 
toelichting over uw projecten, waaronder iets over nasale vaccinatie van 
varkens. Het onderwerp en het interdisciplinaire sprak me heel erg aan en 
ik besloot om toch in Gent te blijven. Intussen ging het wel over droge 
poeder vaccinatie van kippen, maar dat maakte het er niet minder 
interessant op, integendeel (al was het alleen maar dat kippen toch iets 
beter handelbaar zijn dan varkens). Verder van harte bedankt voor 
begeleiding bij onderzoek en schrijven, creativiteit, ondersteuning, en voor 
de kansen tot presenteren van dit werk op en bijwonen van 
wetenschappelijke manifestaties in binnen- en buitenland, wat telkens heel 
erg verrijkend was. 
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Dr. Jo van Eck Jo, je praktische ingesteldheid, je plezier in onderzoek (‘spelen’), je 
bewonderenswaardige kennis van dit en zovele andere onderwerpen 
werkten inspirerend. En ook heel erg bemoedigend, want vaak dacht ik in de 
auto tussen Utrecht en Gent ‘oef, we gaan weer verder, zo erg vallen die 
resultaten dus toch niet tegen’. 
  
Dr. Wil Landman Wil, tijdens de dagen achter computer om samen de verschillende 
manuscripten ‘mooi’ te maken, heb ik waarschijnlijk meer geleerd dan 
tijdens de cursus ‘Academic English’. Het was uitputtend en misschien zelfs 
gevaarlijk om daarna nog van Utrecht naar Gent te rijden (om 21u met 
enkel wat koekjes en een gedeelde appel in de maag), maar die dagen 
behoren tot de goede herinneringen aan dit project. Voor de experimenten 
in Beekbergen en in Deventer (waar ik op een of andere manier een instant-
test had gevonden ter bevestiging van de werkzaamheid van de 
poedervaccins) geldt hetzelfde. 
  
Mieke Matthijs Mieke, zonder jou zou die ganse depositiestudie volgens mij niet tot een 
goed einde gebracht zijn. Het gepriegel met de 1-dags-kuikens leek me echt 
onbegonnen werk. De dagen in de stal in Lemberge werden leuker door jou 
komst naar België (zelfs soms op verlofdagen), de leuke babbels, de 
ontspannen werksfeer en je enthousiasme voor een project dat eigenlijk 
niet eens het jouwe was. 
  
Daniël Tensy Daniël, bedankt voor alle hulp tijdens de eerste experimenten met kippen 
en voor je betrokkenheid en meeleven toen die telkens weer geen resultaat 
opleverden. Zelfs toen het voorbij was met de kippen bleef je geïnteresseerd 
in het reilen en zeilen van mijn project en je aanwezigheid tijdens late 
uurtjes in het lab was vaak erg geruststellend. 
  
Prof. Baeyens 
Thomas De Beer 
Prof. Baeyens, bedankt voor het uitlenen van de fluorescentie-
spectrofotometer. De depositiestudie werd plots makkelijker en efficiënter 
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